CHE staff publications

Staff in CHE publish frequently, including contributing to journals, books and commissioned reports. Recent publications are listed by year.

Archived: 2006 -2010

2019

2019

  • Alexander H, Patton T, Jabbar-Lopez Z, Manca A, Flohr C. Novel systemic therapies in atopic dermatitis: What do we need to fulfil the promise of a treatment revolution? F1000Research 2019;8(F1000 Faculty Rev):132. Download from F1000
  • Alvarado M, Unwin N, Sharp SJ, Hambleton I, Murphy MM, Samuels TA, Suhrcke M, Adams J. Assessing the impact of the Barbados sugar-sweetened beverage tax on beverage sales: an observational study. International Journal of Behavioral Nutrition and Physical Activity 2019;16(1):13. Download from BMC  
  • Aragon MJ, Castelli A, Chalkley MJ, Gaughan JM. Can productivity growth measures identify best performing hospitals? Evidence from the English NHS. Health Economics 2019;28(3):364-372. Download from Wiley  
  • Armitage C, Conner M, Grogan S, West R, Simms-Ellis R, Scholtens K, Sykes-Muskett B, Cowap L, Lawton R, Meads D, Schmitt L, Togerson C, Siddiqi, K. Effectiveness and cost-effectiveness of repeated implementation intention formation plus anti-smoking messages on adolescent smoking initiation: A cluster randomized controlled trial. Journal of Consulting and Clinical Psychology 2019;doi:10.1037/ccp0000387. Download from APA    
  • Arnold M, Griffin S, Ochalek J, Revill P, Walker S. A one stop shop for cost-effectiveness evidence? Recommendations for improving Disease Control Priorities. Cost Effectiveness and Resource Allocation 2019;17:7. Download from BMC
  • Atella V, Belotti F, Bojke C, Castelli A, Grašič K, et al. How health policy shapes healthcare sector productivity? Evidence from Italy and UK. Health Policy 2019;123(1):27-36. Download from ScienceDirect
  • Barbosa E, Cookson R. Multiple inequity in health care: An example from Brazil. Social Science & Medicine 2019 May;228:1-8. Download from ScienceDirect       
  • Bawa S, McNab C, Nkwogu L, Braka F, Obinya E, Galway M, Mirelman A, et al. Using the polio programme to deliver primary health care in Nigeria: Implementation research. Bulletin of the World Health Organization 2019;97:24-32. Download from WHO
  • Bórquez A, Guanira JV, Revill P, Caballero P, Silva-Santisteban A, Kelly S et al. The impact and cost-effectiveness of combined HIV prevention scenarios among transgender women sex-workers in Lima, Peru: a mathematical modelling study. The Lancet Public Health 2019;4(3):e127-e136. Download from The Lancet
  • Cambiano V, Johnson C, Hatzold K, Terris-Prestholt F, Haheswaran H, Thirumurthy H, Figueroa C, Cowan F, Sibanda E, Ncube G, Revill P et al. The impact and cost-effectiveness of community-based HIV self-testing in sub-Saharan Africa. A health economic and modelling analysis. Journal of the International Aids Society 2019;22(S1):e25243. Download from Wiley
  • Chetter I, Oswald A, McGinnis E, Stubbs N, Arundel C, Buckley H, Bell K, Dumville J, Cullum N, Soares MSaramago P. Patients with surgical wounds healing by secondary intention: A prospective, cohort study. International Journal of Nursing Studies 2019;89:62-71. Download from ScienceDirect
  • Claxton K, Asaria M, Chansa C, Jamison J, Lomas J, Ochalek J, Paulden M. Accounting for timing when assessing health-related policies. Journal of Benefit-Cost Analysis 2019;10(S1):73-105. Download from Cambridge UP
  • Cox E, Wade R, Peron M, Dietz KC, Eastwood A, Palmer S, Griffin S. The clinical and cost-effectiveness of Inotuzumab Ozogamicin for the treatment of adult relapsed or refractory B-cell acute lymphoblastic Leukaemia: An evidence review group evaluation of a NICE single technology appraisal. PharmacoEconomics 2019;doi:10.1007/s40273-019-00779-4. Download from Springer   
  • Deidda M, Geue C, Kreif N, Dundas R, McIntosh E. A framework for conducting economic evaluations alongside natural experiments. Social Science & Medicine 2019;220:353-361. Download from ScienceDirect
  • Drummond MF, Towse A. Is rate of return pricing a useful approach when value-based pricing is not appropriate? European Journal of Health Economics 2019;doi:10.1007/s10198-019-01032-7. Download from Springer   
  • Franklin M, Lomas J, Walker S, Young T. An educational review about using cost data for the purpose of cost-effectiveness analysis. PharmacoEconomics 2019:doi:10.1007/s40273-019-00771-y. Download from Springer
  • Gridley K, Aspinal F, Parker G, Weatherly H, Faria R, Longo F, van den Berg B. Specialist nursing support for unpaid carers of people with dementia: a mixed-methods feasibility study. Health Serv Deliv Res 2019;7(12). Download from NIHR   
  • Griffin S, Love-Koh J, Pennington B, Owen L. Evaluation of intervention impact on health inequality for resource allocation. Medical Decision Making 2019;doi:10.1177/0272989X19829726. Download from Sage
  • Gutacker N, Bloor KE, Bojke C, Archer J, Walshe K. Does regulation increase the rate at which doctors leave practice? Analysis of routine hospital data in the English NHS following the introduction of medical revalidation. BMC Medicine 2019;17:33. Download from BMC
  • Gutacker N, Street A. Calls for routine collection of patient-reported outcome measures (PROMs) are getting louder. Journal of Health Services Research & Policy 2019;24(1):1-2. Download from Sage
  • Jones A, Laporte A, Zucchelli E, Rice N. Dynamic panel data estimation of an integrated Grossman and Becker-Murphy model of health and addiction. Empirical Economics 2019;56(2):703-733. Download from Springer
  • Kanavos P, Angelis A, Drummond M. An EU-wide approach to HTA: An irrelevant development or an opportunity not to be missed? European Journal of Health Economics 2019;20(3):329-332. Download from Springer
  • Kristensen FB, Husereau D, Huic M, Drummond MF, Berger M, Bond K et al. Identifying the need for good practices in Health Technology Assessment: summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA. Value in Health 2019;22(1):13-20. Download from Value in Health
  • Liu D, Green E, Kasteridis P, Goddard M, Jacobs R, Wittenberg R, Mason A. Incentive schemes to increase dementia diagnoses in primary care in England: a retrospective cohort study of unintended consequences. British Journal of General Practice 2019;69 (680):e154-e163. Download from BJGP
  • Longo F, Siciliani L, Moscelli G, Gravelle H. Does hospital competition improve efficiency? The effect of the patient choice reform in England. Health Economics 2019;doi.10.1002/hec.3868. Download from Wiley
  • Longo F, Siciliani L, Street AD. Are costs differences between specialist and general hospitals compensated by the prospective payment system? European Journal of Health Economics 2019;20(1):7-26. Download from Springer
  • Mengqi Qin V, Hone T, Millett C, Moreno Serra RA, McPake B, Atun R, Tayu Lee J. The impact of user charges on health outcomes in low- and middle- income countries: a systematic review. BMJ Global Health 2019;3:e001087. Download from BMJ
  • Mirelman A, Trujillo A, Niessen L, Ahmed S, Khan J, Peters D. Household coping strategies after an adult non-communicable disease death in Bangladesh. International Journal of Health Planning and Management 2019;34(1):e203-e218. Download from Wiley
  • Moscelli G, Jacobs RGutacker N, Aragon MJMChalkley MJMason A, Bohnke J. Prospective payment systems and discretionary coding - Evidence from English mental health providers. Health Economics 2019;28(3):387-402. Download from Wiley
  • Phillips A, Venter F, Havlir D, Pozniak A, Kuritzkes D, Wensing A, Lundgren J, De Luca A, Pillay D, Mellors J, Cambiano V, Bansi-Matharu L, Nakagawa F, Kalua T, Jahn A, Apollo T, Mugurungi O, Clayden P, Gupta R, Barnabas R, Revill P, Cohn J, Bertagnolio S, Calmy A. Risks and benefits for use of dolutegravir-based antiretroviral drug regimens in sub Saharan Africa: a modelling study. The Lancet HIV 2019;6(2):e116-e127. Download from Sciencedirect
  • Regan J, Frison E, Collin F, Dawes P, Hann M, Himmelsbach I, Hooper E, Reeves D, Simkin Z, Thodi C, Yang F, Leroi I for the SENSE-Cog Trial Development Team. Individualised sensory intervention to improve quality of life in people with dementia and their companions (SENSE-Cog trial): study protocol for a randomised controlled trial. Trials 2019;20(80):1-15. Download from BMC
  • Saramago P, Espinoza MA, Sutton AJ, Manca A, Claxton K. The value of further research: The added value of individual-participant level data. Applied Health Economics and Health Policy 2019;doi:10.1007/s40258-019-00462-x. Download from Springer
  • Selinger C, Bershteyn A, Dimitrov DT, Adamson BJS, Revill P, Hallett T et al. Targeting and vaccine durability are key for population-level impact and cost-effectiveness of a pox-protein HIV vaccine regimen in South Africa. Vaccine 2019;37(16):2258-2267. Download from ScienceDirect
  • Taraldsen K, Mikolaizak AS, Maier A, Boulton E, Aminian K, Ancum J, Bandinelli S, Becker C, Bergquist R, Chiari L, Clemson L, French D, Gannon B, Hawley-Hague H, Jonkman N, Mellone S, Paraschiv-Ionescu A, Pijnappels M, Schwenk M, Todd C, Yang F et al. Protocol for the PreventIT feasibility randomised controlled trial of a lifestyle-integrated exercise intervention in young older adults. BMJ Open 2019;9(3);e023526. Download from BMJ
  • Toffolutti V, Suhrcke M.  Does austerity really kill? Economics & Human Biology 2019;33:211-223. Download from Elsevier
  • Vermeulen F, Gerbens L, Bosma A, Apfelbacher C, Irvine A, Arents B, Barbarot S, Deleuran M, Eichenfield L, Manca A et al on behalf of the international TREAT Registry Taskforce. TREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on how and when to measure the core data set for atopic eczema research registries. British Journal of Dermatology 2019;doi:10.1111/bjd.17715. Download from Wiley
  • Wade R, Grosso A, South E, Rothery CSaramago PSchmitt L, Wright K, Palmer S. Brodalumab for the treatment of moderate to severe plaque psoriasis: an Evidence Review Group evaluation of a NICE Single Technology Appraisal. Pharmacoeconomics 2019;37(2):131-139. Download from Springer
  • Weir S, Tzu-Chun K, Samnaliev M, Tierney T, Manca A et al. Reoperation following lumbar spinal surgery: costs and outcomes in a UK population cohort study using the Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES). European Spine Journal 2019;doi:10.1007/s00586-018-05871-5. Download from Springer
  • Yang F, Devlin N, Luo N. Cost-utility analysis using EQ-5D-5L data: does how the utilities are derived matter? Value in Health 2019;22(1):45-49. Download from ScienceDirect
  • Yang F, Devlin N, Luo N. Impact of mapped EQ-5D utilities on cost effectiveness analysis: in the case of dialysis treatments. European Journal of Health Economics 2019;20(1):99-105. Download from Springer
  • Yang H, Llewellyn A, Walker R, Harden M, Saramago Goncalves P, Griffin S et al. High-throughput, non-invasive prenatal testing for fetal rhesus D status in RhD- negative women: a systematic review and meta-analysis. BMC Medicine 2019;17:37. Download from BMC

2018

2018

  • Abongomera G, Chiwaula L, Revill P, Mabugu T, Tumwesige E, Nkhata M, Cataldo F, van Oosterhout J, Colebunders R, Chan A, Kityo C, Gilks C, Hakim J, Seeley J, Gibb D, Ford D. Patient-level benefits associated with decentralization of antiretroviral therapy services to primary health facilities in Malawi and Uganda. International Health 2018:10(1):8-19. Download from Oxford Academic
  • Ahmed S, Hasan MZ, Ahmed MW, Dorin F, Sultana M, Islam Z, Mirelman A et al. Evaluating the implementation related challenges of Shasthyo Suroksha Karmasuchi (health protection scheme) of the government of Bangladesh: a study protocol. BMC Health Services Research 2018;18:552. Download from Biomedcentral
  • Ahmed S, Razzaque Sarker A, Sultana M, Chakrovorty S, Ahmed MW, Dorin F, Mirelman A et al. The impact of community-based health insurance on the utilization of medically trained healthcare providers among informal workers in Bangladesh. PloS One 2018;13(7):e0200265. Download from Plosone
  • Ahmed S, Razzaque Sarker A, Sultana M, Chakrovorty S, Zahid Hasan M, Mirelman A et al. Adverse Selection in Community Based Health Insurance among Informal Workers in Bangladesh: An EQ-5D Assessment. International Journal of Environmental Research and Public Health 2018;15(2):242. Download from MDPI
  • Aragon MJChalkley MJ. How do time trends in inhospital mortality compare? A retrospective study of England and Scotland over 17 years using administrative data. BMJ Open 2018;8(2):e107195. Download from BMJ
  • Arundel C, Fairhurst C, Corbacho Martin M, Buckley H, et al, Saramago Goncalves PSoares M et al. Pilot feasibility randomized clinical trial of negative-pressure wound therapy versus usual care in patients with surgical wounds healing by secondary intention. BJS Open 2018;2(3):99-111. Download from Wiley
  • Asaria M, Dhami S, van Ree R, Gerth van Wijk R, Muraro A, Roberts G, Sheikh A. Health economic analysis of Allergen Immunotherapy (AIT) for the management of allergic rhinitis, asthma, food allergy and venom allergy: A systematic overview. Allergy 2018;73(2):269-283. Download from Wiley 
  • Baltagi BH, Moscone F, Santos R. Spatial health econometrics. In Baltagi BH, Moscone F (eds). Health Econometrics Contributions to Economic Analysis: Volume 294. Emerald Group Publishing Limited 2018;13.
  • Banks H, Torbica A, Valzania C, Varabyova Y, Prevolnik Rupel V, Taylor RS, Hunger T, Walker S, Boriani G, Fattore G. For the MedtecHTA group. Five year trends (2008-2012) in cardiac implantable electrical device utilization in five European nations: a case study in cross-country comparisons using administrative databases. EP Europace 2018;20(4):643-653. Download from OUP 
  • Barbieri M, Richardson G, Paisley S. The cost-effectiveness of follow-up strategies after cancer treatment: a systematic literature review. British Medical Bulletin 2018;126(1):85-100. Download from OUP
  • Bee P, Pedley R, Rithalia A, Richardson G, Pryjmachuk S, Kirk S, Bower P. Self-care support for children and adolescents with long-term conditions:the REfOCUS evidence synthesis. NIHR HS&DR Journal 2018;6(3). Download from NIHR
  • Bell K, Corbacho Martín B, Ronaldson S, Richardson G, Torgerson D, Robling M et al. The impact of pre and perinatal lifestyle factors on child long term health and social outcomes: a systematic review. Health Economics Review 2018;8:2. Download from Springer Open
  • Bloor K, Goddard M. Public spending must improve health, not just healthcare. BMJ 2018;363:k4673. Download from BMJ 
  • Bojke C, Grasic K, Street A. How should hospital reimbursement be refined to support concentration of complex care services? Health Economics 2018;27(1):e26-e38. Download from Wiley
  • Bojke LSchmitt LLomas JRichardson GWeatherly H. Economic evaluation of environmental interventions:reflections on methodological challenges and developments. International Journal of Environmental Research and Public Health 2018;15(11):2459. Download from IJERPH
  • Boujaoude M-A, Mirelman A, Dalziel K, Carvalho N. Accounting for equity considerations in cost-effectiveness analysis: A systematic review of rotavirus vaccine in low- and middle-income countries. Cost Effectiveness and Resource Allocation 2018;16:18. Download from biomedcentral
  • Brown LC, Ahmed HU, Faria R, El-Shater Bosaily A, Soares MScupher M et al. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study. Health Technology Assessment 2018;22(39). Download from NIHR
  • Bywater T, Berry V, Blower SL, Cohen J, Gridley N, Kiernan K, Mandefield L, Mason-Jones A, McGilloway S, McKendrick K, Pickett K, Richardson G, Teare MD, Tracey L, Walker S, Whittaker K, Wright J. Enhancing Social-Emotional Health and Wellbeing in the Early Years (E-SEE): A study protocol of a community-based randomised controlled trial with process and economic evaluations of the incredible years infant and toddler parenting programmes, delivered in a proportionate universal model. BMJ Open 2018;8(12):e026906. Download from BMJ 
  • Chalkley MJ. Incentives and performance of health care professionals. Oxford Research Encyclopedia of Economics and Finance Aug 2018;doi:10.1093/acrefore/9780190625979.013.264. Download from Oxfordre.com
  • Chalkley M, Listl S. First do no harm – The impact of financial incentives on dental x-rays. Journal of Health Economics 2018;58:1-9. Download from Elsevier
  • Chansa C, Mwase T, Matsebula T, Kandoole P, Revill P, Makumba J-B et al. Fresh money for health? The (false?) promise of “innovative financing” for health in Malawi. Health Systems & Reform 2018:4(4):324-335. Download from tandfonline
  • Ciani O, Epstein D, Rothery C, Taylor RS, Sculpher M. Decision uncertainty and value of further research: a case-study in fenestrated endovascular aneurysm repair for complex abdominal aortic aneurysms. Cost Effectiveness and Resource Allocation 2018;16:15. Download from BMC
  • Ciani O, Torbica A, Lecci F, Morelli M, Drummond M, Tarricone R et al. Myth #5: Health care is rightly left to the private sector, for the sake of efficiency. In Adinolfi P, Borgonovi E (eds). The Myths of Health Care. Springer 2018; chapter 5: pp123-154. Download from Springer
  • Ciaranello A, Sohn AH, Collins IJ, Rothery C, Abrams EJ, Woods B et al. Simulation modeling and metamodeling to inform national and international HIV policies for children and adolescents. Jaids-Journal of Acquired Immune Deficiency Syndromes 2018;78(S1):S49-S57. Download from JAIDS
  • Claxton KLomas J, Martin S. The impact of NHS expenditure on health outcomes in England: Alternative approaches to identification in all-cause and disease specific models of mortality. Health Economics 2018;27(6):1017-1023. Download from Wiley
  • Clemes S, Bingham D, Pearson N, Chen Y-L, Edwardson C, Mceachan R, Tolfrey K, Cale L, Richardson G et al. Stand out in class: restructuring the classroom environment to reduce sedentary behaviour in 9-10-year-olds- study protocol for a pilot cluster randomised controlled trial. Pilot and Feasibility Studies 2018;4;103. Download from Biomedcentral
  • Coelho T, Ines M, Conceicao I, Soares MFO, Carvalho M, Costa J. Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy. Neurology 2018;91(21):e1999-e2009. Download from Neurology
  • Cookson R, Ali S, Tsuchiya A, Asaria M. E-learning and health inequality aversion: A questionnaire experiment. Health Economics 2018;27(11):17754-1771. Download from Wiley
  • Cookson R, Asaria M, Ali S, Shaw R, Doran T, Goldblatt P. Health equity monitoring for healthcare quality assurance. Social Science & Medicine 2018;198:148-156. Download from ScienceDirect
  • Danzon P, Drummond MF, Towse A, Pauly M. Objectives, budgets, thresholds, and opportunity costs—A health economics approach: An ISPOR special task force report [4]. Value in Health 2018;21(2):140-145. Download from ScienceDirect
  • Dawkins B, Mirelman AAsaria M, Johansson KA, Cookson RA. Distributional cost-effectiveness analysis in low- and middle-income countries: illustrative example of rotavirus vaccination in Ethiopia. Health Policy and Planning 2018;33(3):456-463. Download from Oxford
  • Dodd P, Yuen CM, Becerra MC, Revill P, Jenkins HE, Seddon JA. The potential impact of household contact management on childhood tuberculosis: a mathematical modelling study. Lancet Global Health 2018;6(12):e1329-e1338. Download from ScienceDirect
  • Drummond MF, Tarricone R, Torbica A. Economic evaluation of medical devices. Oxford Research Encyclopedia of Economics and Finance, Economics and Finance March 2018;doi: 10.1093/acrefore/9780190625979.013.105. Download from OUP 
  • Duarte A, Bojke C, Cayton W, Salawu A, Case B, Bojke LRichardson G. Impact of specialist rehabilitation services on hospital length of stay and associated costs. The European Journal of Health Economics 2018;19(7):1-27-1034. Download from Springer
  • Dusheiko MA, Gravelle HSE. Choosing and booking – and attending? Impact of an electronic booking system on outpatient referrals and non-attendances. Health Economics 2018;27(2):357-371. Download from Wiley 
  • Edwardson C, Biddle S, Clarke-Cornwell A, Clemes S, Davies M, Richardson G et al. A three arm cluster randomised controlled trial to test the effectiveness and cost-effectiveness of the SMART Work & Life intervention for reducing daily sitting time in office workers: study protocol. BMC Public Health 2018;18:1120. Download from BMC
  • Elliott R, Camacho E, Campbell F, Jankovic D, Martyn-St James M, Kaltenthaler E, Wong R, Sculpher MFaria R. Prevalence and economic burden of medication errors in the NHS in England: Rapid evidence synthesis and economic analysis of the prevalence and burden of medication error in the UK. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) Report 2018;174p. Download from EEPRU
  • Espinoza MA, Manca AClaxton KSculpher M. Social value and individual choice: the value of a choice-based decision making process in a collectively funded health system. Health Economics 2018;27(2):e28-e40. Download from Wiley
  • Evans R, Brutsche M, Busca R, Deslee G, de Soyza A, Fellrath J-M, Franzen D, Hartman J, Mealing S, Morton T, Munavvar M, Sculpher M et al. Quantifying patient centered outcomes associated with the use of bilateral endobronchial coil treatment in patients with severe emphysema. Current Medical Research and Opinion 2018;34(11):1927-1932. Download from Taylor & Francis
  • Faria RSoares MO, Spackman E, Ahmed HU, Brown L, Kaplan R, Emberton M, Sculpher M. Optimising the diagnosis of prostate cancer in the era of multi-parametric magnetic resonance imaging: a cost-effectiveness analysis based on the Prostate MR Imaging Study (PROMIS). European Urology 2018;73(1):23-30. Download from European Urology
  • Faria RSoares M, Spackman E, Ahmed H, Brown L, Kaplan R, Emberton M, Sculpher M. Re: Jochen Walz. The "PROMIS" of magnetic resonance imaging cost effectiveness in prostate cancer diagnosis? Eur Urol 2018;73:31-2. European Urology 2018;73(6):e151-e152. Download from European Urology
  • Forster A, Hartley S, Bernard L, Ozer S, Schmitt L et al. An intervention to support stroke survivors and their carers in the longer term (LoTS2Care): study protocol for a cluster randomised controlled feasibility trial. Trials 2018;19:317. Download from Trials
  • Garrison L, Neumann P, Willke R, Basu A, Danzon P, Doshi J, Drummond M, Lakdawalla D, Pauly M, Phelps C, Ramsey SD, Towse A, Weinstein M. A health economics approach to US value assessment frameworks - Summary and recommendations of the ISPOR special task force report [7]. Value in Health 2018;21(2):161-165. Download from Value in health
  • Gc VSuhrcke M, Hardeman W, Sutton S, Wilson EC. Cost-effectiveness and value of information analysis of brief interventions to promote physical activity in primary care. Value in Health 2018;21(1):18-26. Download from ScienceDirect
  • Goddard M, Bloor K. Alan Maynard: A sceptical economist and his view of health care and health policy. Political Quarterly 2018;89(4):714-718.12573. Download from Wiley
  • Gridley K, Aspinal FJ, Parker GM, Weatherly HFaria RLongo F et al. Supporting Carers of People with Dementia: A mixed methods evaluation and feasibility study. Social Policy Research Unit, University of York, 2018. Download from SPRU
  • Gutacker N, Bloor KE, Bojke C, Walshe K. Should interventions to reduce variation in care quality target doctors or hospitals? Health Policy 2018;122(6):660-666. Download from ScienceDirect
  • Gutacker N, Street A. Multidimensional performance assessment of public sector organisations using dominance criteria. Health Economics 2018;27(2):e13-e27. Download from Wiley
  • Haji Ali Afzali H, Bojke L, Karnon J. Model structuring for economic evaluations of new health technologies. Pharmacoeconomics 2018;36(11):1309-1319. Download from Springer
  • Hinde S, Crilly T, Balata H, Bartlett R, Crilly J, Barber P et al. The cost-effectiveness of The Manchester ‘Lung Health Checks’, a community-based lung cancer low-dose CT screening pilot. Lung Cancer 2018;126:119-124. Download from Lung cancer journal
  • Hinde S, Theriou C, May S, Matthews L, Arbon A, Fallowfield L, Bloomfield D. The cost-effectiveness of EndoPredict to inform adjuvant chemotherapy decisions in early breast cancer. Health Policy and Technology 2018;doi:10.1016/j.hlpt.2018.12.001. Download from ScienceDirect
  • Howdon D, Rice N. Health care expenditures, age, proximity to death and morbidity: implications for an ageing population. Journal of Health Economics 2018;57:60-74. Download from ScienceDirect
  • Jacobs RChalkley MAragon MJ, Böhnke JR, Clark M, Moran V. Funding approaches for mental health services: Is there still a role for clustering? BJPsych Advances 2018;24(6):412-421. Download from Cambridge UP
  • Jehu L, Visram S, Marks L, Hunter D, Davis H, Mason A, Liu D, Smithson J. Directors of public health as “a protected species”: qualitative study of the changing role of public health professionals in England following the 2013 reforms. Journal of Public Health 2018;40(3):e203-e210. Download from OUP
  • Johannesen KM, Claxton KSculpher MJ, Wailoo AJ. How to design the cost-effectiveness appraisal process of new healthcare technologies to maximise population health: A conceptual framework. Health Economics 2018;27(2):e41-e54. Download from Wiley
  • Jones A, Rice N, Robone S. Anchoring vignettes and cross-country comparability: an empirical assessment of self-reported mobility. In Baltagi BH, Moscone F (eds). Health Econometrics Contributions to Economic Analysis: Volume 294. Emerald Group Publishing Limited 2018;7.
  • Knuchel-Takano A, Hunt D, Jaccard A, Bhimjiyani A, Brown M, Retat L, Brown K, Hinde S, Selvarajah C, Bauld L, Webber L. Modelling the implications of reducing smoking prevalence: the benefits of increasing the UK tobacco duty escalator to public health and economic outcomes. Tobacco Control 2018;27:e124-e129. Download from BMJ
  • Kundu D, Sharma N, Chadha S, Laokri S, Awungafac G, Jiang L, Asaria M. Analysis of multi drug resistant tuberculosis (MDR-TB) financial protection policy: MDR-TB health insurance schemes, in Chhattisgarh state, India. Health Economics Review 2018;8:3. Download from Springer Open
  • Leurent B, Gomes M, Faria R, Morris S, Grieve R, Carpenter J. Sensitivity analysis for not-at-random missing data in trial-based cost-effectiveness analysis: A tutorial. PharmacoEconomics 2018;36(8)889-901. Download from Springer
  • Liu DMason A, Marks L, Davis H, Hunter DJ, Jehu LM, Smithson J, Visram S. Effects of local authority expenditure on childhood obesity. European Journal of Public Health 2018;doi:10.1093/eurpub/cky252. Download from OUP
  • Lomas J, Asaria MBojke L, Gale C, Richardson GWalker S. Which costs matter? Costs included in economic evaluation and their impact on decision uncertainty for stable coronary artery disease. PharmacoEconomics - Open 2018;2(4):403-413Download from Springer
  • Lomas JClaxton K, Martin S, Soares M. Resolving the ‘cost-effective but unaffordable’ ‘paradox’: estimating the health opportunity costs of non-marginal budget impacts. Value in Health 2018;21(3):266-275. Download from ScienceDirect
  • Love-Koh J, Peel A, Rejon-Parilla JC, Ennis K, Lovett R, Manca A, Chalkidou A, Wood H, Taylor M. The future of precision medicine: Potential impacts for Health Technology Assessment. Pharmacoeconomics 2018;36(12):1439-1451. Download from Springer
  • Marsh KD, Sculpher M, Caro J, Tervonen T. The use of MCDA in HTA: great potential, but more effort needed. Value in Health 2018;21(4):394-97. Download from Value in health
  • Mason ALiu DKasteridis PGoddard MJacobs R, Wittenberg R, McGonigal G. Investigating the impact of primary care payments on underdiagnosis in dementia: A difference-in-differences analysis. International Journal of Geriatric Psychiatry 2018;33(8):1090-1097. Download from Wiley
  • Mason ALiu D, Marks L, Davis H, Hunter D, Jehu L et al. Local authority commissioning of NHS Health Checks: A regression analysis of the first three years. Health Policy 2018;122(9):1035-1042. Download from Sciencedirect
  • Mauskopf J, Standaert B, Connolly MP, Culyer AJ, Garrison LP, Hutubessy R, Jit M, Pitman R, Revill P, Severens J. Economic analysis of vaccination programs: An ISPOR good practices for outcomes research task force report. Value in Health 2018;21(10):1133-1149. Download from ScienceDirect
  • Moran V, Jacobs R. Investigating the relationship between costs and outcomes for English mental health providers: a bi-variate multi-level regression analysis. The European Journal of Health Economics 2018;19(5):709-718. Download from Springer
  • Morton K, Voss S, Adamson J, Baxter H, Bloor KE, Brandling J, Cowlishaw S, Doran T, Gibson A, Gutacker N, Liu D, et al. General practitioners and emergency departments (GPED): Efficient models of care. A mixed-methods study protocol. BMJ Open 2018;8(10):e024012. Download from BMJ
  • Moscelli G, Gravelle H, Siciliani L, Gutacker N. The effect of hospital ownership on quality of care: evidence from England. Journal of Economic Behavior & Organization 2018;153:322-344. Download from ScienceDirect
  • Moscelli G, Siciliani L, Gutacker NCookson R. Socioeconomic inequality of access to healthcare: Does choice explain the gradient? Journal of Health Economics 2018;57:290-314. Download from Sciencedirect
  • Nakamura R, Mirelman A, Cuadrado C, Silva N, Dunstan J, Suhrcke ME. Evaluating the 2014 sugar-sweetened beverage tax in Chile: An observational study in urban areas. PLoS Medicine 2018;15(7):e1002596. Downolad from Plosmedicine
  • Neumann PJ, Kim DD, Trikalinos TA, Sculpher MJ et al. Future directions in cost-effectiveness analyses in health and medicine. Medical Decision Making 2018;38(7):767-777. Download from Sagepub
  • Niessen L, Mohan D, Akuoku J, Mirelman A, Ahmed S, Koehlmoos T, Trujillo A, Khan J, Peters D. Tackling socioeconomic inequalities and non-communicable diseases in low-income and middle-income countries under the Sustainable Development agenda. The Lancet 2018;391(10134):2036-2046. Download from the Lancet
  • Norman G, Westby M, Rithalia A, Stubbs N, Soares M, Dumville JC. Dressings and topical agents for treating venous leg ulcers. Cochrane Database of Systematic Reviews 2018;15(6):CD012583. Download from Cochrane
  • Ochalek J, Lomas JClaxton K. Estimating health opportunity costs in low- and middle-income countries: a novel approach and evidence from cross-country data. BMJ Global Health 2018;3(6):e000964. Download from BMJ
  • Ochalek JRevill P, Manthalu G, McGuire F, Nkhoma D, Rollinger ASculpher MClaxton K. Supporting the development of a health benefits package in Malawi. BMJ Global Health 2018;3(2):e000607. Download from BMJ
  • O'Hara JK, Grasic KGutacker N, Street A et al. Identifying positive deviants in healthcare quality and safety: a mixed methods study. Journal of the Royal Society of Medicine 2018;111(8):276-291. Download from Sage journals
  • Pandya A, Doran T, Zhu J, Walker S, Arntson E, Ryan AM. Modeling the cost-effectiveness of pay-for-performance in primary care for the UK. BMC Medicine 2018;16:135. Download from BMC
  • Patton T, Hu H, Luan L, Yang K, Li S-C. Mapping between HAQ-DI and EQ-5D-5L in a Chinese patient population. Quality of Life Research 2018;27(11):2815-2822. Download from Springer
  • Perera D, Clayton T, Petrie M, Greenwood J, O'Kane P, Evans R, Sculpher M et al. Percutaneous revascularization for ischemic ventricular dysfunction: Rationale and design of the REVIVED-BCIS2 trial: Percutaneous coronary intervention for ischemic cardiomyopathy. JACC: Heart failure 2018;6(6):517-526. Download from Elsevier
  • Peron M, Llewellyn A, Moe-Byrne T, Walker S, Walton M, Harden M, Palmer S, Simmonds M. Adjunctive colposcopy technologies for assessing suspected cervical  abnormalities: Systematic reviews and economic evaluation. Health Technology Assessment 2018;22(54). Download from NIHR
  • Phelps C, Lakdawalla D, Basu A, Drummond MF, Towse A, Danzon P. Approaches to aggregation and decision making - A health economics approach: An ISPOR special task force report [5]. Value in Health 2018; 21(2):146-154. Download from Value in health
  • Phillippo D, Ades T, Dias S, Palmer S, Abrams K, Welton NJ. Methods for population-adjusted indirect comparisons in Health Technology Appraisal. Medical Decision Making 2018;38(2):200-211. Download from Sagepub
  • Phillips AN, Cambiano V, Nakagawa F, Revill P, Jordan MR, Hallett TB, Doherty M, De Luca A, Lundgren JD, Mhangara M, Apollo T, Mellors J, Nichols B, Parikh U, Pillay D, Rinke de Wit T, Sigaloff K, Havlir D, Kuritzkes DR, Pozniak A, van de Vijver D, Vitoria M, Wainberg MA, Raizes E, Bertagnolio S & Working Group on Modelling Potential Responses to High Levels of Pre-ART Drug Resistance in Sub-Saharan Africa 2017. Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study. Lancet HIV 2018;5(3):e146-e154. Download from ScienceDirect
  • Pinho M, Pinto Borges A, Cookson R. Do healthcare professionals have different views about healthcare rationing than college students? A mixed methods study in Portugal. Public Health Ethics 2018:11(1):90-1-2. Download from Oxford oup
  • Reichert AJacobs R. Socioeconomic inequalities in duration of untreated psychosis: Evidence from administrative data in England. Psychological Medicine 2018;48(5):822-833. Download from Cambridge UP
  • Reichert AJacobs R. The impact of waiting time on patient outcomes: Evidence from early intervention in psychosis services in England. Health Economics 2018;27(11):1772-1787. Download from Wiley
  • Revill P, Dwyer E. Pre-exposure prophylaxis is cost-effective for HIV in the UK. Lancet Infectious Diseases 2018;18(1):10-11. Download from Sciencedirect
  • Revill PWalker S, Cambiano V, Phillips A, Sculpher M. Reflecting the real value of health care resources in modelling and cost-effectiveness studies-The example of viral load informed differentiated care. PloS One 2018;13(1):1-13e0190283. Download from Plosone
  • Ride J. Setting the boundaries for economic evaluation: investigating time horizon and family effects in the case of postnatal depression. Value in Health 2018;21(5):573-580. Download from Value in Health
  • Ride JKasteridis P, Gutacker N, et al. Do care plans and annual reviews of physical health influence unplanned hospital utilisation for people with serious mental illness? Analysis of linked longitudinal primary and secondary healthcare records in England. BMJ Open 2018;8(11):e023135. Download from BMJ
  • Rothery CWoods BSchmitt LClaxton KPalmer S,Sculpher M. Framework for value assessment of new antimicrobials: Implications of alternative funding arrangements for NICE Appraisal. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) Report 2018;178p. Download from EEPRU
  • Saramago P, Yang H, Llewellyn A, Walker R, Harden M, Palmer SGriffin S, Simmonds M.High-throughput non-invasive prenatal testing for fetal rhesus D status in RhD-negative women not known to be sensitised to the RhD antigen: a systematic review and economic evaluation. Health Technology Assessment 2018;22(13):1-172. Download from NIHR
  • Saramago Goncalves PR, Yang H, Llewellyn A, Palmer SJ, Simmonds MC, Griffin S. High-throughput, non-invasive prenatal testing for fetal RHD genotype to guide antenatal prophylaxis with anti-D immunoglobulin: a cost-effectiveness analysis. BJOG An International Journal of Obstetrics and Gynaecology 2018;125(11):1414-1422. Download from Wiley
  • Sassi F, Belloni A, Mirelman ASuhrcke M, Thomas A, Salti N, Vellakkal S, Visaruthvong C, Popkin B, Nugent R. Equity impacts of price policies to promote healthy behaviours. The Lancet 2018;391(10134):2059-2070. Download from the Lancet
  • Sculpher M. ISPOR’s initiative on US value assessment frameworks: seeking a role for health economics. Value in Health 2018;21(2):171-2. Download from Value in Health
  • Siddharthan T, Pollard SL, Quaderi SA, Mirelman A, Cardenas MK, Kirenga B et al. Effectiveness-implementation of COPD case finding and self-management action plans in low- and middle-income countries: global excellence in COPD outcomes (GECo) study protocol. Trials 2018;19(571):1-15. Download from Trials
  • Soares M, Bojke L. Expert elicitation to inform Health Technology Assessment. In Dias LC, Morton A, Quigley J (eds). Elicitation: The Science and Art of Structuring Judgement. Springer International Publishing 2018;Chapter 18:pp479-494. 
  • Soares MFO, Sharples L, Morton A, Claxton KP, Bojke L. Experiences of structured elicitation for model based cost-effectiveness analyses. Value in Health 2018;21(6):715-723. Download from ScienceDirect
  • Soares MO, Walker S, Palmer SJ, Sculpher MJ. Establishing the value of diagnostic and prognostic tests in Health Technology Assessment. Medical Decision Making 2018;38:495-508. Download from Sage Journals
  • South E, Cox E, Meader N, Woolacott N, Griffin S. Strimvelis® for treating severe combined immunodeficiency caused by adenosine deaminase deficiency: An evidence review group perspective of a NICE highly specialised technology evaluation. Pharmacoeconomics - Open 2018;doi:10.1007/s41669-018-0102-3. Download from Springer
  • Suhrcke M. Disability and development: an economic perspective. In Eradicating extreme poverty. Special report, commissioned by the Credit Suisse Research Institute 2018 Davos Edition. Download from Credit Suisse
  • Sum G, Hone T, Atun R, Millett C, Suhrcke M, Mahal A, Koh G, Tayu Lee J. Multimorbidity and out-of-pocket expenditure on medicines: A systematic review. BMJ Global Health 2018;3(1):e000505. Download from BMJ
  • Sutton M, Garfield-Birkbeck S, Martin G, Meacock R, Morris S, Sculpher M, Street A, Watson SI, Lilford RJ. Economic analysis of service and interventions in health care.  Health Serv Deliv Res 2018;6(5). Download from NIHR
  • Swami M, Gravelle H, Scott A, Williams J. Hours worked by General Practitioners and waiting times for Primary Care. Health Economics 2018;27(10):1513-1532. Download from Wiley
  • Sweeney R, Suhrcke M, Jeon YJ, Mortimer D. The impact of SWAps on health aid displacement of domestic health expenditure. The Journal of Development Studies (FJDS) 2018;54(4):719-737. Download from T and F online
  • Tafesse W. The effect of mandatory iodine fortification on cognitive test scores in rural India. Health, Econometrics and Data Group (HEDG), University of York 2018; working paper 18/10. Download from HEDG
  • Thokala P, Ochalek J, Leech A, Tong T. Cost effectiveness thresholds: the past, the present and the future. PharmacoEconomics 2018;36(5)509-522. Download from Springer
  • Thompson DG, O'Brien S, Kennedy A, Rogers A, Whorwell P, Lovell K, Richardson G et al. A randomised controlled trial, cost-effectiveness and process evaluation of the implementation of self-management for chronic gastrointestinal disorders in primary care, and linked projects on identification and risk assessment. Programme Grants for Applied Research 2018;6(1). Download from NIHR
  • Tierrablanca L, Ochalek J, Ford D, Babiker A, Gibb D, Butler K, Turkova A, Griffin SRevill P. Economic evaluation of weekends-off antiretroviral therapy for young people in 11 countries. Medicine 2018;97(5):e9698. Download from Medicine
  • Torbica A, Tarricone R, Drummond M. Does the approach to economic evaluation in health care depend on culture, values, and institutional context? The European Journal of Health Economics 2018;19(6):769-774. Download from Springer
  • Tosetti E, Santos R, Moscone F, Arbia G. The spatial dimension of health systems. In: Econometrics, Experimental and Quantitative Methods, Health, Education, and Welfare, Public Economics and Policy. Oxford Research Encyclopedia, Economics and Finance 2018;30p. 
  • Thwaites GE, Scarborough M, Szubert A, Saramago P, Soares M, Bostock J et al. Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT. Health Technology Assessment 2018;22(59):1-148. Download from NIHR 
  • Verzulli R, Jacobs RGoddard M. Autonomy and performance in the public sector: The experience of English NHS hospitals. European Journal of Health Economics 2018;19(4):607-626. Download from Springer
  • Woods BS, Sideris E, Sydes MR, Gannon MR, Parmar MKB, Alzouebi M, Attard G, Birtle AJ, Brock S, Cathomas R, Chakraborti PR, Cook A, Cross WR, Dearnaley DP, Gale J, Gibbs S, Graham JD, Hughes R, Jones RJ, Laing R, Mason MD, Matheson D, McLaren DB, Millman R, O’Sullivan JM, Parikh O, Parker CC, Peedell C, Protheroe A, Ritchie AWS, Robinson A, Russell MJ, Simms MS, Srihari NN, Srinivasan R, Staffurth JN, Sundar S, Thalmann GN, Tolan S, Tran ATH, Tsang D, Wagstaff J, James ND, Sculpher MJ. Addition of docetaxel to first-line long-term hormone therapy in prostate cancer (STAMPEDE): Modelling to estimate long-term survival, quality-adjusted survival, and cost-effectiveness. Eur Urol Oncol 2018;1(6):449-458. Download from ScienceDirect 
  • Woods BRothery C, Anderson S-J, Eaton JW, Revill P, Hallett TB, Claxton K. Appraising the value of evidence generation activities: An HIV Modelling Study. BMJ Global Health 2018;3(6):e000488. Download from BMJ
  • Yang F, Gannon B, Weightman A. Public's willingness to pay towards a medical device for detecting foot ulceration in people with diabetes. Applied Health Economics and Health Policy 2018;16(4):559-567. Download from Springer 
  • Yong J, Scott A, Gravelle H, Sivey P, McGrail M. Do rural incentives payments affect entries and exits of general practitioners? Social Science and Medicine 2018;214:197-205. Download from Sciencedirect

2017

2017

  • Abongomera G, Kiwuwa-Muyingo S, Revill P, Chiwaula L, Mabugu T, Phillips AN et al. Impact of decentralisation of antiretroviral therapy services on HIV testing and care at a population level in Agago District in rural Northern Uganda: results from the Lablite population surveys. International Health 2017;9(2):91-99. Download from Oxford Academic
  • Abu-Omar K, Rütten A, Burlacu I, Schätzlein V, Messing S, Suhrcke M. The cost-effectiveness of physical activity interventions: A systematic review of reviews. Preventive Medicine Reports 2017;8:72-78. Download from ScienceDirect
  • Afshin A, Micha R, Webb M, Capewell S, Whitsel L, Rubinstein A, Prabhakaran D, Suhrcke M, Mozaffarian  D. Effectiveness of dietary policies to reduce noncommunicable diseases. In Prabhakaran D, Anand S, Gaziano T,  Mbanya JC, Wu Y, Nugent R (eds). Disease Control Priorities, (3rd edition) Volume 5, Cardiovascular, Respiratory, and Related Disorders 2017. Washington, DC: World Bank; Chapter 6. 
  • Ahern AL, Wheeler GM, Aveyard P, Boyland EJ, Halford JCG, Mander AP, Woolston J, Thomson AM, Tsiountsioura M, Cole D, Mead BR, Irvine L, Turner D, Suhrcke M, Pimpin L, Retat L, Jaccard A, Webber L, Cohn SR, Jebb S. Extended and standard duration weight loss referrals for adults in primary care (WRAP): a pragmatic randomised controlled trial. Lancet 2017;389(10085):2214-2225. Download from ScienceDirect
  • Alguera-Lara V, Dowsey MM, Ride J, Kinder S, Castle D. Shared decision making in mental health: the importance for current clinical practice. Australasian Psychiatry: Bulletin of Royal Australian and New Zealand College of Psychiatrists 2017;25(6):578-582. Download from Sage
  • Al-Janabi H, Manca A, Coast J. Predicting carer health effects for use in economic evaluation. PLoS ONE 2017;12(9):e0184886. Download from plosone
  • Al Quait A, Doherty P, Gutacker N, Mills J. In the modern era of percutaneous coronary intervention: Is cardiac rehabilitation engagement purely a patient or a service level decision? European Journal of Preventive Cardiology 2017;24(13):1351-1357. Download from Sage 
  • Ali S, Cookson R, Dusheiko M. Addressing care-seeking as well as insurance-seeking selection biases in estimating the impact of health insurance on out-of-pocket expenditure. Social Science and Medicine 2017;177:127-140. Download from ScienceDirect
  • Ali S, Tsuchiya A, Asaria MCookson R. How robust are value judgments of health inequality aversion? Testing for framing and cognitive effects. Medical Decision Making 2017;37(6):635-646. Download from Sage journals
  • Alvarado M, Kostova D, Suhrcke M, Hambleton I, Hassell T, Samuels A, Adams J, Unwin J. Trends in beverage prices following the introduction of a tax on sugar-sweetened beverages in Barbados. Preventive Medicine 2017;105:523-525. Download from ScienceDirect
  • Antioch K, Drummond MF, Niessen L, Vondeling H. International lessons in new methods for grading and integrating cost effectiveness evidence into clinical practice guidelines. Cost Effectiveness and Resource Allocation 2017;15(1). Download from BioMed Central
  • Aragon MJCastelli AGaughan J. Hospital Trusts productivity in the English NHS: uncovering possible drivers of productivity variations. PloS One 2017;12(8):e0182253. Download from plosone
  • Barnabas RV, Revill P, Tan N, Phillips A. Cost-effectiveness of routine viral load monitoring in low- and middle-income countries: a systematic review. Journal of the International Aids Society 2017:20 (S7):50-61. Download from Wiley
  • Barratt H, Asaria M, Sheringham J, Stone P, Raine R, Cookson R. Dying in hospital: socioeconomic inequality trends in England. Journal of Health Services Research & Policy 2017;22(3):149-154. Download from Sage
  • Bojke CCastelli AGrasic KStreet AD. Productivity growth in the English National Health Service from 1998/1999 to 2013/2014. Health Economics 2017;26(5):547-565. Download from Wiley
  • Bojke L, Grigore B, Jankovic D, Peters J, Soares M, Stein K. Informing reimbursement decisions using cost-effectiveness modelling: a guide to the process of generating elicited priors to capture model uncertainties. Pharmacoeconomics 2017;35(9):867-877. Download from Springer
  • Bojke LManca AAsaria M, Mahon R, Shijie R, Palmer S. How to appropriately extrapolate costs and utilities in cost-effectiveness analysis. Pharmacoeconomics 2017;35(8):767-776. Download from Springer
  • Brealey S, Armstrong A, Brooksbank A, et al, Richardson G, et al. United Kingdom Frozen Shoulder Trial (UK FROST), multi-centre, randomised, 12 month, parallel group, superiority study to compare the clinical and cost-effectiveness of Early Structured Physiotherapy versus manipulation under anaesthesia versus arthroscopic capsular release for patients referred to secondary care with a primary frozen shoulder: study protocol for a randomised controlled trial. Trials.2017;18:614. Download from Trials
  • Burgers LT, Redekop W, Al MJ, Lhachimi SK, Armstrong N, Walker SM, Rothery C, et al. Cost-effectiveness analysis of new generation coronary CT scanners for difficult-to-image patients. European Journal of Health Economics 2017;18(6):731-742. Download from Springer
  • Burns DK, Jones AP, Goryakin Y, Suhrcke M. Is foreign direct investment good for health in low and middle income countries? An instrumental variable approach. Social Science & Medicine 2017;181:74-82. Download from Elsevier
  • Chalkley MJ, McCormick B, Anderson R, Aragon MJ, Nessa N, Nicodemo C, Redding S, Wittenberg R. Elective hospital admissions: secondary data analysis and modelling with an emphasis on policies to moderate growth. Health Services and Delivery Research 2017;5(7). Download from NIHR
  • Chalkley M, Siciliani L, Gravelle H. Policies towards hospital and GP competition in five European countries. Health Policy 2017;121(2):103-110. Download from Elsevier 
  • Ciani O, Buyse M, Drummond MF, et al. Time to review the role of surrogate endpoints in health policy. Value in Health 2017;20(3):487-495. Download from Value in Health
  • Cookson RMirelman A. Equity in HTA: what doesn’t get measured, gets marginalized. Israel Journal of Health Policy Research 2017;6:38. Download from BioMedCentral
  • Cookson RMirelman AGriffin SAsaria M, Dawkins B, Frithjof Norheim O, Verguet S, Culyer AJ. Using cost-effectiveness analysis to address health equity concerns. Value in Health 2017;20(2):206-212. Download from Value in Health 
  • Cookson R, Mondor L, Asaria M, Kringos DS, Klazinga NS, Wodchis WP.  Primary care and health inequality: difference-in-difference study comparing England and Ontario. PLOS one 2017;doi:10.1371/journal.pone.0188560. Download from Plosone
  • Cookson R, Walden A. Inequality and the NHS hospital crisis: Why social disadvantage needs attention. British Journal of Hospital Medicine 2017;78(2):64-65. Download from Magonlinelibrary
  • Corbacho Martin MB, Bell KJ, Stamuli E, Richardson G, Ronaldson SJ, Hood K, Sanders J, Robling M, Torgerson DJ. Cost-effectiveness of the Family Nurse Partnership (FNP) programme in England: evidence from the Building Blocks Trial. Journal of Evaluation in Clinical Practice 2017;23(6):1367-1374. Download from Wiley
  • Corbett M, Chehadah F, Biswas M, Moe-Byrne T, Palmer SSoares M, Walton M, Harden M, Ho P, Woolacott N, Bojke L. Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation. Health Technology Assessment 2017;21(56):1-326. Download from NIHR
  • Dhami S, Zaman H, Varga E-M, et al. Asaria M, Netuveli G, Sheikh A, Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis. Allergy 2017;72(3):342-365. Download from Wiley
  • Dhami S, Kakourou A, Asamoah F, et al. Asaria M, Netuveli G, Zaman H, Akhlaq A, Sheikh A. Allergen immunotherapy for allergic asthma: a systematic review and meta-analysis. Allergy 2017;72(12):1825-1848. Download from Wiley
  • Dhami S, Nurmatov U, Arasi S, Khan T, Asaria M, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis. Allergy 2017;72(11):1597-1631. Download from Wiley  
  • Drummond MF, Houwing N, Slothuus U, Giangrande P. Making economic evaluations more helpful for treatment choices in haemophilia. Haemophilia Journal 2017;23(2):e58-e66. Download from Wiley
  • Duarte A, Mebrahtu T, Goncalves PS, Harden M, Murphy R, Palmer S, Woolacott N, Rodgers M, Rothery C. Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people: systematic review and economic evaluation. Health Technology Assessment 2017;21(64):1-244. Download from NIHR
  • Duarte AWalker S, Littlewood E, Brabyn S, Hewitt C, Gilbody S, Palmer S. Cost-effectiveness of computerized cognitive–behavioural therapy for the treatment of depression in primary care:: findings from the Randomised Evaluation of the Effectiveness and Acceptability of Computerised Therapy (REEACT) trial. Psychological Medicine 2017;47(10):1825-1835. Download from Cambridge university press
  • Fleetcroft R, Asaria M, Ali S, Cookson R. Outcomes and inequalities in diabetes from 2004/2005 to 2011/2012: English longitudinal study. British Journal of General Practice 2017;67(654):e1-e9. Download from BJGP 
  • French EB, McCauley J, Aragon M, Bakx P, Chalkley M, et al., Rice N, Skinner JS, van Doorslaer E, Ziebarth NR, Kelly E. End-of-life medical spending in last twelve months of life is lower than previously reported. Health Affairs 2017;36(7):1211-1217. Download from Health Affairs
  • Gaughan JM, Gravelle HSESantos R, Siciliani L. Long-term care provision, hospital bed blocking, and discharge destination for hip fracture and stroke patients. International Journal of Health Economics and Management 2017;17(3):311-331. Download from Springer
  • Gaughan JGravelle H, Siciliani L. Delayed discharges and hospital type: Evidence from the English NHS. Fiscal Studies 2017;38(3):495-519. Download from Wiley
  • Gaziano TA, Suhrcke M, Brouwer E, Levin C, Nikolic I, Nugent R. Costs and cost-effectiveness of interventions and policies to prevent and treat cardiovascular and respiratory diseases. In Prabhakaran D, Anand S, Gaziano T,  Mbanya JC, Wu Y, Nugent R (eds). Disease Control Priorities, (3rd edition) Volume 5, Cardiovascular, Respiratory, and Related Disorders 2017. Washington, DC: World Bank; Chapter 19.
  • Goddard MMason A. Integrated  care: A pill for all ills? International Journal of Health Policy and Management 2017;6(1):1-3. Download from IJHPM
  • Goryakin Y, Monsivais P, Suhrcke M. Soft drink prices, sales, body mass index and diabetes: Evidence from a panel of low-, middle- and high-income countries. Food Policy 2017;73:88-94. Download from ScienceDirect 
  • Goryakin Y, Revill PMirelman A, Sweeney R, Ochalek JSuhrcke M. Public financial management and health service delivery: A literature review. Overseas Development Institute Report; London: April 2017. Download from White Rose
  • Goryakin Y, Rocco L, Suhrcke M. The contribution of urbanization to non-communicable diseases: evidence from 173 countries from 1980 to 2008. Economics and Human Biology 2017;26:151-163. Download from ScienceDirect
  • Goryakin Y, Suhrcke M. The impact of poor adult health on labor supply in the Russian Federation. European Journal of Health Economics 2017;18(3):361-372. Download from Springer 
  • Graham H, Bland M, Cookson R, Kanaan M, White P. Do people favour policies that protect future generations? Evidence from a British survey of adults. Journal of Social Policy 2017;46(3):423-445. Download from Cambridge UP
  • Gutacker N, Bloor K, Cookson R, Gale CP, Maynard A, Pagano D, Pomar J, Bernal-Delgado E. Hospital surgical volumes and mortality after coronary artery bypass grafting: using international comparisons to determine a safe threshold. Health Services Research 2017;52(2):863-878. Download from Wiley
  • Gutacker NStreet A. Use of large scale HRQoL datasets to generate individualised predictions and inform patients about the likely benefit of surgery. Quality of Life Research 2017;26(9):2497-2505. Download from Springer
  • Hakim J, Musiime V, Szubert A, Mallewa J, Siika A, Agutu C, Walker S, Pett SL, Bwakura-Dangarembizi M, Lugemwa A, Kaunda S, Karoney M, Musoro G, Kabahenda S, Nathoo K, Maitland K, Griffiths A, Thomason MJ, Kityo C, Mugyenyi P, Prendergast AJ, Walker AS, Gibb DM for the REALITY Trial Team. Enhanced prophylaxis with antiretroviral therapy for advanced HIV in Africa. New England Journal of Medicine 2017;377:233-245. Download from NEJM  
  • Hettle R, Corbett M, Hinde S, Hodgson R, Jones-Diette J, Woolacott N, Palmer S. The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal. Health Technology Assessment 2017;21(7):1-238. Download from NIHR
  • Hinde S, Allgar VL, Richardson G, Spiers G, Parker GM, Birks YF. An evaluation of the costs and consequences of Children Community Nursing teams. Journal of Evaluation in Clinical Practice 2017;23(4):767-772. Download from Wiley 
  • Hinde SBojke LRichardson G, Retat L, Webber L. The cost-effectiveness of population health checks: have the NHS health checks been unfairly maligned? Journal of Public Health 2017;25(4):425-431. Download from Springer
  • Hinde S, Wiyani A, Griffin SWalker SM. Who bears the cost of NICE public health recommendations? British Medical Bulletin 2017;124(1):113-120. Download from OUP
  • Jackson C, Stevens J, Latimer N, Bojke LManca A, Sharples L. Extrapolating survival from randomised trials using external data: a review of methods. Medical Decision Making 2017;37(4):377-390. Download from Sage
  • Joyce VR, Sun H, Barnett PG, Bansback N, Griffin SC, Bayoumi AM, Anis AH, Sculpher M, Cameron W, Brown ST, Holodniy M, Owens DK. Mapping MOS-HIV to HUI3 and EQ-5D-3L in patients with HIV. MDM Policy & Practice 2017;2(2). Download from Sage
  • Jull J, Whitehead M, Petticrew M, Kristjansson E, Gough D, Petkovic J, Volmink J, Weijer C, Taljaard M, Edwards S, Mbuagbaw L, Cookson R, et al. When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework. BMJ Open 2017;7(9):1-9.e015815. Download from BMJ
  • Kendrick D, Ablewhite J, Achana F, Benford P, Clacy R, Coffey F, Cooper N, Coupland C, Deave T, Goodenough T, Hawkins A, Hayes M, Hindmarch P, Hubbard S, Kay B, Kumar A, Majsak-Newman G, McColl E, McDaid L, Miller P, Mulvaney C, Peel I, Pitchforth E, Reading R,  Saramago P, Stewart J, Sutton A, Timblin C, Towner E, Watson M, Wynn P, Young B, Zou K. Keeping children safe: a multicentre programme of research to increase the evidence base for preventing unintentional injuries in the home in the under-fives. Programme Grants for Applied Research 2017;5(14). Download fromNCBI
  • Kreif N, Tran L, Grieve R, De Stavola B, Tasker R, Petersen M. Estimating the comparative effectiveness of feeding interventions in the paediatric intensive care unit: a demonstration of longitudinal targeted maximum likelihood estimation. American Journal of Epidemiology 2017;186(12):1370-1379. Download from Oxford UP
  • Kronenberg C, Doran T, Goddard M, Kendrick T, Gilbody S, Dare C, Aylott L, Jacobs R. Identifying primary care quality indicators for people with serious mental illness: a systematic review. British Journal of General Practice 2017;67(661):e519-e530. Download from BJGP  
  • Kronenberg C, Jacobs R, Zucchelli E. The impact of the UK National Minimum Wage on mental health. SSM - Population Health 2017;3:749-755. Download from ScienceDirect
  • Longo F, Siciliani L, Gravelle HSantos R. Do hospitals respond to rivals’ quality and efficiency? A spatial panel econometric analysis. Health Economics 2017;26(S2);38-62. Download from Wiley  
  • MacPherson H, Vickers A, Bland M, Torgerson D, Corbett M, Spackman E, Saramago PWoods BWeatherly HSculpher MManca A, Richmond S, Hopeton A, Eldred J, Watt I. Acupuncture for chronic pain and depression in primary care:  a programme of research. Programme Grants for Applied Research 2017;5(3). Download from NIHR
  • Mannion R, Davies HTO, Jacobs RKasteridis P, Millar R, Freeman T. Do hospital boards matter for better, safer, patient care? Social Science & Medicine 2017;177:278-287. Download from Elsevier
  • Manthalu G, Nkhoma D, Ochalek JM, Phillips A, Revill P. Confronting tight fiscal, human resource, and evidence constraints, Malawi revises its benefits package. In Glassman A, Giedion U, Smith PC, (eds) What's In, What's Out: Designing Benefits for Universal Health Coverage 2017. Washington D.C.;Center for Global Development:pp247-252. Download from CGD
  • Masters R, Anwar E, Collins B, Cookson R, Capewell S. Return on investment of public health interventions: a systematic review. Journal of Epidemiology and Community Health 2017;71(8):827-834. Download from BMJ 
  • Moran V, Jacobs R. Costs and performance of English mental health providers. The Journal of Mental Health Policy and Economics 2017;20(2):83-94. Download from ICMPE
  • Moran V, Jacobs RMason A. Variations in performance of mental health providers in the English NHS: An analysis of the relationship between readmission rates and length-of-stay. Administration and Policy in Mental Health and Mental Health Services Research 2017;44(2):188-200. Erratum;44(2):201-202. Download from Springer  
  • Morton K, Atkin A, Corder K, Suhrcke M, Turner D, van Sluijs E. Engaging stakeholders and target groups in prioritising a public health intervention: The Creating Active School Environments (CASE) online Delphi study. BMJ Open 2017;7(1):e013340. Download from BMJ
  • Mosquera I, González-Rábago Y, Bacigalupe A, Suhrcke M. The impact of fiscal policies on the socioeconomic determinants of health: A structured review. Int J Health Serv 2017;47(2):189-206. Download from Sage Journals 
  • Nakamura R, Suhrcke M, Zizzo DA. Triple test for behavioral economics models and public health policy. Theory and Decision 2017;83(4):513-533. Download from Springer
  • Ochalek JRevill P, van den Berg B. Causal effects of HIV on employment status in low-income settings. Economics and Human Biology 2017;27(Pt A):248-260. Download from Elsevier
  • Ozawa S, Clark S, Portnoy A, Grewal S, Stack M, Sinha A, Mirelman A, Franklin H, Freiberg I, Tam Y, Walker N, Clark A, Ferrari M, Suraratdecha C, Sweet S, Goldie S, Garske T, Li M, Hansen P, Johnson H, Walker D. Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001–2020WHO Bulletin 2017;95(9):629-638. Download from WHO
  • Palafox B, Goryakin Y, Stuckler D, Suhrcke M, et al.Does greater individual social capital improve the management of hypertension? Cross-national analysis of 61,229 individuals in 21 countries. BMJ Global Health 2017;
  • Parker C, Woods B, Eaton J, Ma E, Selby R, Benson E, Engstrom A, Sajosi P, Briggs A, Bonthapally V. Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma post-autologous stem cell transplant: a cost-effectiveness analysis in Scotland. Journal of Medical Economics 2017;20(1):8-18. Download from Taylor & Francis
  • Patton TBojke L, Walton M, Manca A, Helliwell P. Evaluating the cost-effectiveness of biologic treatments for psoriatic arthritis: can we make better use of patient data registries? Clinical Rheumatology 2017;36(8):1803-1810. Download from Springer
  • Phillips AN, Stover J, Cambiano V, Nakagawa F, Jordan MR, Pillay D, Doherty M, Revill P, Bertagnolio S. Impact of HIV drug resistance on HIV/AIDS associated mortality, new infections and antiretroviral therapy program costs in sub-Saharan Africa. The Journal of Infectious Diseases 2017;215(9):1362-1365. Download from Oxford Academic
  • Regan J, Dawes P, Pye A, Armitage C, Hann M, Himmelsbach I, Reeves D, Simkin Z, Yang F, Leroi I. Improving hearing and vision in dementia: Protocol for a field trial of a new intervention. BMJ Open 2017;7(11):e018744. Download from BMJ
  • Robson M, Asaria MCookson R, Tsuchiya A, Ali S. Eliciting the level of health inequality aversion in England. Health Economics 2017;26(10):1328-1334. Download from Wiley
  • Rodriguez Santana IChalkley M. Getting the right balance? A mixed logit analysis of the relationship between UK training doctors' characteristics and their specialties using the 2013 National Training Survey. BMJ Open 2017;7(8):e015219. Download from BMJ
  • Rothery CClaxton KPalmer S, Epstein D, Tarricone R, Sculpher M. Characterising uncertainty in the assessment of medical devices and determining future research needs. Health Economics 2017;26(S1):109-123.  Download from Wiley
  • Santos J, Palumbo F, Molsen-David E, Willke RJ, Binder L, Drummond M et al. ISPOR Code of Ethics 2017 (4th Edition). Value in Health 2017;20(10):1227-1242. Download from Elsevier
  • Santos RGravelle H, Propper C. Does quality affect patients’ choice of doctor? Evidence from England. The Economic Journal 2017;127(600):445-494. Download from Wiley
  • Saramago PDuarte ARothery CPalmer S. Tackling network meta-analysis methodological challenges: a case study on biologic treatments for moderate to severe plaque psoriasis in children and young people. Value in Health 2017;20(9):A756. Download from Value in Health
  • Saramago PPalmer SGriffin S. Cost-effectiveness of high-throughput, non-invasive prenatal testing for fetal rhesus D status. Value in Health 2017;20(9):A588. Download from Value in Health
  • Sculpher MClaxton K, Pearson SD. Developing a value framework: the need to reflect the opportunity costs of funding decisions. Value in Health 2017;20(2):234-9. Download from Value in Health
  • Sculpher MJRevill POchalek JMClaxton KP. How much health for the money? Using cost-effectiveness analysis to support benefits plan decisions. In Glassman A, Giedion U, Smith PC, (eds) What's In, What's Out: Designing Benefits for Universal Health Coverage 2017. Washington D.C.;Center for Global Development: Chapter 4. Download from CGD
  • Sheringham J, Asaria M, Barratt H, Raine R, Cookson RA. Are some areas more equal than others? Socioeconomic inequality in potentially avoidable emergency hospital admissions within English local authority areas. Journal of Health Services Research & Policy 2017;22(2):83-90. Download from Sage
  • Spackman E, Hinde SBojke L, Payne K, Sculpher M. Using cost-effectiveness analysis to quantify the value of genomic-based diagnostic tests: recommendations for practice and research. Genetic Testing and Molecular Biomarkers 2017;21(12):705-716. 
  • Tarricone R, Torbica A, Drummond MF. Challenges in the assessment of medical devices: the MedtecHTA project. Health Economics 2017;26(Suppl 1):5-12. Download from Wiley
  • Tarricone R, Torbica A, Drummond M for the MedtecHTA Project Group. Key recommendations from the MedtecHTA project. Health Economics 2017;26(Suppl 1):145-152. Download from Wiley
  • Wailoo AJ, Hernandez-Alava M, Manca A, Mejia A, Ray J, Crawford B, Botteman M, Busschbach J. Mapping to estimate health-state utility from non–preference outcome measures: an ISPOR good practices for outcomes research task force report. Value in Health 2017;20:130-139. Download from ScienceDirect
  • Walker SM, Spackman E, Conrad N, Edmin CA, Griffin E, Rahimi K, Sculpher M. Impact of missed treatment opportunities on outcomes in hospitalised patients with heart failure. Open Heart 2017;4(2):e000726. Download from BMJ
  • Weatherly HFaria R, van den Berg B. Quantifying informal care for economic evaluation in mental health. In Razzouk D (ed). Mental Health Economics: The Costs and Benefits of Psychiatric Care 1st edition. Springer 2017;Ch17:pp.267-280.  
  • Weir S, Samnaliev M, Kuo T-C, Choitir CN, Tierney TS, Cumming D, Bruce J, Manca A, Taylor RS, Eldabe S. The incidence and healthcare costs of persistent postoperative pain following lumbar spine surgery in the UK: A cohort study using the Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES). BMJ Open 2017;7(9):e017585. Download from BMJ
  • Westby M, Dumville JC, Soares M, Stubbs N, Norman G. Dressings and topical agents for treating pressure ulcers. Cochrane Database of Systematic Reviews 2017; Issue 6:CD011947. Download from Wiley
  • Woods BManca AWeatherly HSaramago PSideris E, Giannopoulou C, Rice S, Corbett M, Vickers A, Bowes M, MacPhersonH, Sculpher M. Cost-effectiveness of adjunct non-pharmacological interventions for osteoarthritis of the knee. PLoS ONE 2017;12(3): e0172749. Download from Plosone 
  • Woods BSideris EPalmer S, Latimer N, Soares M. NICE DSU technical support document 19: Partitioned survival analysis for decision modelling in health care: a critical review. 2 Jun 2017, NICE Decision Support Unit;72p. Download from SCHARR  

2016

2016

  • Allen R, Bryden P, Grotzinger K, Stapelkamp C, Woods BS. Cost-effectiveness of Eltrombopag versus Romiplostim for the treatment of chronic immune thrombocytopenia in England and Wales. Value in Health 2016;19(5):614-622. Download from ScienceDirect
  • Aragon Aragon MJMChalkley MJRice N. Medical spending and hospital inpatient care in England: An analysis over time. Fiscal Studies 2016:37(3-4):405-432. Download from Wiley
  • Arundel C, Buckley H, Clarke E, Cullum N, Dixon S, Dumville J, Fairhurst C, Firth A, Henderson E, Lamb K, McGinnis E, Oswald A, Saramago Goncalves PSoares M, et al. Negative pressure wound therapy versus usual care for Surgical Wounds Healing by Secondary Intention (SWHSI trial): study protocol for a randomised controlled pilot trial. Trials 2016;17(535):1-7. Download from BioMed Central
  • Asaria MAli S, Doran T, Ferguson B, Fleetcroft R, Goddard M, Goldblatt P, Laudicella M, Raine R, Cookson R. How a universal health system reduces inequalities – Lessons from England. Journal of Epidemiology and Community Health 2016;70:637-643. Download from BMJ
  • Asaria MCookson R, Fleetcroft R, Ali S. Unequal socioeconomic distribution of the primary care workforce: whole-population small area longitudinal study. BMJ Open 2016;6(1):e8783. Download from BMJ
  • Asaria M, Doran T, Cookson R. The costs of inequality: whole-population modelling study of lifetime inpatient hospital costs in the English National Health Service by level of neighbourhood deprivation. Journal of Epidemiology and Community Health 2016;70(10):990-996. Download from BMJ
  • Asaria MGrasic KWalker S. Using linked electronic health records to estimate healthcare costs: key challenges and opportunities. PharmacoEconomics 2016;34(2):155-160. Download from Springer
  • Asaria MGriffin SCookson R. Distributional cost-effectiveness analysis: A tutorial. Medical Decision Making 2016;36(1):8-19. Download from Sage
  • Asaria MWalker SPalmer S, Gale C, Shah A, Abrams K, Crowther M, Manca A, Timmis A, Hemingway H, Sculpher M. Using electronic health records to predict costs and outcomes in stable coronary artery disease. Heart 2016;102(10):755-762. Download from BMJ and Associated model code
  • Barber S, Jackson C, Hewitt C, Ainsworth H, Buckley H, Akhtar S, Bingham D, Routen A, Summerbell C, Richardson G, et al. Assessing the feasibility of evaluating and delivering a physical activity intervention for pre-school children: a pilot randomised controlled trial. Pilot and Feasibility Studies 2016;2(12). Download from BioMed Central
  • Becker D, Chit A, DiazGranados C, Maschio M, Yau E, Drummond M. High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors. Human Vaccines & Immunotherapeutics 2016;12(12):3036-3042. Download from Taylor & Francis 
  • Bojke CCastelli AGrasic KHowdon DStreet A. Did NHS productivity increase under the Coalition government? In Exworthy M, Mannion R, Powell M. (eds) Dismantling the NHS: Evaluating the Impact of Health Reforms. Bristol (UK);Policy Press 2016:p65-86. Further details  
  • Brabyn S, Araya R, Barkham M, Bower P, Cooper C, Duarte A, Kessler D, Knowles S, Lovell K, Littlewood E, Mattock RPalmer S, Pervin J, Richards D, Tallon D, White D, Walker S, Worthy G, Gilbody S. The second Randomised Evaluation of the Effectiveness, cost-effectiveness and Acceptability of Computerised Therapy (REEACT-2) trial: does the provision of telephone support enhance the effectiveness of computer-delivered cognitive behaviour therapy? A randomised controlled trial. Health Technol Assess 2016;20(89). Download from NIHR
  • Burns DK, Jones AP, Suhrcke M. The relationship between international trade and non-nutritional health outcomes: A systematic review of quantitative studies. Social Science & Medicine 2016;152:9-17. Download from ScienceDirect
  • Chiwaula L, Revill P, Ford D, et al, for the Lablite Project Team. Measuring and valuing informal care for economic evaluations of HIV/AIDS interventions: methods and application in Malawi. Value in Health Regional Issues 2016;10:73-78. Download from ScienceDirect
  • Ciani O, Buyse M, Drummond MF, et al. Use of surrogate endpoints in healthcare policy: proposal for consistent adoption of a validation framework. Nature Reviews Drug Discovery 2016;15(7):516. Download from Nature Reviews
  • Claxton KPPalmer SJ, Longworth L, Bojke L, Griffin SSoares MFO, Spackman E, Rothery C.  A comprehensive algorithm for approval of health technologies with, without, or only in research: the key principles for informing coverage decisions. Value in Health 2016;19(6):885-891. Download from Value in Health
  • Cookson R. Equity-informative health technology assessment - a commentary on Ngalesoni, Ruhago, Mori, Robberstad & Norheim. Social Science and Medicine 2016;170:218-219. Download from ScienceDirect
  • Cookson RAsaria M, Ali S, Ferguson B, Fleetcroft R, Goddard M, et al. Health equity indicators for the English NHS: a longitudinal whole-population study at the small-area level. Health Services and Delivery Research 2016;4(26). Download from NIHR
  • Cookson R, Propper C, Asaria M, Raine R. Socio-economic inequalities in health care in England. Fiscal Studies 2016:37(3-4):371-403. Download from Wiley
  • Corbacho Martin MB, Duarte A, Keding A, et al. Cost effectiveness of surgical versus non-surgical treatment of adults with displaced fractures of the proximal humerus: economic evaluation alongside the PROFHER trial. Bone and Joint Journal 2016;98B(2):152-159. Download from Bone and Joint
  • Corbett M, Soares M, Jhuti G, Rice S, Spackman E, Sideris E, Moe-Byrne T, Fox D, Marzo-Ortega H, Kay L, Woolacott N, Palmer S. Tumour necrosis factor-inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation. Health Technology Assessment 2016;20(9). Download from NIHR
  • Cullum N, Buckley H, Dumville J, Hall J, Lamb K, Madden M, Morley R, O’Meara S,  Saramago PSoares MO, Stubbs N. Wounds research for patient benefit programme. Programme Grants for Applied Research. NIHR Journals Library 2016;4(13). Download from NIHR   
  • Dalton J, Chambers D, Harden M, Street A, et al. Service user engagement and health service reconfiguration: a rapid evidence synthesis. Journal of  Health Services Research & Policy 2016;21(3):195-205. Download from sagepub
  • Davis H, Marks L, Jehu L, Virsram S, Hunter DJ, Liu DMason A, Melvin K, Smithson J. Commissioning public health services: the impact of the health reforms on access, health inequalities and innovation in service provision: An innovation framework for public health commissioning. Durham University2016 Report 6 Sept;pp1-90. Further details
  • Dias J, Brealey S, Choudhary S, Cook L, Costa M, Fairhurst C, Hewitt C, Hodgson S, Jefferson L, Jeyapalan K, Keding A, Leighton P, Rangan A, Richardson GRothery C, et al. Scaphoid Waist Internal Fixation for Fractures Trial (SWIFFT) protocol: a pragmatic multi-centre randomised controlled trial of cast treatment versus surgical fixation for the treatment of bi-cortical, minimally displaced fractures of the scaphoid waist in adults. BMC Musculoskeletal Disorders 2016;17(248):1-15. Download from BioMed Central 
  • Drummond MF. Clinical Guidelines: a NICE way to introduce cost-effectiveness considerations? Value in Health 2016;19(5):525-530. Download from Value in health 
  • Drummond MF, Augustovski F, Kalo Z, et al. Challenges faced in transferring economic evaluations to middle income countries. International Journal of Technology Assessment in Health Care 2016;31(6):442-448. Download from Cambridge UP
  • Drummond MF, Tarricone R, Torbica A. Incentivizing research into the effectiveness of medical devices. European Journal of Health Economics 2016;17(9)1055-1058. Download from Springer
  • Faria R, Kiss N, Aspinal F, Harden M, Weatherly H.  Economic evaluation of social care interventions: Lessons drawn from a systematic review of the methods used to evaluate reablement. Health Economics & Outcome Research:Open Access 2016;2(1):107. Download from omicsonline
  • Faria RWalker S, Whyte S, Dixon S, Palmer SSculpher M. How to invest in getting cost-effective technologies into practice? A framework for value of implementation analysis applied to novel oral anticoagulants. Medical Decision Making 2016;37(2):148-161. Download from Sage
  • Faria RWoods BGriffin SPalmer SSculpher M, Ryder SD. Prevention of progression to cirrhosis in hepatitis C with fibrosis: effectiveness and cost effectiveness of sequential therapy with new direct-acting anti-virals. Alimentary Pharmacology & Therapeutics 2016;44(8):866-876. Download from Wiley ‌
  • Farrar D, Simmonds M, Griffin SDuarte A, Lawlor DA, Sculpher M et al. The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation. Health Technology Assessment 2016;20(86):1-382. ‌Download from NIHR
  • Fazio L, Rosner A, Drummond MF. How do U.S. payers use economic models submitted by Life Sciences Organizations? Value & Outcomes Spotlight 2016;2(2):18-21. 
  • Fischera E, Gravelle H, Pezzino M, Sutton M. Quality target negotiation in health care: evidence from the English NHS. European Journal of Health Economics 2016;17(7):811-822. Download from Springer
  • France J, Sennett J, Jones A, Fordham R, Williams J, Burke A, Meierkord A, Fong-Soe-Khioe R, Suhrcke M. Evaluation of walking for health: Final report to Macmillan and the Ramblers 2016;Ecorys UK Limited:191p. 
  • Garnett G, Krishnaratne S, Harris K, Hallett T, Santos M, Endstone J, Hensen B, Dallabetta G, Revill P, Gregson S, Hargreaves J. The cost-effectiveness of interventions to prevent HIV acquisition. In Holmes K, Bertozzi S, Bloom B, Jha P (eds). Disease Control Priorities 3: HIV/AIDS and Other Sexually Transmitted Infections 2016; World Bank: vol 6, part 1(7). 
  • Goddard MKasteridis P, Jacobs R, Santos RMason A. Bridging the gap: the impact of quality of primary care on duration of hospital stay for people with dementia. Journal of Integrated Care 2016;24(1):15-25. Download from Emerald Insight
  • Gomes M, Gutacker N, Bojke C, Street AAddressing missing data in Patient-Reported Outcome Measures (PROMs): implications for the use of PROMs for comparing provider performance. Health Economics 2016;25(5):515-528. Download from Wiley
  • Gravelle H, Scott A, Sivey P, Yong J. Competition, prices and quality in the market for physician consultations. Journal of Industrial Economics 2016;64(1):135-169. Download fromWiley
  • Greene W, Harris MN, Hollingsworth B, Knott R, Rice N. Reporting heterogeneity effects in modelling self-reports of health. Working Paper Ec-16-12, Stern School of Business, New York University. Download here
  • Greenwood JP, Ripley DP, Berry C, McCann GP, Plein S, Bucciarelli-Ducci C, Dall’Armellina E, Prasad A, Bijsterveld P, Foley JR, Mangion K, Sculpher MWalker S, et al, for the CE-MARC 2 Investigators. Effect of care guided by cardiovascular magnetic resonance, myocardial perfusion scintigraphy, or NICE guidelines on subsequent unnecessary angiography rates - The CE-MARC 2 Randomized Clinical Trial.  JAMA 2016;316(10):1051-1060. Download from JAMA
  • Grieve R, Abrams K, Claxton K, Goldacre B, James N, Nicholl J, Parmar M, Parker C, Sekhon JS, Smeeth L, Spiegelhalter D, Sculpher M.  Cancer Drugs Fund requires further reform: Reliance on “real world” observational data undermines evidence base for clinical practice. BMJ 2016;354:i5090. Download from BMJ
  • Gutacker N, Siciliani L, Cookson RA. Waiting time prioritisation: Evidence from England. Social Science & Medicine 2016;159:140-151. Download from ScienceDirect 
  • Gutacker N, Siciliani L, Moscelli GGravelle H. Choice of hospital: which type of quality matters? Journal of Health Economics 2016;50:230-246. Download from ScienceDirect
  • Hall M, Laut K, Dondo TB, Alabas OA, Brogan RA, Gutacker NCookson R, et al. Patient and hospital determinants of primary percutaneous coronary intervention in England, 2003-13. Heart 2016;102(4):313-319. Download from BMJ journals
  • Hawkins N, Scott DA, Woods B. ‘Arm-based’ parameterization for network meta-analysis. Research Synthesis Methods 2016;7(3):306-313. Download from Wiley
  • Hinde SBojke LRichardson G. Have the NHS health checks been unfairly maligned? Value in Health 2016;19(7):A613. Download from Value in health
  • Hinde S, Epstein D, Cook A, Embleton A, Perren TJ, Sculpher MJ. The cost-effectiveness of Bevacizumab in advanced ovarian cancer using evidence from the ICON7 trial. Value in Health 2016;19(4):431-439. Download from Value in health
  • Hinde S, Wade R, Palmer S, Woolacott N, Spackman E. Apremilast for the treatment of moderate to severe plaque psoriasis: A critique of the evidence. PharmacoEconomics 2016;34(6):587-596. Download from Springer 
  • Howard-Wilsher S, Irvine L, Fan H, Shakespeare T, Suhrcke M, et al. Systematic overview of economic evaluations of health related rehabilitation. Disability and Health Journal 2016;9(1):11-25. Download from Disability and health
  • Jones AM, Rice N, Zantomio F. Acute health shocks and labour market outcomes. University Ca' Foscari of Venice, Dept. of Economics Research Paper Series No 9 March 2016. Download from SSRN 
  • Jones AM, Rice N, Zantomio F. What happens to employment after an acute health shock? Understanding Society: Insights 2016;p22-23. Institute for Social and Economic Research (ISER), University of Essex, 2016.
  • Kasteridis PMason AGoddard MJacobs RSantos R, Rodriguez-Sanchez B, McGonigal G. Risk of care home placement following acute hospital admission: Effects of a pay-for-performance scheme for dementia. PLoS ONE 2016;11(5):e0155850. Download from plosone Dementia Plos one lay summary (PDF  , 358kb)
  • Li Y, Wang JL, Zhang XC, Liu D, Shi WH, Liang XF, Wu J. Effectiveness of adherence to standardized hypertension management by primary health care workers in China: a cross-sectional survey 3 years after the healthcare reform. Biomedical and Environmental Sciences 2016;29(12):915-921. Download from BES
  • Llewellyn A, Faria RWoods B, Simmonds M, Lomas J, Woolacott N, Griffin S. Daclatasvir for the treatment of chronic hepatitis C: A critique of the clinical and economic evidence. PharmacoEconomics 2016;34(10):981-992. Download from Springer
  • Lomas J, Llewellyn A, Soares M, Simmonds M, Wright K, Eastwood A, Palmer S. The clinical and cost effectiveness of Vortioxetine for the treatment of a major depressive episode in patients with failed prior antidepressant therapy: A critique of the evidence. PharmacoEconomics 2016;34(9): 901-912. Download from Springer
  • Lomas J, Schmitt L, Jones S, McGeorge M, Bates E, Holland M, Cooper D, Crowther R, Ashmore M, Rojas Rueda D, Weatherly HRichardson GBojke L. A pharmacoeconomic approach to assessing the costs and benefits of air quality interventions that improve health: a case study. BMJ Open 2016;6(6):e010686. Download from bmj
  • Majuru B, Suhrcke M, Hunter P. How do households respond to unreliable water supplies? A systematic review.  International Journal of Environmental Research and Public Health 2016;13(12):1222. Download from mdpi
  • Malone DC, Berg NS, Claxton K, Garrison LP, IJzerman M, Marsh K, Neumann PJ, Sculpher M, et al. International Society for Pharmacoeconomics and Outcomes Research comments on the American Society of Clinical Oncology value framework. Journal of Clinical Oncology 2016;34(24):2936-2937. Download from ASCO
  • Mann R, Beresford B, Parker G, Rabiee P, Weatherly HFaria R, et al. Models of reablement evaluation (MoRE): a study protocol of a quasi-experimental mixed methods evaluation of reablement services in England. BMC Health Services Research 2016;16:375. Download from BioMed
  • Marks L, Jehu L, Visram S, Melvin K, Davis H, Hunter D, Liu DMason A, Smithson J. Commissioning public health services: the impact of the health reforms on access, health inequalities and innovation in service provision: Results from first phase fieldwork in ten case study sites across England. Durham University 2016 Report 5 October;pp1-107. Further details
  • Marks L, Mason ALiu D, et al. Commissioning public health services: the impact of the health reforms on access, health inequalities and innovation in service provision: Results of a national survey of Directors of Public Health and Clinical Commissioning Group members of Health and Wellbeing Boards. Durham University 2016 report 4 Jun;pp1-55. Further details
  • Marks L, Visram S, Brown S, Davis H, Hunter DJ, Liu DMason A, et al. Commissioning public health services: the impact of the health reforms on access, health inequalities and innovation in service provision: Views of national stakeholders. Durham University 2016 Report 1 Feb;pp1-36. Further details
  • Martin S, Street A, Han L, Hutton J. Have hospital readmissions increased in the face of reductions in length of stay? Evidence from England. Health Policy 2016;120(1):89-99. Download from ScienceDirect
  • Mason ALiu D, Marks L, et al. Commissioning public health services: the impact of the health reforms on access, health inequalities and innovation in service provision: The Public Health Budget. Durham University 2016 Report 2 Feb;pp1-95. Further details
  • McAuliffe E, Galligan M, Revill P, Kamwendo F, Sidat M, Masanja H, Pinho Hd, Araujo E. Factors influencing job preferences of health workers providing obstetric care: results from discrete choice experiments in Malawi, Mozambique and Tanzania. Globalization and Health 2016;12:86. Download from BioMed
  • McEachan R, Santorelli G, et al, Richardson G, et al. The HAPPY (Healthy and Active Parenting Programmme for early Years) feasibility randomised control trial: Acceptability and feasibility of an intervention to reduce infant obesity. BMC Public Health 2016;16:211. Download from BioMed
  • McKenna CGriffin S, Koffijberg H, Claxton K. Methods to place a value on additional evidence are illustrated using a case study of corticosteroids after traumatic brain injury. Journal of Clinical Epidemiology 2016;70:183-190. Download from JCE
  • McNamee P, Murray E, Kelly MP, Bojke L, et al. Designing and undertaking a health economics study of digital health interventions. American Journal of Preventive Medicine 2016;51(5):852-860. Download from AJPM
  • Mealing S, Woods B, Hawkins N, Cowie M, Plummer C, Abraham W, Beshai J, Klein H, Sculpher M. Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure. Heart 2016;102(21):1742-1749. Download from Heart 
  • Meltzer DO, Basu A, Sculpher MJ. Theoretical foundations of cost-effectiveness analysis in health and medicine. In Neumann PJ, Sanders GD, Russell LB, Siegel JE, Ganiats TG (eds). Cost-Effectiveness in Health and Medicine 2016, Oxford University Press, 2nd edition. 
  • Mentzakis E, Roberts B, Suhrcke M, McKee M. Psychological distress and problem drinking. Health Economics 2016;25(3):337-356. Download from Wiley
  • Morton KL, Atkin AJ, Corder K, Suhrcke M, van Sluijs EMF. The school environment and adolescent physical activity and sedentary behaviour: a mixed-studies systematic review. Obesity Reviews 2016;17(2):142-158. Download from Wiley
  • Morton KL, Corder K, Suhrcke M, et al. School polices, programmes and facilities, and objectively measured sedentary time, LPA and MVPA: associations in secondary school and over the transition from primary to secondary school. The International Journal of Behavioral Nutrition Physical Activity 2016;13:54. Download from Biomed 
  • Moscelli G, Siciliani L, Gutacker NGravelle H. Location, quality and choice of hospital: Evidence from England 2002–2013. Regional Science and Urban Economics 2016;60:112-124. Download from Elsevier
  • Moscelli G, Siciliani L, Tonei V. Do waiting times affect health outcomes?: Evidence from coronary bypass. Social Science and Medicine 2016;161:151-159. Download from ScienceDirect
  • Mirelman A, Rose S, Khan J, et al. The relationship between non-communicable disease occurrence and poverty—evidence from demographic surveillance in Matlab, Bangladesh. Health Policy and Planning 2016;31(6):785-792. Download from Oxford Academic
  • Nkhata MJ, Muzambi M, Ford D, et al, Revill P, et al and the Lablite team. Shifting human resources for health in the context of ART provision: qualitative and quantitative findings from the Lablite baseline study. BMC Health Services Research 2016;16(1):660. Download from BioMed  
  • Obure CD, Jacobs R, Guinness L, et al. Does integration of HIV and sexual and reproductive health services improve technical efficiency in Kenya and Swaziland? An application of a two-stage semi parametric approach incorporating quality measures. Social Science & Medicine 2016;151:147-156. Download from ScienceDirect
  • Oddershede L, Walker S, Stohr W, Dunn DT, Arenas-Pinto A, Paton NI, Sculpher MJ for the Protease Inhibitor monotherapy Versus Ongoing Triple therapy (PIVOT) Trial Team. Cost effectiveness of protease inhibitor monotherapy versus standard triple therapy in the long-term management of HIV patients: analysis using evidence from the PIVOT trial. Pharmacoeconomics 2016;34(8):795-804. Download from Springer
  • Owens DK, Siegel JE,  Sculpher MJ, Salomon JA.  Designing a cost-effectiveness analysis. In Neumann PJ, Sanders GD, Russell LB, Siegel JE, Ganiats TG (eds). Cost-Effectiveness in Health and Medicine 2016, Oxford University Press, 2nd edition. 
  • Paton N, Stöhr W, Oddershede L, Arenas-Pinto A, Walker SSculpher MJ, Dunn D. The Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) trial: a randomised controlled trial of a protease inhibitor monotherapy strategy for long-term management of human immunodeficiency virus infection. Health Technology Assessment 2016;20(21). Download from NIHR
  • Phillips A, Cambiano V, Nakagawa F, Ford D, et al, Revill P. Point-of-care viral load testing for sub-Saharan Africa: informing a target product profile. Open Forum Infectious Diseases 2016;3(3):doi:10.1093/ofid/ofw161. Download from Oxford Journals
  • Phillips A, Cambiano V, Nakagawa F, Bansi-Matharu L, Salif Sow P, Ehrenkranz P, Ford D, Mugurungi O, Apollo T, Murungu J, Bangsberg D, Revill P. Cost effectiveness of potential ART adherence monitoring interventions in sub-Saharan Africa. PLoS ONE 2016;11(12):e0167654. Download from PLOS
  • Phillips A, Cambiano V, Revill P, Nakagawa F, Lundgren J, Bansi-Matharu L, Mabugu T, Sculpher M, et al. Identifying key drivers of the impact of an HIV cure intervention in sub-Saharan Africa. The Journal of Infectious Diseases 2016;214(1):73-79. Download from Oxford Academic
  • Pletscher M, Walker S, Moschetti K, Pinget C, et al. Cost-effectiveness of functional cardiac imaging in the diagnostic work-up of coronary heart disease. European Heart Journal 2016;2(3):201-207. Download from Oxford University Press
  • Portrait F, van der Galien O, van den Berg B. Measuring healthcare providers’ performances within managed competition using multidimensional quality and cost indicators. Health Economics 2016;25(4):408-423. Download from Wiley
  • Protheroe J, Rathod T, Bartlam B, Rowlands G, Richardson G and Reeves DJ. The feasibility of health-trainer improved patient self-management in patients with low health literacy and poorly controlled diabetes: a pilot randomised controlled trial. Journal of Diabetes Research 2016;6903245:11. Download from Hindawi
  • Puig-Peiro R, Mason A, Mestre-Ferrandiz J, et al. Relative effectiveness in breast cancer treatment: A health production approach. International Journal of Health Technology Assessment 2016;31(6):371-379. Download from Cambridge UP
  • Rencz F, Gulacsi L, Drummond M, Golicki D, Rupel V, Simon J, et al. EQ-5D in Central and Eastern Europe: 2000-2015. Quality of Life Research 2016;25(11):2693-2710. Download from Springer
  • Rodgers M, Dalton J, Harden M, Street A, Parker G, Eastwood A. Integrated care to address the physical health needs of people with severe mental illness: a rapid review. Health Services and Delivery Research 2016;4(13). Download from NIHR
  • Rodgers M, Thomas S, Harden M, Parker G, Street A, Eastwood A. Developing a methodological framework for organisational case studies: a rapid review and consensus development process. Health Services and Delivery Research 2016;4(1). Download from NIHR
  • Rothery CBojke L, Richardson G, Bojke C, Moverley A, Coates L, Thorp L, Waxman R, Helliwell P. A discrete choice experiment to explore patients’ willingness to risk disease relapse from treatment withdrawal in psoriatic arthritis. Clinical Rheumatology 2016;35(12):2967-2974. Download from Springer
  • Russell H, Street A, Ho V. How well do all patient refined–diagnosis-related groups explain costs of pediatric cancer chemotherapy admissions in the United States? Journal of Oncology Practice 2016;12(5):e564-e575. Download from ascopubs
  • Sanders GD, Neumann PJ, Basu A, Brock DW, Feeny D, Krahn M, Kuntz KM, Meltzer DO, Owens DK, Prosser LA, Salomon JA, Sculpher MJ, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: Second panel on cost effectiveness in health and medicine. JAMA2016;316(10):1093-1103. Download from JAMA
  • Saramago Goncalves PWoods BWeatherly HManca A, Sculpher M, et al. Methods for network meta-analysis of continuous outcomes using individual patient data: a case study in acupuncture for chronic pain. BMC Medical Research Methodology 2016;6;16(131). Download from BioMed
  • Sculpher MJ, Basu A, Kuntz KM, Meltzer DO. Reflecting uncertainty in cost-effectiveness analysis. In Neumann PJ, Sanders GD, Russell LB, Siegel JE, Ganiats TG (eds). Cost-Effectiveness in Health and Medicine 2016, Oxford University Press, 2nd edition. 
  • Sideris E, Corbett M, Palmer S, Woolacott N, Bojke L. The clinical and cost effectiveness of Apremilast for treating active psoriatic arthritis: A critique of the evidence. Pharmacoeconomics 2016;34(11):1101-1110. Download from Springer
  • Spiers GF, Allgar VL, Richardson G, Thurland K, Hinde S, et al. Transforming community health services for children and young people who are Ill: A quasi-experimental evaluation. Health Services and Delivery Research 2016;4(25). Download from NIHR
  • Taylor C, Marks L, Smithson J, Davis H, Hunter DJ, Liu D, Mason A, Visram S. Commissioning public health services: the impact of the health reforms on access, health inequalities and innovation in service provision: National surveys. Durham University 2016 report 3 Jun;pp1-55. Download from Durham
  • Towse A, Jonsson B, McGrath C, Mason A, et al. Understanding variations in relative effectiveness: A health production approach. International Journal of Health Technology Assessment 2016;31(6):363-370. Download from Cambridge UP
  • V GC, Wilson ECF, Suhrcke M, Hardeman W, Sutton S. Are brief interventions to increase physical activity cost-effective? A systematic review. British Journal of Sports Medicine 2016;50(7):408-417. Download from BJSM
  • Walker SAsaria MManca A, Palmer S, Gale C, Shah A, Abrams K, Crowther M, Timmis A, Hemingway H, Sculpher M. Long term health care use and costs in patients with stable coronary artery disease: a population based cohort using linked health records (CALIBER). European Heart Journal - Quality of Care & Clinical Outcomes 2016;2(2):125-140. Download from oxfordjournals
  • Whyte S, Dixon S, Faria RWalker SPalmer S, Sculpher M, Radford S. Estimating the cost-effectiveness of implementation: Is sufficient evidence available? Value in Health 2016;19(2):138-144. Download from ScienceDirect
  • Wilkinson T, Sculpher MClaxton K, Revill P, Briggs A, Cairns JA, Teerawattananon Y, Asfaw E, Lopert R, Culyer AJ, Walker DG. The international decision support initiative reference case for economic evaluation: an aid to thought. Value in Health 2016:19(8):921-928. Download from Value in Health
  • Woods B, Faria R, Griffin S. Assessing the value of new treatments for Hepatitis C: Are international decision makers getting this right? PharmacoEconomics 2016;34(5):427-433. Download from Springer
  • Woods BRevill PSculpher MClaxton K. Country-level cost-effectiveness thresholds: initial estimates and the need for further research. Value in Health 2016:19(8):929-35. Download from Value in Health

2015

2015

  • Abongomera G, Kiwuwa-Muyingo S, Revill P, Chiwaula L, et al, for the Lablite Project Team. Population level usage of health services, and HIV testing and care, prior to decentralization of antiretroviral therapy in Agago District in rural Northern Uganda. BMC Health Services Research 2015;15:527. Download from biomedcentral
  • Alfonso Ross Terres J, Lozano-Ortega G, Kendall R, Sculpher M. Cost-effectiveness of fondaparinux versus enoxaparin in non-ST-elevation acute coronary syndrome in Canada (OASIS-5). BMC Cardiovascular Disorders 2015;15:180. Download from Springer 
  • Asaria M, Griffin S, Cookson R, et al. Distributional cost-effectiveness analysis of health care programmes – a methodological case study of the UK bowel cancer screening programme. Health Economics 2015;24(6):742-754. Download from Wiley
  • Ball K, Lamb KE, Costa C, et al, Santos R, et al. Neighbourhood socioeconomic disadvantage and fruit and vegetable consumption: a seven countries comparison. International Journal of Behavioral Nutrition and Physical Activity 2015;12:68. Download from ijbnpa
  • Ballard SB, Saito M, Mirelman AJ, et al. Tropical and travel-associated norovirus: current concepts. Current Opinion in Infectious Diseases 2015;28(5):408-416.
  • Barber S, Akhtar S, Jackson C, Bingham D, Hewitt C, Routen A, Richardson G, et al. Preschoolers in the Playground: a pilot cluster randomised controlled trial of a physical activity intervention for children aged 18 months to 4 years. Public Health Research 2015;3(5). Download from NIHR
  • Barnabus RV, Bendavid E, et al, Revill P, et al. Priorities for HIV Care in sub-Saharan Africa: a Population Perspective, HIV Modelling Consortium. Report for the World Health Organization HIV Treatment Guidelines Development Committee 2015. Download from HIV modelling
  • Bartoll X, Toffolutti V, Malmusi D, Palència L, Borrell C, Suhrcke M. Health and health behaviours before and during the Great Recession, overall and by socioeconomic status, using data from four repeated cross-sectional Health Surveys in Spain (2001-2012). BMC Public Health 2015;15:865. Download from BioMed 
  • Bubela T, McCabe C, et al, Soares M, et al. Bringing regenerative medicines to the clinic: the future for regulation and reimbursement. Regenerative Medicine 2015;10(7):897–911. Download from Futuremedicine
  • Cambiano V, Ford D, et al, Revill P, Phillips A. Assessment of the potential impact and cost-effectiveness of self-testing for HIV in low-income countries. The Journal of Infectious Diseases 2015;212(4):570-577. Download from Oxford journals
  • Campbell JD, McQueen RB, Libby AM, Spackman E, et al. Cost-effectiveness uncertainty analysis methods: A comparison of one-way sensitivity, analysis of covariance, and expected value of partial perfect information. Medical Decision Making 2015;35(5):596-607Download from Sage
  • Cardenas MK, Mirelman AJ, et al. The cost of illness attributable to diabetic foot and cost-effectiveness of secondary prevention in Peru. BMC Health Services Research 2015;15:483. Download from BioMed
  • Castelli A, Daidone S, Jacobs RKasteridis PStreet A. The determinants of costs and length of stay for hip fracture patients. PLoS One 2015;10(7):e0133545. Download from Plosone
  • Castelli A, Street A, Verzulli R, Ward P. Examining variations in hospital productivity in the English NHS. European Journal of Health Economics 2015;16(3):243-254. Download from Springer
  • Chit A, Becker DL, DiazGranados CA, Maschio M, Yau E, Drummond M. Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: An economic evaluation of data from a randomised controlled trial. The Lancet Infectious Diseases 2015;15(12):1459-1466. Download from The Lancet
  • Clark AL, Johnson M, Fairhurst C, Torgerson D, Cockayne S, Rodgers S, Griffin S, et al. Does home oxygen therapy (HOT) in addition to standard care reduce disease severity and improve symptoms in people with chronic heart failure? A randomised trial of home oxygen therapy for patients with chronic heart failure. Health Technology Assessment 2015;19(75). Download from NIHR
  • Claxton KGriffin S, Koffijberg H, McKenna C. How to estimate the health benefits of additional research and changing clinical practice. BMJ 2015;351:h5987. Download from bmj
  • Claxton KP, Martin S, Soares MO, Rice N, Spackman E, Hinde S, Devlin N, Smith PC, Sculpher M. Methods for the estimation of the NICE cost effectiveness threshold. Health Technology Assessment 2015;19(14). Download fron NIHR
  • Claxton K, Sculpher M, Palmer S, Culyer AJ. Causes for concern: is NICE failing to uphold its responsibilities to all NHS patients? Health Economics 2015;24(1):1–7. Download from Wiley
  • Conigliani C, Manca A, Tancredi A. Prediction of patient reported outcome measures via multivariate ordered probit models. Journal of the Royal Statistical Society: Series A (Statistics in Society) 2015;178(3):567-591. Download from Wiley
  • Cookson R. Justice and the NICE approach. Journal of Medical Ethics 2015;41(1):99-102. Download from BMJ
  • Cookson RGutacker N, Garcia-Armesto S, et al. Socioeconomic inequality in hip replacement in four European countries from 2002 to 2009 – area level analysis of hospital data. European Journal of Public Health 2015;25(suppl1):21-27. Download from Oxford journals
  • Corbett M, Heirs M, Rose M, Smith A, Stirk L, Richardson G, et al. The delivery of chemotherapy at home: an evidence synthesis. Health Services and Delivery Research 2015;3:14. Download from NIHR
  • Dakin H, Devlin N, Feng Y, Rice N, et al. The influence of cost-effectiveness and other factors on NICE decisions. Health Economics 2015;24(10):1256-1271. Download from Wiley
  • Delgadillo J, Asaria MAli S, Gilbody S. On poverty, politics and psychology: the socioeconomic gradient of mental healthcare utilisation and outcomes. The British Journal of Psychiatry 2015;doi:10.1192/bjp.bp.115.171017. Download from BJP
  • de Goeij MCM, Suhrcke M, Toffolutti V, et al. How economic crises affect alcohol consumption and alcohol-related health problems: a realist systematic review. Social Science & Medicine 2015;131:131-146. Download from Sciencedirect
  • Di Novi C, Jacobs R, Migheli M. The quality of life of female informal caregivers: from Scandinavia to the Mediterranean sea. European Journal of Population 2015;31(3):309-333. Download from springer
  • Drummond M. When do performance-based risk-sharing arrangements make sense? The European Journal of Health Economics 2015;16(6):569-571. Download from Springer
  • Drummond M, Husereau D. David Sackett 1934 – 2015. Value in Health 2015;18(5):549. Download from Value in Health
  • Drummond MFSculpher MJClaxton K, Stoddart GL, Torrance GW. Methods For The Economic Evaluation of Health Care Programmes. Fourth Edition: Oxford: Oxford University Press;2015. Download from OUP
  • Duarte A, Walker J, Walker SRichardson G, Holm Hansen C, Martin P, Murray G, Sculpher M, Sharpe M. Cost-effectiveness of integrated collaborative care for comorbid major depression in patients with cancer. Journal of Psychosomatic Research 2015;79(6):465-70. Download from ScienceDirect
  • Dusheiko MGravelle H, Martin S, Smith PC. Quality of disease management and risk of mortality in English primary care practices. Health Services Research 2015;50(5):1452-1471. Download from Wiley
  • Faria R, Hernandez Alava M, Manca A, Wailoo A. The use of observational data to inform estimates of treatment effectiveness in technology appraisal: methods for comparative individual patient data. NICE DSU technical support document 17;2015. NICE. Download from NDSU
  • Faria RWeatherly HLA, Kiss N, Manca A, Parker GM, Beresford B A, Aspinal FJ. The challenges in evaluating the cost-effectiveness of complex interventions. Value in Health 2015;18(7):A727-A728. Download from Value in Health
  • Galdas P, Darwin Z, Fell J, Kidd L, Bower P, Blickem C, McPherson K, Hunt K, Gilbody S, Richardson G. A systematic review and metaethnography to identify how effective, cost-effective, accessible and acceptable self-management support interventions are for men with long-term conditions (SELF-MAN). Health Services and Delivery Research 2015;3(34). Download from NIHR
  • Galdas P, Fell J, Bower P, et al, Richardson G. The effectiveness of self-management support interventions for men with long term conditions: a systematic review and meta-analysis. BMJ Open 2015;5(3):e006620. Download from BMJ   
  • Gaughan J, Gravelle H, Siciliani L. Testing the bed-blocking hypothesis: does nursing and care home supply reduce delayed hospital discharges? Health Economics 2015;24(S1):32–44. Download from Wiley
  • Giannopoulou C, Sideris E, Wade R, Moe-Byrne T, Eastwood A, McKenna C.  Ipilimumab for previously untreated unresectable malignant melanoma: a critique of the evidence. PharmacoEconomics 2015;33(12):1269-1279. Download from Springer
  • Goddard M. Competition in healthcare: Good, bad or ugly? International Journal of Health Policy and Management 2015;4(9):567-569. Download from IJHPM
  • Goddard M, Sheldon T. Reflecting on the impact of health services research on society. Journal of Health Services Research & Policy 2015;20(4):201. Download from Sage journals
  • Goryakin Y, Lobstein T, James WPT, Suhrcke M. The impact of economic, political and social globalization on overweight and obesity in 56 low and middle income countries. Social Science & Medicine 2015;133:67-76. Download from Sciencedirect
  • Goryakin Y, Rocco L, Suhrcke M, Roberts B, McKee M. Fruit and vegetable consumption in the former Soviet Union: the role of individual and community-level factors. Public Health Nutrition 2015;18(15):2825-1835. Download from Cambridge journals
  • Goryakin Y, Suhrcke M, Roberts B, McKee M. Mental health inequalities in 9 former Soviet Union Countries: evidence from the previous decade. Social Science & Medicine 2015;124:142-51. Download from ScienceDirect
  • Grašič KMason ARStreet A. Paying for the quantity and quality of hospital care: the foundations and evolution of payment policy in England. Health Economics Review 2015;5(15). Download from Health economics review
  • Gutacker N, Bloor K, Cookson R. Comparing the performance of the Charlson/Deyo and Elixhauser co-morbidity indices across five European countries and three conditions. European Journal of Public Health 2015;(suppl1):15-20. Download from Oxford journals
  • Gutacker N, Bloor K, Cookson R, Garcia-Armesto S, Bernal-Delgado E. Comparing hospital performance within and across countries: an illustrative study of coronary artery bypass graft surgery in England and Spain. European Journal of Public Health 2015;25(suppl1):28-34. Download from Oxford journals
  • Gutacker N, Harris A, Brennan D, Hollingsworth B. The determinants of dentists’ productivity and the measurement of output. Social Science & Medicine 2015;124:76-84. Download from ScienceDirect
  • Gutacker NMason A, Kendrick T, Goddard MGravelle H, Gilbody S, Aylott L, Wainwright J, Jacobs R. Does the quality and outcomes framework reduce psychiatric admissions in people with serious mental illness? A regression analysis. BMJ Open 2015;5(4):e007342. Download from bmjopen
  • Gutacker NStreet A, Gomes C, Bojke C. Should English healthcare providers be penalised for failing to collect patient-reported outcome measures (PROMs)? A retrospective analysis. Journal of the Royal Society of Medicine 2015;108(8):304-316. Download from sagepub
  • Halliday S, Formby A, Cookson R. An assessment of the court’s role in the withdrawal of clinically assisted nutrition and hydration from patients in the permanent vegetative state. Medical Law Review 2015;23(4):556-587. Download from Oxford Academic
  • Harris M, Knott R, Lorgelly P, Rice N. Survey self-assessments, reporting behaviour and the use of externally collected vignettes. Bankwest Curtin Economics Centre Working Paper 15/8;Perth:Curtin University. 2015. Download from Curtin
  • Hernandez-Quevedo C, Weatherly H. Health promotion, disease prevention and health inequalities. In McDaid D, Sassi F, Merkur S (eds.). Promoting Health, Preventing Disease: The Economic Case. Chapter 12;pp:259-278. 2015. Open University Press, Maidenhead, UK.  
  • Hinde SMcKenna C, Whyte S, Peake M, Callister M, Rogers T, Sculpher M. Modelling the cost-effectiveness of public awareness campaigns for the early detection of non-small cell lung cancer. British Journal of Cancer2015;113(1):135-41. Download from BJC
  • Hinde SSpackman E. Bidirectional citation searching to completion: an exploration of literature searching methods. Pharmacoeconomics 2015;33(1):5-11. Download from Springer
  • Howdon D, Jones AM. A discrete latent factor model for smoking, cancer and mortality. Economics & Human Biology 2015;18:57-73. Download from Elsevier
  • Husereau D, Drummond M, Petrou S, et al. Reply to Roberts et al.: CHEERS is sufficient for reporting cost-benefit analysis, but may require further elaboration. PharmacoEconomics 2015;33(5):535-536. Download from Springer
  • Ijzerman M, Manca A, Keizer J, Ramsey S. Implementation of comparative effectiveness research in personalized medicine applications in oncology: current and future perspectives. Comparative Effectiveness Research 2015;5:65-72. Download from Dovepress
  • Jacobs RGutacker NMason AGoddard MGravelle H, Kendrick T. Do higher primary care practice performance scores predict lower rates of emergency admissions for persons with serious mental illness? An analysis of secondary panel data. NIHR HS & DR Journal 2015;3(16). Download from NIHR
  • Jacobs RGutacker NMason AGoddard MGravelle H, et al. Determinants of hospital length of stay for people with serious mental illness in England and implications for payment systems: a regression analysis. BMC Health Services Research 2015;15:439. Download from Biomed Central
  • Johnson M, Kanaan M, Richardson G, et al.  A randomised controlled trial of three or one breathing technique training sessions for breathlessness in people with malignant lung disease. BMC Medicine 2015;13:213. Download from BioMed Central
  • Jones AM, Lomas J, Moore PT, Rice N. A quasi-Monte-Carlo comparison of parametric and semiparametric regression methods for heavy-tailed and non-normal data: an application to healthcare costs. Journal of the Royal Statistical Society: Series A (Statistics in Society) 2015;doi:10.1111/rssa.12141. Download from Wiley
  • Jones AM, Lomas JRice N. Healthcare cost regressions: going beyond the mean to estimate the full distribution. Health Economics 2015;24(9):1192-1212. Download from Wiley
  • Kasteridis PMason AGoddard MJacobs RSantos R, McGonigal G. The influence of primary care quality on hospital admissions for people with dementia in England: a regression analysis. PLoS One 2015;10(3):e0121506. Download from plosoneDementia Lay Summary (PDF  , 353kb), , Dementia S2 Appendix (PDF  , 50kb)
  • Kasteridis PStreet A, Dolman M, et al. Who would benefit most for improved integrated care? Implementing an analytical strategy in South Somerset. International Journal of Integrated Care 2015;15:Jan-Mar:1-11. Download from ijic
  • Khan J, Trujillo A, Ahmed S, Siddiquee AT, Alam N, Mirelman A, et al. Distribution of chronic disease mortality and deterioration in household socioeconomic status in rural Bangladesh: an analysis over a 24-year period. International Journal of Epidemiology 2015;44(6):1917-1926. Download from Oxford Academic
  • Kronenberg C, Jacobs R, Zucchelli E. The impact of a wage increase on mental health: Evidence from the UK minimum wage. Health, Econometrics and Data Group (HEDG), University of York 2015; working paper 15/08Download from HERC
  • Kumar G, Woods B, et al. Cost-effectiveness of first-line induction and maintenance treatment sequences in non-squamous non-small cell lung cancer (NSCLC) in the U.S. Lung Cancer 2015;89(3):294-300. Download from ScienceDirect
  • Lakshman R, Whittle F, Hardeman W, Suhrcke M, et al. Effectiveness of a behavioural intervention to prevent excessive weight gain during infancy (The Baby Milk Trial): study protocol for a randomised controlled trial. Trials 2015;16:442. Download from Trialsjournal
  • Lipton JH, Bryden P, Sidhu MK, et al, Woods B, et al. Comparative efficacy of tyrosine kinase inhibitor treatments in the third-line setting, for chronic-phase chronic myelogenous leukemia after failure of second-generation tyrosine kinase inhibitors. Leukemia Research 2015;39(1):58-64. Download from Elsevier
  • Littlewood E, Duarte A, Hewitt C, Knowles S, Palmer SWalker S, et al on behalf of the REEACT Team. A randomised controlled trial of computerised cognitive behaviour therapy for the treatment of depression in primary care: the Randomised Evaluation of the Effectiveness and Acceptability of Computerised Therapy (REEACT) trial. Health Technology Assessment 2015;19(101). Download from NIHR
  • Love-Koh JAsaria MCookson RGriffin S. The social distribution of health: Estimating quality-adjusted life expectancy in England. Value in Health 2015;18(5):655-662. Download from ScienceDirect
  • Mannion R, Davies H, Freeman T, Millar R, Jacobs RKasteridis P. Overseeing oversight: governance of quality and safety by hospital boards in the English NHS. Journal of Health Services Research and Policy 2015;20:(1):1-8. Download from Sagepub
  • Martin A, Panter J, Suhrcke M, Ogilvie D. Impact of changes in mode of travel to work on changes in body mass index: evidence from the British Household Panel Survey. Journal of Epidemiology & Community Health 2015;69(8):753-761. Download from BMJ
  • Mason AGoddard MWeatherly HChalkley M. Integrating funds for health and social care: an evidence review. Journal of Health Services Research & Policy 2015;20(3):177-188. Download from Sagepub
  • McGuire A, Drummond MF, Martin M, Just N. End of life or end of the road? Are rising cancer costs sustainable? Is it time to consider alternative incentive and funding schemes? Expert Review of Pharmacoeconomics and Outcomes Research 2015;15(4): 599-605. Download from Tandfonline
  • McKenna CSoares M, Claxton KBojke LGriffin SPalmer SSpackman E. Unifying research and reimbursement decisions: case studies demonstrating the sequence of assessment and judgments required. Value in Health 2015;18(6):865-875. Download from ScienceDirect
  • McMillan A, Bratton D, Faria R, et al. A multicentre randomised controlled trial and economic evaluation of continuous positive airway pressure for the treatment of obstructive sleep apnoea syndrome in older people: PREDICT. Health Technology Assessment 2015;19(40). Download from NIHR
  • Mirelman A, Blythe Ballard S, Saito M, et al. Cost-effectiveness of norovirus vaccination in children in Peru. Vaccine 2015;33(27):3084-3091. Download from ScienceDirect
  • Monsivais P, Martin A, Suhrcke M, et al. Job-loss and weight gain in British adults: Evidence from two longitudinal studies. Social Science & Medicine 2015;143:223-231. Download from Sciencedirect
  • Montresor A, A Porta N, Albonico M, Gabrielli AF, Jankovic D, et al. Soil-transmitted helminthiasis: the relationship between prevalence and classes of intensity of infection. Transactions of the Royal Society of Tropical Medicine and Hygiene 2015;109(4):262-267. Download from Oxford Academic
  • Moran VJacobs R. Comparing the performance of English mental health providers in achieving patient outcomes. Social Science & Medicine 2015;140:127-136. Download from Elsevier
  • Nakamura RSuhrcke M, et al. Price promotions on healthier vs. less healthy foods: a hierarchical regression analysis of the impact on sales and social patterning of responses to promotions in Great Britain. American Journal of Clinical Nutrition 2015;101(4):808-816. Download from AJCN
  • Pan J, Liu D, Ali S. Patient dissatisfaction in China: What matters. Social Science and Medicine 2015;143:145-153. Download from ScienceDirect
  • Pennington M, Baker R, Werner B, et al, Manca A, The EuroVaQ Team. Comparing WTP values of different types of QALY gain elicited from the general public. Health Economics 2015;24(3):280-293. Download from Wiley
  • Phillips A, et al, Revill P. (Working group on modelling of antiretroviral therapy monitoring strategies in sub-Saharan Africa). Sustainable HIV treatment in Africa through viral-load-informed differentiated care. Nature2015;528:7580:S68–S76. Download from nature
  • Pichon-Riviere A, Garay OU, Augustovski F, Vallejos C, Huayanay L, del Pilar Navia Bueno M, Rodriguez A, Coelho de Andrade CJ, Buendia JA, Drummond MF. Implications of global pricing policies on access to innovative drugs: the case of trastuzumab in seven Latin American countries. International Journal of Technology Assessment in Health Care 2015;31(1-2):2-11. Download from Cambridge UP
  • Portrait F, Bakker M, Slootman B, Gafni A, van den Berg B. How do patients receiving radiotherapy in a Dutch hospital value their time? A contingent valuation study. Journal of Radiotherapy in Practice 2015;14(2):152-161. Download from Cambridge UP
  • Revill P, Hallett T, Phillips A. The costs and benefits of alternatives approaches to monitoring patients on antiretroviral therapy: modelling and economic analysis, HIV Modelling Consortium report for the World Health Organization HIV Treatment Guidelines Development Committee 2015. Download from HIV modelling 
  • Revill PWalker S, Mabugu T, Nathoo KJ, Mugyenyi P, Kekitinwa A, et al, Sculpher M, Gibb DM. Opportunities for improving the efficiency of paediatric HIV treatment programmes. AIDS 2015;29(2):201-210. Download from Wolters Kluwer
  • Revill PWoods BSculpher M. Economic evaluation of healthcare programs and interventions: Applications to low- and middle-Income. In: Scheffler RM, (ed). World Scientific Handbook of Global Health Economics and Public Policy Volume 1 2015. More details
  • Ricciardi GW, Toumi M, Weil-Olivier C, et al, Drummond M. Comparison of NITAG policies and working processes in selected developed countries. Vaccine 2015;33(1):3-11. Download from Elsevier
  • Richardson R, Trépel D, Perry A, Ali S, Duffy S, Gabe R, Gilbody S, Glanville J, Hewitt C, Manea L, Palmer S, et al. Screening for psychological and mental health difficulties in young people who offend: a systematic review and decision model. Health Technology Assessment 2015;19(1). Download from NIHR
  • Ripley DP, Brown JM, Everett CC,  Bijsterveld P, Walker S, Sculpher M, et al.  Rationale and design of the Clinical Evaluation of Magnetic Resonance Imaging in Coronary heart disease 2 trial (CE-MARC ): A prospective, multicenter, randomized trial of diagnostic strategies in suspected coronary heart disease. American Heart Journal 2015;169(1): 17-24e1. Download from ahjonline
  • Robling M, Bekkers M-J, Bell K, Butler C, et al, Richardson G, et al. Effectiveness of a nurse-led intensive home-visitation programme for first-time teenage mothers (Building Blocks): a pragmatic randomised controlled trial. The Lancet 2015;387(10014):146-155. Download  from The Lancet
  • Rogowski W, Payne K, Schnell-Inderst P, Manca A, et al. Concepts of ‘personalization’ in personalized medicine: implications for economic evaluation. PharmacoEconomics 2015;33(1):49-59. Download from Springer
  • Ruggeri M, Manca A, Coretti S, et al. Investigating the generalizability of economic evaluations conducted in Italy: A critical review. Value in Health;2015:18(5):709-20. Download from Value in Health
  • Santana P, Santos R, Alves I, et al. Avaliação das condições individuais e contextuais no peso dos recém‐nascidos (filhos de mães imigrantes e portuguesas) na área metropolitana de Lisboa. Revista Portuguesa de Saude Publica 2015;33(2):157-169. Download from Sciencedirect 
  • Scott DA, Woods B, Thompson JC, et al.  Mortality and drug therapy in patients with chronic obstructive pulmonary disease: a network meta-analysis. BMC Pulmonary Medicine 2015;15:145. Download from biomedcentral
  • Sculpher M, Clinical trials provide essential evidence, but rarely offer a vehicle for cost-effectiveness analysis. Value in Health 2015;18(2):141-2. Download from Value in Health
  • Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: a global systematic review. PharmacoEconomics 2015;33(8):811-831. Download from Springer
  • Seuring T, Goryakin Y, Suhrcke M. The impact of diabetes on employment in Mexico. Economics & Human Biology 2015;18:85-100. Download from Sciencedirect
  • Shepherd K, Hubbard D, Fenton N, Claxton K, et al. Policy: Development goals should enable decision-making. Nature 2015;523(7559):152-154. Download from Nature 
  • Stamuli E, Richardson G, Duffy S, et al. Systematic review of the economic evidence on home visitation programmes for vulnerable pregnant women. British Medical Bulletin 2015;115(1):19-44. Download from Oxford UP 
  • Sorenson C, Drummond MF, et al. The role of hospital payments in the adoption of new medical technologies: an international survey of current practice. Health Economics, Policy and Law 2015;10(2):133-59. Download from Cambridge UP
  • Street ANot as it seems: Productivity growth isn't always a good thing. Health Service Journal 9 April 2015.
  • Suhrcke M, Kenkel D. Social determinants of health: early childhood development and education. In: McDaid D, Sassi S, Merkur S (eds.). Promoting Health, Preventing Disease: The Economic Case. Chapter 11;pp:237-256. 2015. Open University Press, Berkshire, UK. 
  • Threlfall AG, Meah S, Fischer AJ, Cookson R, et al. The appraisal of health interventions: The use of theory. Journal of Public Health 2015;37(1):166-171. Download from Oxford journals
  • Tsoi B, O’Reilly D, Masucci L, Drummond MF, et al. Harmonization of HTA-based reimbursement and regulatory approval activities: a qualitative study. Journal of Population Therapeutics and Clinical Pharmacology 2015;22(1):e78-e89. Download from JPTCP
  • Vogl M, Leidl R, Plotz W, Gutacker N. Comparison of pre- and post-operative health-related quality of life and length of stay after primary total hip replacement in matched English and German patient cohorts. Quality of Life Research 2015;24(2):513-520. Download from springer
  • Waddell KM, Kagame K, Ndamira A, Twinamasiko A, Picton SV, Simmons IG, Revill P, et al. Improving survival of retinoblastoma in Uganda. British Journal of Ophthalmology 2015;99(7):937-942Download from bjo 
  • Wade R, Duarte A, Simmonds M, Rodriguez-Lopez R, Duffy S, Woolacott N, Spackman E. The clinical and cost effectiveness of aflibercept in combination with irinotecan and fluorouracil-based therapy (FOLFIRI) for the treatment of metastatic colorectal cancer which has progressed following prior oxaliplatin-based chemotherapy: a critique of the evidence. Pharmacoeconomics 2015;33(5):457-466. Download from Springer
  • Wade R, Sideris E, Paton F, Rice S, Palmer S, Fox D, Woolacott N, Spackman E. Graduated compression stockings for the prevention of deep-vein thrombosis in postoperative surgical patients: a systematic review and economic model with a value of information analysis. Health Technology Assessment 2015;19(98). Download from NIHR
  • Welton N J, Soares MOPalmer S, et al. Accounting for heterogeneity in relative treatment effects for use in cost-effectiveness models and value-of-information analyses. Medical Decision Making 2015;35(5):608-621. Download from Sage
  • Westby MJ, Dumville JC, Soares MO, et al. Dressings and topical agents for treating pressure ulcers. Cochrane Database of Systematic Reviews 2015;Issue 11:Art No.:CD011947. Download from Wiley
  • Wilkinson G, Drummond MF. Alternative approaches for assessing the socioeconomic benefits of medical devices: a systematic review. Expert Review of Medical Devices 2015;12(5):629-648. Download from tandfonline
  • Woods B, Hawkins N, Mealing S, Sutton A, Abraham WT, Beshai JF, Klein H, Sculpher M, et al. Individual patient data network meta-analysis of mortality effects of implantable cardiac devices. Heart 2015;101(22):1800-1806. Download from Heart
  • Woods B, Llewellyn A, Faria R, Simmonds M, Lomas J, Harden M, Woolacott N, Griffin S. Evidence Review Group's Report: Daclatasvir for treating chronic hepatitis C. TA364 Report to NICE. 2015. Download from NICE
  • Wright B, Barry M, Hughes E, Trépel D, Ali S, Allgar V, Cottrill L, Duffy S, Fell J, Glanville J, Glaser D, Hackney L, Manea L, McMillan D, Palmer S, et al. Clinical effectiveness and cost-effectiveness of parenting interventions for children with severe attachment problems: a systematic review and meta-analysis. Health Technology Assessment 2015;19(52). Download from NIHR

2013/2014

2014

  • Allen T, Sutton M, Cookson R. How do economic incentive schemes influence rationing decisions by primary care physicians?  In: Danis M, Hurst SA, Fleck L, Forde R, Slowther A. (Eds).  Fair Resource Allocation and Rationing at the Bedside.Oxford University Press;2014:Ch7.
  • Ara R, Basarir H, Keetharuth A, Barbieri M, Weatherly HSculpher M, Ahmed H, Brown S. Are policy decisions on surgical procedures informed by robust economic evidence? A systematic review. International Journal of Technology Assessment in Health Care 2014;30(4):381-393. Download from Cambridge Journals
  • Asaria M, Cookson R, Griffin S. ‌. In:Culyer AJ (ed.) Encyclopedia of Health Economics, Vol 1. San Diego:Elsevier;2014. pp.22-26.
  • Ashby RL, Gabe R, Ali S, Adderley UJ, Bland M, et al, Soares MO, et al. Clinical and cost-effectiveness of compression hosiery versus compression bandages in treatment of venous leg ulcers  (Venous leg Ulcer Study IV, VenUS IV): a randomised controlled trial. Lancet 2014;383(9920):871-879.
  • Ashby RL, Gabe R, Ali SSaramago P, et al, Soares M, Stubbs N, Torgerson D. VenUS IV (Venous leg Ulcer Study IV) - compression hosiery compared with compression bandaging in the treatment of venous leg ulcers: a randomised controlled trial, mixed-treatment comparison and decision-analytic model. Health Technology Assessment 2014;18(57). Download from NIHR
  • Barbieri M, Richardson G, Paisley S, Sculpher MRapid review of existing literature on the cost-effectiveness of alternative systems for diagnosis and referral of any cancer in primary care. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) 2014; Research Report 020. Download from EEPRU
  • Barbieri M, Richardson G, Paisley S, Sculpher MRapid review of existing literature on the cost-effectiveness of follow-up strategies after cancer treatment. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) Research Report 021. Download from EEPRU
  • Barbieri M, Weatherly HLA, Ara R, Basarir H, Sculpher M, Adams R, Ahmed H, Coles C, Guerrero-Urbano T, Nutting C, Powell M. What is the quality of economic evaluations of non-drug therapies? A systematic review and critical appraisal of economic evaluations of radiotherapy for cancer. Applied Health Economics and Health Policy 2014;12(5):497-510. Download from Springer
  • Bardsley M, Street A. Cost of integrated care. In: Curtis L. (ed). Unit Costs of Health & Social Care 2014. PSSRU University of Kent, Canterbury;2014:pp13-18. Download from PSSRU
  • Barnett PG, Chow A, Joyce VR, Bayoumi AM, Griffin SC, Sun H, Holodniy M, Brown ST, Cameron DW, Sculpher M, Youle M, Anis AH, Owens DK.  Effect of management strategies and clinical status on costs of care for advanced HIV. American Journal of Managed Care 2014;20(5):129-137. Download from AJMC
  • Bartoll X, Palencia P, Malmusi D, Suhrcke M, Borrell C. The evolution of mental health during the Spanish economic crisis. European Journal of Public Health 2014;24(3):415-418. 
  • Blakeman T, Blickem C, Kennedy A, Reeves D, Bower P, Gaffney H, Gardner C, Lee V, Jariwala P, Dawson S, Bossabir R, Brooks H, Richardson G, Spackman E, Vassilev I, Chew-Graham C, Rogers A. Effect of information and telephone-guided access to community support for people with chronic kidney disease: randomised controlled trial. PLoS ONE 2014;9(10):e109135.
  • Bojke L, Soares M. Decision analysis: Eliciting experts’ beliefs to characterise uncertainties. In:Culyer AJ (ed.) Encyclopedia of Health Economics, Vol 1. San Diego:Elsevier;2014:pp149-154. 
  • Brekke KR, Gravelle H, Siciliani L, Straume OR. Patient choice, mobility and competition among health care providers. In: Levaggi R, Montefioro M (eds). Health Care Provision and Patient Mobility. Vol.12. Springer;2014 pp. 1-26.
  • Briggs A, Drummond MF. Reporting guidelines for health economic evaluation: BMJ guidelines for authors and peer reviewers of economic submissions. In:Moher D, Altman DG, Schulz KF, Simera I, Wager E (eds.) Guidelines for Reporting Health Research: A Users Manual. John Wiley & Sons;2014. 
  • Brilleman SL, Gravelle H, Hollinghurst S, Purdy S, Salisbury C, Windmeijer F.  Keep it simple? Predicting primary health care costs with clinical morbidity measures. Journal of Health Economics 2014; 35:109-122.
  • Buxton M, Longworth L, Raftery J, Sculpher M, Towse A.  Reforming the cancer drug fund: focus on drugs that might be shown to be cost effective. BMJ 2014;349:g7276. Download from BMJ
  • Callery P, Kyle RG, Weatherly H, Banks M, Ewing C, Powell P, Kirk S. Substituting community children's nursing services for inpatient care: a case study of costs and effects. Emergency Medicine Journal 2014;31(e55-e59). Download from BMJ.
  • Carrieri V, Di Novi C, Jacobs R, Robone S. Insecure, sick and unhappy? Well-being consequences of temporary employment contracts, Chapter 4. In: Polachek SW, Tatsiramos K (eds). Factors Affecting Worker Well-Being: The Impact of Change in the Labor MarketBook Series. Research in Labor Economics Vol.40. 2014;pp. 157-193:Emerald Group Publishing Limited:ISBN:978-1-78441-150-3.
  • Cary M, Byford S, Faria R. Measurement and valuation of health outcomes for economic evaluation and decision-making in healthcare. In Faria R, Mejia A (eds). Guidelines for the economic evaluation of healthcare technologies in Colombia: technical support documents. Instituto de Evaluación Tecnológica en Salud. Bogotá D.C.:IETS;2014 pp. 5-14. 
  • Chan AK, Ford D, Namata H, Muzambi M, Nkhata MJ, Abongomera G, Mambule I, South A, Revill P  et al and the Lablite Team. The Lablite project: A cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe. BMC Health Services Research 2014;14:352.
  • Christiansen T, Cookson RGutacker N, García-Armesto S, Angulo-Pueyo E, Bernal-Delgado E, on behalf of the ECHO consortium. Handbook on methodology: Measurement of socioeconomic equity; ECHO 2014: Apr 27.
  • Claxton K, Revill P, Sculpher M, Wilkinson T, Cairns J, Briggs A. The Gates Reference Case for Economic Evaluation. The Bill and Melinda Gates Foundation;2014. Methods for Economic Evaluation Project (MEEP) (PDF  , 2,265kb)
  • Cockayne S, Pattenden J, Worthy G, Richardson G, Lewin R. Nurse facilitated Self-management support for people with heart failure and their family carers (SEMAPHFOR): a randomised controlled trial. International Journal of Nursing Studies 2014;51(9); 1207-1213. 
  • Conklin AI, Forouhi NG, Suhrcke M, Surtees P, Wareham NJ, Monsivais P. Variety more than quantity of fruit and vegetable intake varies by socioeconomic status and financial hardship. Findings from older adults in the EPIC cohort. Appetite 2014;83: 248-55.
  • Cookson R, Griffin S, Nord E. Incorporation of concerns for fairness in economic evaluation of health programs: overview. In: Culyer AJ (ed.) Encyclopedia of Health Economics, Vol 1. San Diego:Elsevier;2014. pp27-34.
  • Cookson RSuhrcke M. Public Health: Overview. In: Culyer AJ (ed.) Encyclopedia of Health Economics, Vol 1. San Diego :Elsevier;2014. pp. 210-217. 
  • Drummond M. Why has Sweden been so prominent in health economics? In: Culyer A, Kobelt G, (eds). Portrait of a Health Economist. Lund, Sweden. The Swedish Institute for Health Economics 2014;pp:39-44.
  • Drummond M, de Pouvourville G, Jones E, Haig J, Saba G, Cawston H. A comparative analysis of two contrasting European approaches for rewarding the value added by drugs for cancer: England versus France. Pharmacoeconomics 2014;32(5):509-20.
  • Drummond M, Towse A. Orphan drugs policies: a suitable case for treatment. European Journal of Health Economics 2014;15(4):335-340.
  • Duarte A. Discounting in economic valuation of healthcare interventions. In Faria R, Mejia A (eds). Guidelines for the economic evaluation of healthcare technologies in Colombia: technical support documents. Instituto de Evaluación Tecnológica en Salud. Bogotá D.C.:IETS;2014 pp. 15-24.
  • Dusheiko M. Patient choice and mobility in the UK health system: internal and external markets. In : Levaggi R, Montefioro M (eds). Health Care Provision and Patient Mobility,Vol.12. Springer;2014 pp.81-132. 
  • Eaton J, Menzies NA, Stover J, et al, Revill P, Sangrujee N, et al. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Global Health 2014;2(1):e23-34. Download from the Lancet
  • Epstein D, Sculpher MJ, Powell JT, Thompson SG, Brown LC, Greenhalgh RM (2014).  Long-term cost-effectiveness analysis of endovascular versus open repair for abdominal aortic aneurysm based on four randomized clinical trials.  British Journal of Surgery 2014;101(6):623–631.
  • Espinoza MA, Manca A, Claxton K, Sculpher MJ.  The value of heterogeneity for cost-effectiveness subgroup analysis: conceptual framework and application. Medical Decision Making 2014;34(8):951-964. Download from sagepub
  • Espinoza MA, Sculpher MJ, Manca A, Basu A. Analysing heterogeneity to support decision making. In: Culyer AJ (ed.) Encyclopedia of Health Economics, Vol 1. San Diego:Elsevier;2014. pp.71-76.
  • Essat M, Faria R, Gomersall T, Grimm S, Keetharuth A, Walker S, Dixon S, Palmer S, Sculpher M. (2014). Getting cost-effective technologies into practice: the value of implementation. Initial scoping review for phase 1. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU)2014; Research Report 023:pp172. Download from EEPRU
  • Faria R, Barbieri M, Light K, Elliott KA, Sculpher MJ. The economics of medicines optimization: policy developments, remaining challenges and research priorities. British Medical Bulletin 2014;111(1):45-61. Download from Oxfordjournals
  • Faria R, Barbieri M, Light K, Sculpher MEconomics of Medicines Optimisation: Report for the Department of Health. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) 2014;research report RR0005:pp38. Download from EEPRU
  • Faria R, Gomes M, Epstein D, White IR. A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials. PharmacoEconomics 2014;32(12):1157-1170. Download from springer
  • Faria R, McKenna C, Palmer S. Optimizing the position and use of omalizumab for severe persistent allergic asthma using cost-effectiveness analysis. Value in Health 2014;17(8): 772-782. 
  • Faria R, Mejia A (eds). Guidelines for the economic evaluation of healthcare technologies in Colombia: technical support documents. Instituto de Evaluación Tecnológica en Salud. Bogotá D.C.;IETS:2014.pp55.
  • Faria RRevill P. Decision rules in economic evaluation of healthcare interventions. In Faria R, Mejia A (eds). Guidelines for the economic evaluation of healthcare technologies in Colombia: technical support documents. Instituto de Evaluación Tecnológica en Salud. Bogotá D.C.:IETS;2014 pp. 42-54. 
  • Faria RWalker S, Whyte S, Dixon S, Palmer SSculpher MGetting cost-effective technologies into practice: the value of implementation. An application to novel anticoagulants in the prevention of stroke and systemic embolism. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) 2014; Research Report 022:pp82. Download from EEPRU
  • Gaughan J. Kobel C. Coronary artery bypass grafts and diagnosis related groups: Patient classification and hospital reimbursement in 10 European countries. Health Economics Review 2014;4(4).
  • Gavan S, Harrison M, Iglesias Urrutia CP, Barton A, Manca A, Payne K. Economics of stratified medicine in rheumatoid arthritis. Current Rheumatology Reports 2014;16:468.
  • Goryakin Y, Suhrcke M. The prevalence and determinants of catastrophic health expenditures attributable to non-communicable diseases in low- and middle-income countries: a methodological commentary. International Journal for Equity in Health 2014;13:107. 
  • Goryakin Y, Suhrcke M. Economic development, urbanisation, technological change and overweight: what do we learn from 244 Demographic and Health Surveys? Economics and Human Biology 2014;14:109–127. 
  • Gravelle H, Santos RSiciliani L. Does a hospital’s quality depend on the quality of other hospitals? A spatial econometrics approach. Regional Science and Urban Economics 2014;49:203-216. Download from ScienceDirect
  • Griffiths A, Paracha N, Davies A, Branscombe N, Cowie MR, Sculpher MJ.  The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective. Heart 2014;100:1031-1036. Download from BMJ
  • Haakma W, Steuten LM, Bojke L, IJzerman MJ. Belief elicitation to populate health economic models of medical diagnostic devices in development. Applied Health Economics and Health Policy 2014;12(3):327-34.
  • Hall J, Buckley HL, Lamb KA, Stubbs N, Saramago P, Dumville JC, Cullum NA. Point prevalence of complex wounds in a defined United Kingdom population. Wound Repair and Regeneration 2014;22(6):694-700.
  • Hallett TB, Menzies NA, Revill P, Keebler D, Borquez A, McRobie R, Eaton JW, Using modeling to inform international guidelines for antiretroviral therapy. AIDS 2014;28(S1):S1-S4.
  • Harrison M, Dusheiko M, Sutton M, Gravelle H, Doran T, Roland M. Effect of a national primary care pay for performance scheme on emergency hospital admissions for ambulatory care sensitive conditions: controlled longitudinal study. BMJ 2014;349:g6423. 
  • Hinde S, Soares M, Burch J, Marson A, Woolacott N, Palmer S. The added clinical and economic value of diagnostic testing for epilepsy surgery. Epilepsy Research 2014;108(4)775-781. Download from sciencedirect
  • Jacobs R. Payment by results for mental health services: economic considerations of case-mix funding. Advances in Psychiatric Treatment 2014;20:155-164.
  • Jones AM, Laporte A, Rice N, Zucchelli E. A synthesis of the Grossman and Becker-Murphy models of health and addiction: theoretical and empirical implications. Health, Econometrics and Data Group (HEDG), University of York 2014; working paper 14/07Download from HERC
  • Jones AM, Lomas J, Rice N. Going beyond the mean in healthcare cost regressions: a comparison of methods for estimating the full conditional distribution. Health Econometrics and Data Group (HEDG), University of York 2014;working paper 14/26Download from HERC
  • Jönsson L, Sandin R, Ekman M, Ramsberg J, Charbonneau C, Huang X, Jönsson B, Weinstein M, Drummond MF. Analyzing overall survival in randomized controlled trials with cross-over and implications for economic evaluation. Value in Health 2014;17(6);707-713.
  • Kasteridis P, Yen S. Occasional smoking and body weight among adults. Applied Economic Perspectives and Policy 2014;36(3):479-503.
  • Keebler D, Revill P, (joint 1st authors) et al, Walker S, Welte A, et al.  Cost effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models. Lancet Global Health 2014;2(1):e35-43.
  • Kronenberg C, Barros PP. Catastrophic healthcare expenditure–drivers and protection: The Portuguese case. Health Policy 2014;115(1):44-51. Download from elsevier
  • Lin B, Ver Ploeg M, Kasteridis P, Yen ST. The roles of food prices and food access in determining food purchases of low-income households. Journal of Policy Modeling 2014;36(5):938-952.
  • Listl S, Chalkley M. Provider payment bares teeth: Dentist reimbursement and the use of check-up examinations. Social Science & Medicine 2014;111:110-116.
  • Madan J, Ades AE, Price M, Maitland K, Jemutai J, Revill P, Welton NJ. Strategies for the efficient computation of the expected value of partial perfect information. Medical Decision Making 2014;34(3):327-342. Download from sagepub 
  • Mason A, Goddard M, Weatherly H. Financial mechanisms for integrating funds for health and social care: do they enable integrated care?  International Journal of Integrated Care 2014;14(6);Annual Conference Supplement;URN:NBN:NL:UI:10-1-116181. 
  • McKenna C. Uncertainty and the value of additional evidence in health care decisions. In Faria R, Mejia A. (eds). Guidelines for the economic evaluation of healthcare technologies in Colombia: technical support documents. Instituto de Evaluación Tecnológica en Salud. Bogotá D.C.:IETS;2014 pp. 25-41. Download from IETS
  • McMillan A, Bratton DJ, Faria R, Laskawiec-Szkonter M, Griffin S, Davies RJ, Nunn AJ, Stradling JR, Riha RL, Morrell MJ. Continuous positive airway pressure in older people with obstructive sleep apnoea syndrome (PREDICT): a 12-month, multicentre, randomised trial. The Lancet, Respiratory Medicine 2014;2(10):804-812. 
  • Mejia A, Richardson G, Pattenden J, Cockayne S, Lewin R. Cost-effectiveness of a nurse facilitated, cognitive behavioural self-management programme compared with usual care using CBT manual alone for patients with heart failure: secondary analysis of data from the SEMAPHFOR trial. International Journal of Nursing Studies 2014;51(9):1214-1220.
  • Norheim O, Johri M, Chisholm D, et al, Cookson R, Daniels N, Danis M, et al. Guidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysis. Cost Effectiveness and Resource Allocation 2014;12:18.
  • Panagioti M, Richardson G, Small N, et al. Self-management support interventions to reduce health care utilisation without compromising outcomes: a systematic review and meta-analysis.  BMC Health Services Research 2014;14:356.
  • Penazzato M, Revill P, Prendergast AJ, Collins IJ, Walker S, Elyanu P, Sculpher M, Gibb D. Early infant diagnosis of HIV infection in low and middle income countries: Does one size fit all? Lancet Infectious Diseases 2014;14(7):650-655. Download from the lancet
  • Phillips A, Cambiano V, Miners A, Revill P, et al. Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysisThe Lancet HIV 2014;1(2):e85-e93. Download from Elsevier
  • Phillips A, Cambiano V, Nakagawa F, et al,  Revill P. Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settings. PLoS ONE 2014;9(10);e109148. Download from plosone
  • Phillips AN, Munderi P, Revill P, El-Sadr WM, Lundgren JD. Antiretroviral therapy recommendations for the global community: aspiration versus reality. AIDS 2014;28(7):939-941. Download from aidsonline
  • Reeves D, Blickem C, Vassilev I, Brooks H, Kennedy A, Richardson G, Rogers A. The contribution of social networks to the health and self-management of patients with long-term conditions: A longitudinal study. PLoS ONE 2014;9(6):e98340.
  • Reeves D, Hann M, Rick J, Rowe K, et al, Richardson G, Kennedy A, Bower P.  Care plans and care planning in the management of long-term conditions in the UK: A controlled prospective cohort study.  British Journal of General Practice 2014;64(626):e568-e575.
  • Saramago P, Chuang LH, Soares MO. Network meta-analysis of (individual patient) time to event data alongside (aggregate) count data. BMC Medical Research Methodology 2014;14:105. Download from biomedcentral
  • Saramago P, Cooper NJ, Sutton AJ, Hayes M, Dunn K, Manca A, Kendrick D. Cost-effectiveness of interventions for increasing the possession of functioning smoke alarms in households with pre-school children: a modelling study. BMC Public Health 2014;14:459.
  • Sculpher M, Walker S, Hinde S, Claxton KResearch to inform resource allocation in health and social care. Results of a scoping study. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU)2014; Research Report 017. Download from EEPRU
  • Shih Y-CT, Mullins CD, Drummond MF. The role of economic evaluation in meeting IOM's recommendations on delivering high-quality cancer care. Value in health 2014;17(5):497-500. 
  • Siciliani LMoran V, Borowitz M. Measuring and comparing health care waiting times in OECD countries. Health Policy 2014;118(3):292-303. Download from healthpolicyjrnl 
  • Soares MO, Dumville J, Ades AE, Welton NJ. Treatment comparisons for decision making: facing the problems of sparse and few data. Journal of the Royal Statistical Society: Series A (Statistics in Society) 2014;177(1):259-279. Download from wiley
  • Soares MO, Welton NJ, Harrison DA, Peura P, Shankar-Hari M, Harvey SE, Madan J, Ades AE, Rowan KM, Palmer SJ. Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost effectiveness and value of a further randomised controlled trial. Critical Care 2014;18(6):649.
  • Soárez PC, Soares MO, Novaes HM. Modelos de decisão para avaliações econômicas de tecnologias em saúde (Decision modeling for economic evaluation of health technologies). Ciência & Saúde Coletiva 2014;19(10):4209-4222. Download from scielo 
  • Sorenson C, Drummond M. Improving medical device regulation: the United States and Europe in perspective. The Milbank Quarterly 2014;92(1):114-50.
  • Spackman E, Richmond S, Sculpher M, Bland M, et al. Cost-effectiveness analysis of acupuncture, counselling and usual care in treating patients with depression: The results of the ACUDep trial. PLoS ONE 2014;9(11):e113726.
  • Spackman ESculpher M, Howard J, Malfroy M, et al. Cost effectiveness analysis of pre-operative transfusion in patients with Sickle Cell Disease using evidence from the TAPS trial. European Journal of Haematology 2014;92(3):249-55.
  • Street A. Don’t believe the hype, productivity is rising. Health Service Journal 17 January 2014.
  • Street A. Living through the NHS’s famine years. BMJ 2014;349:g6536. Download from BMJ
  • Street A, Castelli A. Eliminating poor productivity is key to NHS improvement. Health Service Journal 13 March 2014.
  • Street A, Gutacker N, Bojke C, Devlin N, Daidone S. Variations in outcome and costs among NHS providers for common surgical procedures: econometric analyses of routinely collected data. National Institute for Health Research. Health Services and Delivery Research 2014:2(1). Download from NIHR and Download spreadsheet showing ‌
  • Street A, Kasteridis P, Martin J. Data is at the heart of Somerset's integration masterpiece, Health Service Journal, 10 April, 2014 http://www.hsj.co.uk/5069580.article#  Data video: http://www.hsj.co.uk/attachments.aspx?js=yes&height=auto&width=454&storycode=5069580&attype=V&atcode=1279348
  • Tarricone R, Ferrè F, Torbica A, Drummond MF. Generating appropriate clinical data for value assessment of medical devices: what role does regulation play? Expert Review of Pharmacoeconomics & Outcomes Research 2014;14(5):707-718.
  • van den Berg B, Fiebig D, Hall J. Well-being losses due to care-giving. Journal of Health Economics 2014;35:123-131.
  • Victoor A, Hansen J, van den Akker-van Marle M E, van den Berg B, van den Hout W B, de Jong J D. Choosing your health insurance package: A method for measuring the public's preferences for changes in the national health insurance plan. Health Policy 2014;117(2):257-165.
  • Walker SFaria R, Whyte S, Dixon S, Palmer SSculpher MGetting cost-effective technologies into practice: the value of implementation. Report on framework for valuing implementation initiatives. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU)2014;Research Report 024:pp26. Download from EEPRU
  • Walker S, Walker J, Richardson GPalmer S, Wu Q, et al, Sculpher M, Sharpe M. Cost-effectiveness of combining systematic identification and treatment of co-morbid major depression for people with chronic diseases: the example of cancer. Psychological Medicine 2014:44(7):1451-1460. Download from Cambridge journals
  • Weatherly H, Cookson R, Drummond M. Economic evaluation of public health interventions: methodological challenges. In: Culyer AJ (ed.) Encyclopedia of Health Economics, Vol 1. San Diego: Elsevier; 2014. pp217-223.
  • Weatherly H, Faria R, van den Berg B. Valuing informal care for economic evaluation. In: Culyer AJ (ed.) Encyclopedia of Health Economics, Vol 1. San Diego:Elsevier;2014. pp459-467.
  • White J, Gutacker NJacobs RMason A. Hospital admissions for severe mental illness in England: Changes in equity of utilisation at the small area level between 2006 and 2010, Social Science & Medicine 2014;120:243-251. Download from Elsevier
  • Whyte S, Dixon S, Faria RWalker SPalmer SSculpher MGetting cost-effective technologies into practice: the value of implementation. An application to B-type natriuretic peptide (BNP) testing in diagnosing chronic heart failure. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) 2014; Research Report 025:pp30. Download from EEPRU
  • Wilkinson G, Drummond M. Impact of reimbursement policies on the adoption of medical devices in an outpatient setting. Health Policy and Technology 2014;3(4):281-286. 

2013

  • Asaria M, Griffin S, Cookson R. Measuring health inequality in the context of cost-effectiveness analysis. In Rosa Dias P, O’Donnell O (eds.) Health and Inequality (Research on Economic Inequality, Volume 21), Emerald Group Publishing Limited.pp:491-507. 2013. Download from emeraldinsight
  • Ashworth M, Schofield P, Doran T, Cookson R, Sutton M, Seed P, et al. The Public Health Impact (PHI) score – a new measure of public health effectiveness for general practices in England. British Journal of General Practice. 2013;63(609):291-9.
  • Barber S, Jackson C, Akhtar S, Bingham D, Ainsworth H, Hewitt C, Richardson G, Summerbell C, Pickett K, Moore H, Routen A, O’ Malley C, Brierley S, Wright J. "Pre-schoolers in the Playground” an outdoor physical activity intervention for children aged 18 months to 4 years old: Study protocol for a randomised controlled trial. Trials 2013;14(326).
  • Bayoumi A, Barnett P, Joyce V, Griffin S, Sun H, Bansback N, Holodniy M, Sanders G, Brown S, Kyriakides T, Angus B, Cameron W, Anis A, Sculpher M, Owens D. Cost-effectiveness of newer antiretroviral drugs in treatment-experienced patients with multi-drug resistant HIV disease. Jaids-Journal of acquired immune deficiency syndromes 2013;64(4):382-391.
  • Bes RE, Van den Berg B. Ranking sources of hospital quality information for orthopedic surgery patients: consequences for the system of managed competition. The Patient - Patient-Centered Outcomes Research 2013;6(2):75-80.
  • Blickem C, Blakeman T, Kennedy A, Bower P, Reeves D, Gardner C, Lee V, Chew-Graham C, Richardson G, Brooks H, Dawson, S, Mossabir R, Jariwala, P, Swallow A, Kontopantelis E, Gaffney H, Small N, Spackman E, Rogers A. The clinical and cost-effectiveness of the BRinging Information and Guided Help Together (BRIGHT) intervention for the self-management support of people with stage 3 chronic kidney disease in primary care: study protocol for a randomized controlled trial. Trials 2013;14(1):28.
  • Bojke C, Castelli A, Laudicella M, Street A, Ward P. Regional variation in the productivity of the English National Health Service. Health Economics 2013;22(2):194-211.
  • Brilleman SL, Purdy S, Salisbury C, Windmeijer F, Gravelle H, Hollinghurst S. Implications of comorbidity for primary care costs in the UK: a retrospective observational study. British Journal of General Practice 2013;63(609):e274-e82.
  • Brown S, Dietrich M, Ortiz-Nuñez A, Taylor K. Business ownership and attitudes towards risk. Applied Economics 2013:45(13): 1731-40.
  • Busse R, Geissler A, Aaviksoo A, Cots F, Häkkinen U, Kobel C, Mateus C, Or Z, O’Reilly J, Serdén L, Street A, Swan Tan S, Quentin W. Diagnosis related groups in Europe: moving towards transparency, efficiency, and quality in hospitals? British Medical Journal 2013;346(F3197). Download from BMJ
  • Callery P, Kyle R, Weatherly H, Banks M, Ewing C, Powell P, Kirk S. Comparison of the costs of care during acute illness by two community children's nursing teams. Emergency Medicine 2013;30:1029-1032. Download from bmj
  • Castelli A, Jacobs R, Goddard M, Smith PC. Health, policy and geography: insights from a multi-level modelling approach. Social Science & Medicine 2013;92:61-73.
  • Cookson, R. Can the NICE ‘‘end-of-life premium’’ be given a coherent ethical justification? Health Politics, Policy and Law 2013;38(6):1129-1148.
  • Cookson R. Can money teach morality? Commentary on Disney, Le Grand and Atkinson. From irresponsible knaves to responsible knights for Just 5p: behavioural public policy and the environment. In Oliver A (ed). Behavioural Public Policy. Cambridge University Press 2013:pp 88-93.
  • Cookson R, Laudicella M, Li Donni P. Does hospital competition harm equity? Evidence from the English National Health Service. Journal of Health Economics 2013;32(2):410-422.
  • Cookson R, Sainsbury R, Glendinning C. (eds.) Jonathan Bradshaw on Social Policy: Selected Writings 1972-2011, University of York, York, 2013.
  • Daidone S, Street AD. How much should be paid for specialised treatment? Social Science and Medicine 2013;84:110-8. Download from Sciencedirect
  • Dakin H, Devlin N, Feng Y, Rice N, O’Neill P, Parkin D. The influence of cost-effectiveness and other factors on NICE decisions. Office for Health Economics (OHE) Research Paper 13/06; London, November 2013.
  • Dakin H, Devlin N, Feng Y, Rice N, O’Neill P, Parkin D. The influence of cost-effectiveness and other factors on NICE decisions. Health Economics Research Centre Research (HERC) Paper 01/13; University of Oxford, November 2013.
  • Davies A, Bakhai A, Schmitt C, Barrett A, Graham-Clarke P, Sculpher M. Prasugrel vs clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a model-based cost-effectiveness analysis for Germany, Sweden, the Netherlands, and Turkey. Journal of Medical Economics 2013;16(4):510–521.
  • Drummond MF. Twenty years of using economic evaluations for drug reimbursement decisions. What has been achieved? Journal of health politics policy and law 2013;38(6):1081-1102.
  • Drummond MF. Future prospects for pharmacoeconomics and outcomes research in the emerging regions. Value in Health Regional Issues May 2013;2(1):3-4.
  • Drummond MF, Daniel Mullins C. Improving the quality of papers published in pharmacoeconomics and outcomes research. Value in health 2013;16(2):229-30.
  • Drummond MF, Shemilt I, Vale L, On behalf of the Campbell and Cochrane Economic Methods group. Should the Cochrane Collaboration be producing reviews of efficiency? Cochrane Database Syst Rev 2013 October 24;10: ED000071
  • Drummond MF, Tarricone R, Torbica A. Assessing the added value of health technologies: reconciling different perspectives. Value in Health 2013;16(1):S7-S13.
  • Eaton J, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Core A, Hontelez JAC, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, Barnighausen T, Bershteyn A, Bloom DE, Boiley M-C, Chang ST, Cohen T, Dodd PJ, Fraser C, Gopalappa C, Lundgren J, Martin NK, Mikkelsen E, Mountain E, Pham QD, Pickles M, Phillips A, Platt L, Pretorius C, Prudden HJ, Salomon JA, can de Vijer DAMC, de Vlas SJ, Wagner BG, White RG, Wilson DP, Zhang L, Blandford J, Meyer-Rath G, Remme M, Revill P, Sangrujee N, Terris-Prestholt F, Vassell A, Doherty M, Shaffer N, Easterbrook P, Hirnschall G, Hallett TB. How Should HIV Programmes Respond to Evidence for the Benefits of Earlier ART Initiation? A Combined Analysis of Twelve Mathematical Models. Report for the Consolidated Clinical and Programmatic ART Guidelines Committees, HIV Department of the World Health Organizations 2013;WHO/HIV:2013.56. Download from WHO
  • Edlin R, McCabe C, Round J, Wright J, Claxton K, Sculpher M, Cookson R. Understanding Harris’ understanding of CEA: is cost effective resource allocation undone? Journal of Health Services Research and Policy 2013;18(1)(1):34-9.
  • Eldabe S, Raphael J, Thompson S, Manca A, deBelder M, Aggarwal R, Banks M, Morag B, Merotra S, Adeniba R, Davies E, Taylor R.S. The effectiveness and cost-effectiveness of spinal cord stimulation for refractory angina (RASCAL study): study protocol for a pilot randomised controlled trial. Trials 2013;15(57).
  • Epstein D, Mochón LG, Espín J, Soares MO. Use of multi-parameter evidence synthesis to assess the appropriateness of data and structure in decision models. Medical Decision Making 2013;33(5):715-730. Download from sagepub
  • Faria R, Bojke L, Epstein D, Corbacho B, Sculpher M, On the behalf of the REFLUX trial group. Cost-effectiveness of laparoscopic fundoplication versus continued medical management for the treatment of gastro-oesophageal reflux disease based on long-term follow-up of the REFLUX trial. British Journal of Surgery 2013;100(9):1205-1213.
  • Faria R, Manca A. Statistical analysis of clinical trial data for resource allocation decisions. In:Durlauf SN, Blume LE. (eds). The New Palgrave Dictionary of Economics Online. Palgrave;Macmillan 2013.
  • Faria R, McKenna C, Wade R, Yang H, Woolacott N, Sculpher M. The EOS 2D/3D X-ray imaging system: A cost-effectiveness analysis quantifying the health benefits from reduced radiation exposure. European Journal of Radiology 2013;82(8):e342-e349.
  • Faria R, Spackman E, Burch JA, Corbacho Martin MB, Todd D, Pepper C, Woolacott NF, Palmer S. Dabigatran for the prevention of stroke and systemic embolism in atrial fibrillation: a NICE single technology appraisal. Pharmacoeconomics 2013;31(7):551-562.
  • Favato G, Baio G, Capone A, Marcellusi A, Costa S, Garganese G, Picardo M, Drummond M, Jonsson B, Scambia G, Zweifel P, Mennini F. Transparency or proper study valuation procedures missed? Medical Care 2013;51(4):374-378.
  • Fischer A, Threlfall A, Meah S, Cookson R, Rutter R, Kelly M. The appraisal of public health interventions: Overview. Journal of Public Health 2013;35(4):488-494.
  • Grant A, Boachie C, Cotton S, Faria R, Bojke L, Epstein D, Ramsay C, Corbacho B, Sculpher M, Krukowski Zh, Heading R, Campbell M. Clinical and economic evaluation of laparoscopic surgery compared with medical management for gastro-oesophageal reflux disease: 5-year follow-up of multicentre randomised trial (the REFLUX trial). Health Technology Assessment 2013;17(22).
  • Grant A, Cotton SC, Boachie C, Ramsay C, Krukowski ZH, Headling RC, Campbell MK, The REFLUX Trial Group (CHE members Bojke L, Faria R, Sculpher M,) Minimal access surgery compared with medical management for gastro-oesophageal reflux disease: five year follow-up of a randomised controlled trial (REFLUX). BMJ 2013;346:f1908.
  • Gray R, Keebler D, Revill P, Braithwaite S, Phillips A, Blaser N, Cambiano V, Ciaranello A, Estill J, Gray R, Hill A, Keiser O, Salazar-Vizcaya L, Hallett T. The Cost and Impact of Alternative Strategies for Monitoring Child Patients on ART. Report for the Consolidated Clinical and Programmatic ART Guidelines Committees, the HIV Department of the World Health Organizations 2013;WHO/HIV:2013.60. Download from WHO.
  • Grutters JPC, Sculpher MJ, Briggs AH, Severens JL, Candel MJ, Stahl SE, De Ruyssche D, Boer A, Ramaekers BLT, Joore MA. Acknowledging patient heterogeneity in economic evaluation.  A systematic literature review.Pharmacoeconomics 2013;31(2)(2):111-23.
  • Gutacker N, Bojke C, Daidone S, Devlin N, Street A. Hospital variation in patient-reported outcomes at the level of EQ-5D dimensions - Evidence from England. Medical Decision Making 2013;33(6):804-818.
  • Gutacker N, Bojke C, Daidone S, Devlin N, Parkin D, Street A. Truly inefficient or providing better quality of care? analysing the relationship between risk-adjusted hospital costs and patients' health outcomes. Health Economics 2013;22(8). Download from wiley
  • Howard J, Malfroy M, Llewelyn C, Choo L, Hodge R, Johnson T, Purohit S, Rees D, Tillyer L, Walker I, Fijnvandraat K, Kirby-Allen M, Spackman E, Davies S, Williamson L.  The transfusion alternatives preoperatively in sickle cell disease (TAPS) study: a randomised controlled multi-centre clinical trial. The Lancet 2013;381(9870):930-938.
  • Husereau D, Drummond M, Petrou S, Carswell C, Mother D, Greenberg D, Augustovski  F, Briggs AH, Mauskopf  J, Loder E.  Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. British Medical Journal 2013;Mar25:346.f1049.
  • Husereau D, Drummond M, Petrou S, Carswell C, Mother D, Greenberg D, Augustovski  F, Briggs AH, Mauskopf  J, Loder E. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)  - explanation and elaboration: A report of the ISPOR health economic evaluation publication guidelines good reporting practices task force. Value in Health 2013;16(2):231-250.
  • Jacobs R, Mannion R, Davies HTO, Harrison S, Konteh F, Walshe K. The relationship between organizational culture and performance in acute hospitals. Social Science and Medicine 2013;76:115-25. Download from Sciencedirect
  • Jones AM, Laporte A, Rice N, Zucchelli E. Do smoking bans have an impact on active smoking? A model with evidence from a policy experiment in the UK. Health Economics 2013;doi: 10.1002/hec.3009.
  • Jones A M, Lomas J, Moore P, Rice N.  A quasi-Monte Carlo comparison of developments in parametric and semi-parametric regression methods for heavy tailed and non-normal data: with an application to healthcare costs. Health Economics and Data Group (HEDG), University of York 2013;working paper 13/30Download from HERC
  • Jones AM, Lomas J, Rice N. Applying beta-type size distributions to healthcare cost regressions. Journal of Applied Econometrics 2013;doi:10.1002/jae.2334. Download from wiley
  • Kearns B, Ara R, Wailoo A, Manca A, Hernandez Alava M, Abrams K, Campbell M. Good practice guidelines for the use of statistical regression models in economic evaluation. Pharmacoeconomics 2013;31(8):643-652.
  • Keebler D, Revill P, Braithwaite S, Phillips A, Blaser N, Borquez A, Cambiano V, Ciaranello A, Estill J, Gray R, Hill A, Keiser O, Kessler J, Menzies NA, Nucifora KA, Salazar-Vizcaya L, Walker S, Welte A, Easterbrook P, Doherty M, Hirnschall G, Hallett T. How Should HIV Programmes Monitor Adults on ART? A Combined Analysis of Three Mathematical models. Report for the Consolidated Clinical and Programmatic ART Guidelines Committees, the HIV Department of the World Health Organizations. 2013;WHO/HIV:2013.61. Download from WHO
  • Kennedy A, Bower P, Reeves D, Blakeman T, Bowen R, Chew-Graham C, Eden M, Fullwood C, Gaffney H, Gardner C, Lee V, Morris R, Protheroe J, Richardson G, Sanders C, Swallow A, Thompson D, Rogers, A. Implementation of self management support for long term conditions in routine primary care settings: cluster randomised controlled trial. British Medical Journal 2013;346:f2882.
  • Lensberg B, Drummond MF, Danchenko N, Despiégel N, François C. Challenges in measuring and valuing productivity costs, and their relevance in mood disorders. ClinicoEconomics and Outcomes Research 2013;5:565-573.
  • Longworth L, Youn J, Bojke L, Palmer S, Griffin S, Spackman E, Claxton, K. When does NICE recommend the use of Health technologies within a programme of evidence development? : A systematic review of NICE guidance. Pharmacoeconomics 2013;31(2):137-49.
  • Mabugu T, Revill P, Van den Berg B. The methodological challenges for the estimation of quality of life in children for use in economic evaluation in low income countries. Value in Health Regional Issues 2013;2(2):231-239.
  • MacPherson H, Richmond S, Bland M, Brealey S, Gabe R, Hopton A, Keding A, Lansdow H,  Perren S, Sculpher MSpackman E,  Torgerson D, Watt I.  Acupuncture and counselling for depression in primary care: a randomised controlled trial.  PLoS Medicine 2013;10(9):e1001518. Download from plosmedicine
  • Marks L, Weatherly HLA, Mason A. Prioritizing investment in public health and health equity: what can commissioners do? Public Health 2013;127(5):410-418.
  • Mason A, Mason JM, Cork M, Hancock H, Dooley G. Topical Treatments for chronic plaque psoriasis of the scalp: a systematic review. British Journal of Dermatology 2013;169(3):519-527.
  • Mason A, Mason JM, Cork M, Dooley G, Hancock H. Topical treatments for chronic plaque psoriasis. Cochrane database of systematic reviews (Online). 2013 Mar 28;(3)Art.No.:CD005028.
  • Mason A, Mason JM, Cork M, Hancock H, Dooley G. Topical treatments for chronic plaque psoriasis: An abridged Cochrane Systematic Review. Journal of the American Academy of Dermatology 2013:69(5):799-807.
  • Moran V, Jacobs R. An international comparison of efficiency of inpatient mental health care systems. Health Policy 2013;112(1):88-99. Download from Elsevier
  • Naci H, Spackman E. National approaches to comparative effectiveness research. In: Handbook of Health Services Research. Springer 2013.
  • Norman G, Faria R, Paton F, Llewellyn A, Fox D, Palmer S, Clifton I, Paton J, Woolacott N, McKenna C. Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation. Health Technology Assessment 2013;17(52):1–342.
  • Norman R, Church J, van den Berg B, Goodall S. Australian health-related quality of life population norms derived from the SF-6D. Australian and New Zealand Journal of Public Health 2013;37(1)(1):17-23.
  • Olsen KR, Gyrd-Hansen D, Højmark TB, Kristensen T, Vedsted P, Street A. Organisational determinants of production and efficiency in General Practice. A population based study. European Journal of Health Economics 2013:14(2):267-276. Download from Springer
  • Owen-Jones E, Bekkers MJ, Butler C, Cannings-John R, Channon S, Hood K, Gregory J, Kemp A, Kenkre J, Martin Corbacho B, Montgomery A, Moody G, Pickett K, Richardson G, Roberts Z, Ronaldson S, Sanders J, Stamuli E, Torgerson D, Robling M, The effectiveness and cost-effectiveness of the Family Nurse Partnership home visiting programme for first time teenage mothers in England: a protocol for the Building Blocks randomised controlled trial. BMC Pediatrics 2013;13(114).
  • Pattenden J, Mason A, Lewin B. Collaborative palliative care for advanced heart failure: outcomes and costs from the 'Better Together' pilot study. BMJ Supportive and Palliative Care 2013;3(1):69-76.
  • Pitman R, Nagy LD, Sculpher MJ.  Cost-effectiveness of childhood influenza vaccination in England and Wales: Results from a dynamic transmission model. Vaccine 2013;31(6):927-42.
  • Revill P, Ryan P, McNamara A, Normand C. A cost and outcomes analysis of alternative models of care for young children with severe disabilities in Ireland. ALTER The European Journal of Disability Research 2013;7(4):260-274.
  • Richardson G, Epstein D, Chew-Graham C, Dowrick C, Bentall RP, Morriss RK, Peters S, Riste L, Lovell K, Dunn G, Wearden AJ. Cost-effectiveness of supported self-management for CFS/ME patients in primary care. BMC Fam Pract 2013;14(12).
  • Rudmik L, Drummond M. Health economic evaluation: Important principles and methodology. Laryngoscope 2013;123(6):1341-1347.
  • Ryan P, Revill P, Devane D, Normand C. An assessment of the cost-effectiveness of midwife-led care in the United Kingdom Midwifery 2013;29(4):368-376. Download from sciencedirect
  • Sampson C, Whitehurst D, Street AD. Do patients registered with CAM-trained GPs really use fewer health care resources and live longer? A response to Kooreman and Baars. European Journal of Health Economics 2013;14(4):703-705.
  • Schmitt LHM, Brugere C. Capturing ecosystem services, stakeholders’ preferences and trade-offs in coastal aquaculture decisions: a bayesian belief network application. PLoS ONE 2013;8(10):e75956.
  • Sculpher MJ. Methods development for health technology assessment: is it time to set priorities? Medical Decision Making 2013;33(3):313-5. Download from sagepub
  • Shah K, Cookson R, Culyer AJ, Littlejohns P. NICE’s social value judgements about equity in health and health care. Health Economics, Policy and Law 2013;8(2):145-65. Download from Cambridge journals
  • Shemilt I, McDaid D, Marsh K, Henderson C, Bertranou E, Mallander J, Drummond MF, Mugford M, Vale L. Issues in the incorporation of economic perspectives and evidence into Cochrane reviews. Systematic Reviews 2013 Sep 20;2(83):10.1186/2046-4053-2-83.
  • Siciliani LMoran V, Borowitz M. Measuring and comparing health care waiting times in OECD countries. OECD Health Working Papers 2013;No.67:OECD Publishing.
  • Siciliani L, Sivey P, Street A. Differences in length of stay for hip replacement between public hospitals, specialised treatment centres and private providers: selection or efficiency? Health Economics 2013;22(2):119-131.
  • Smith PC, Street AD. On the uses of routine patient-reported health outcome data. Health Economics 2013;22(2):119-131.
  • Soares MO, Dumville J, Ashby RL, Iglesias Urrutia CP, Bojke L, Adderley UJ, McGinnis E, Stubbs N, Torgerson D, Claxton K, Cullum N. Methods to assess cost effectiveness and value of further research when data are sparse: Negative-pressure wound therapy for severe pressure ulcers. Medical Decision Making 2013;33(3):415-36.
  • Sorenson C, Drummond MF, Bhuiyan Khan B. Medical technology as a key driver of rising health expenditures: disentangling the relationship. ClinicoEconomics and Outcomes Research 2013;5:223-234.
  • Sorenson C, Drummond MF, Burns LR. Evolving reimbursement and pricing policies for devices in Europe and the United States should encourage greater value. Health affairs (Project Hope) 2013 April;32(4):788-796.
  • Sorenson C, Drummond MF, Wilkinson G. Use of innovation payments to encourage the adoption of new medical technologies in the English NHS. Health Policy and Technology 2013;2(3):168-173.
  • Spackman E. The significance and international influence of NICE.  The Economic Evaluation of Health technology and Public policy - the case from overseas and the course of Japan. Tokyo, Japan: Jiho; 2013.
  • Spackman E, Kadiyala S, Neumann PJ, Veenstra DL, Sullivan SD. The validity of dependence as a health outcome measure in Alzheimer disease.  American Journal of Alzheimer's Disease & Other Dementias 2013;28(3):245-252.
  • Spackman E, Rice S, Norman G, Suh D-C, Eastwood A, Palmer S. Trastuzumab for the treatment of HER2-positive metastatic gastric cancer:A NICE single technology appraisal. Pharmacoeconomics 2013;31(3):185-194.
  • Spackman ESculpher M, Howard J, Malfroy M, Llewelyn C, Choo L,  Hodge R, Johnson T, Rees D, Fijnvandraat K, Kirby-Allen M, Davies S, Williamson L. Cost effectiveness analysis of pre-operative transfusion in patients with sickle cell disease using evidence from the TAPS trial. European Journal of Haematology  2013;doi:10.1111/ejh.12232.
  • Spinner D, Birt J, Walter J, Bowman LLB, Mauskopf J, Drummond M, Copley-Merriman C. Do different clinical evidence bases lead to discordant health-technology assessment decisions? An in-depth case series across three jurisdictions. ClinicoEconomics and Outcomes Research 2013;5:69-85.
  • Street A. An overview of competition in UK health care. In: Competition in UK health care: reflections on an expert workshop. Eds. Charlesworth A, Kelly E. Institute for Fiscal Studies and Nuffield Trust research report, December 2013.
  • Tsoi B, Masucci L, Campbell K, Drummond MF, O'Reilly D, Goeree R. Harmonization of reimbursement and regulatory approval processes: a systematic review of international experiences. Expert Review of Pharmacoeconomics and Outcomes Research 2013;13(4):497-511.
  • Van Dijk CE, Van den Berg B, Verheij RA, Spreeuwenberg P, Groenewegen PP, De Bakker DH. Moral hazard and supplier-induced demand: empirical evidence in general practice. Health Economics 2013;22(3):340-352.
  • Wade R, Spackman E, Corbett M, Walker S, Light K, Naik R, Sculpher M, Eastwood A. Adjunctive colposcopy technologies for examination of the uterine cervix – DySIS, LuViva advanced cervical scan and niris imaging system. Health Technology Assessment 2013;17(8). Download from HTA.
  • Walker S, Girardin F, McKenna C, Ball SG, Nixon J, Plein S, Greenwood JP, Sculpher M. Cost-effectiveness of cardiovascular magnetic resonance in the diagnosis of coronary heart disease: an economic evaluation using data from the CE-MARC study. Heart 2013;99(12):873-81.

2011/2012

2012

  • Allen P, Keen J, Wright J, Dempster PG, Townsend J, Hutchings A, Street AVerzulli R. Investigating the governance of autonomous public hospitals in England: multi-site case study of NHS Foundation Trusts. Journal of Health Services Research and Policy 2012;17(2):94-100. Download from rsmjournals
  • Ashby R, Dumville J, Soares M, McGinnis E, Stubbs N, Torgerson D, Cullum N. A pilot randomised controlled trial of negative pressure wound therapy (NPWT) to treat grade III/IV pressure ulcers. Trials 2012;13(119). Download from trialsjournal
  • Basu A, Manca A. Regression estimators for generic health-related quality of life and quality-adjusted life years. Medical Decision Making 2012;32(1):56-69.
  • Bojke L, Spackman E, Hinde S, Helliwell P. Capturing all of the costs in NICE appraisals: the impact of inflammatory rheumatic diseases on productivity. Rheumatology 2012;51(2):210-15.
  • Bower P, Kennedy A, Reeves D, Richardson G. A cluster randomised controlled trial of the clinical and cost-effectiveness of a “whole-systems” model of self management support for the management of long term conditions in primary care:trial protocol. Implementation Science 2012;7:7(January).
  • Briggs AH, Weinstein MC, Fenwick E, Karnon J, Sculpher MJ, Paltiel AD. Model parameter estimation and uncertainty: A report of the ISPOR-SMDM Modelling Good Research Practices Task Force Working Group-6. Medical Decision Making 2012;32(5):722-32.
  • Briggs AH, Weinstein MC, Fenwick EAL, Karnon J, Sculpher MJ, Paltiel AD. on behalf of the ISPOR-SMDMK Modelling Good Research Practices Task Force (2012).  Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modelling Good Research Practices Task Force-6. Value in Health 2012;15(6):835-42.
  • Brown S, Ortiz-Nuñez A, Taylor K. Parental risk attitudes and children’s academic test scores: evidence from the U.S. panel study of income dynamics. Scottish Journal of Political Economy 2012;59(1):47-70.
  • Burch J, Griffin S, McKenna C, Walker S, Paton J, Wright K, Woolacott N. Omalizumab for the treatment of severe persistent allergic asthma in children Aged 6-11 years: a NICE single technology appraisal. Pharmacoeconomics 2012;30(11):991-1004. Download from springer
  • Burch J, Hinde S, Palmer S, Beyer F, Minton J, Marson A, Wieshmann U, Woolacott N, Soares M. The clinical and cost-effectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: a systematic review and decision-analytical model. Health Technology Assessment 2012;16(34). Download from NIHR
  • Burch J, Marson A, Beyer F, Soares M, Hinde S, Wieshmann U, Woolacott N. Dilemmas in the interpretation of diagnostic accuracy studies on presurgical workup for epilepsy surgery. Epilepsia 2012;53(8):1294-302. Download from wiley 
  • Burton C, Richardson G, Sharpe M. Healthcare costs incurred by repeated referral of patients with medically unexplained symptoms to secondary medical care. Journal of Psychosomatic Research 2012;72(3):242-247.
  • Cabieses B, Espinoza M. The power of chameleonic ideas in the policy decision-making process: the case of the 'students' revolution' in Chile. Journal of Education for Teaching: International research and pedagogy 2012;38(4):509-11.
  • Chuang LH, Soares MO, Tilbrook H, Cox H, Hewitt CE, Aplin J, Semlyen A, Trewhela A, Watt I, Torgerson D. A pragmatic multi-centered randomised controlled trial of yoga for chronic low back pain: economic evaluation Spine 2012;37(18):1593-1601.
  • Claxton K, Palmer S, Longworth L, Bojke L, Griffin S, McKenna C, Soares M, Spackman DE, Youn J. Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development. Health Technology Assessment 2012;16(46). Download from NIHR
  • Conigliani C, Manca A, Tancredi A. Statistical methods for health care economic evaluation. In: Faltin F, Kenett R, Ruggeri F, editors. Statistical Methods in Healthcare:Wiley;2012:Chapter 18.
  • Cookson RClaxton KThe humble economist. Tony Culyer on health, health care and social decision making. Office of Health Economics, London and University of York, 2012. The humble economist
  • Cookson R, Dawson D. Hospital competition and patient choice in publicly funded health care. In: Jones AM, editor. The Elgar Companion to Health Economics (2 nd Edition) Cheltenham: Edward Elgar;2012.
  • Cookson R, Laudicella M, Li Donni P. Measuring change in health care equity using small area administrative data – evidence from the English NHS 2001-8. Social Science and Medicine 2012;75(8):1514-1522.
  • Cookson R, Laudicella M, Li Donni P, Dusheiko M. Effects of the Blair/Brown health reforms on socioeconomic equity in health care. Journal of Health Services Research and Policy 2012;17(Suppl1):55-63.
  • Cooper NJ, Kendrick D, Achana F, Dhiman P, He Z, Wynn P, Le Cozannet E, Saramago P, Sutton A. Network meta-analysis to evaluate the effectiveness of interventions to increase the uptake of smoke alarms. Epidemiologic Reviews 2012;34(1):32-45.
  • Costa-Font J, Karlsson M, Van den Berg B. Redesigning long-term care finance and delivery. Applied Economic Perspectives and Policy 2012;34(2):215-19.
  • Culyer AJ, Bombard Y. An equity framework for health technology assessments. Medical Decision Making 2012;32(3):428-441.
  • Culyer AJ. Hic sunt dracones: the future of Health Technology Assessment - one economist's perspective. Medical Decision Making 2012;32:E25-E32.
  • Daidone S, Street A. Specialisation hierarchy within the Children’s Specialised Services National Definition Set. Report to Department of Health, Economics of Social and Health Care Research Unit, University of York; 2012. Download from eshcru
  • Drummond MF. Economic evaluation and decision makers In: Jones AM, editor. The Elgar Companion to Health Economics. Cheltenham: Edward Elgar;2012:p.640.
  • Drummond M, Neumann P, Jonsson B, Luce B, Schwartz J, Siebert U, Sullivan S. Can we reliably benchmark health technology assessment organizations? International Journal of Technology Assessment in Health Care 2012;28(2):159-65.
  • Drummond MF, Towse A. Is it time to reconsider the role of patient co-payments for pharmaceuticals in Europe? European Journal of Health Economics 2012;13:1-5.
  • Dumville JC, Soares MO, O'Meara S, Cullum N. Systematic review and mixed treatment comparison: Dressings to heal diabetic foot ulcers. Diabetologia 2012;55:1902-1910. Download from springerlink
  • Faria R, Weatherly H, Van den Berg B. A review of approaches to measure and monetarily value informal careBerg. In: Curtis L, editor. Unit costs of health and social care 2012. Kent: PSSRU; 2012. p. 22-31
  • Favato G, Baio G, Capone A, Marcellusi A, Costa S, Garganese G, Picardo M, Drummond MF, Jonsson B, Scambia G, Zweifel P, Mennini F. Novel health economic evaluation of a vaccination strategy to prevent HPV-related diseases. The BEST study. Medical Care 2012;50(12):1076-85.
  • Fleetcroft R, Steel N, Cookson R, Walker S, Howe A. Incentive payments are not related to expected health gain in the pay for performance scheme for UK primary care: cross-sectional analysis. BMC Health Services Research 2012;12(94). Download from biomedcentral
  • Ford JA, Waugh N, Sharma P, Sculpher MJ, Walker A. NICE guidance: a comparative study of the introduction of the single technology appraisal process and comparison with guidance from Scottish Medicines Consortium. BMJ Open 2012;2(1):e000671. Download from bmjopen
  • Garber AM, Sculpher M. Cost-effectiveness and payment policy. In: Pauly MV, McGuire TG, Barros PP, editors. Handbook in Health Economics. Oxford: Elsevier; 2012.
  • Gaughan J, Kobel C, Linhart C, Mason AStreet A, Ward P. Why do patients having coronary artery bypass grafts have different costs or length of stay? An analysis across ten European countries. Health Economics 2012;21(S2):77-88. Download from wiley
  • Howdon D. Time and chance happen to them all? duration modelling versus lifetime incidence of cancer. Health Economics and Data Group (HEDG), University of York 2012;working paper 12/06. Download from HEDG
  • Jones AM, Rice N, Bago d'Uva T, Balia S. Applied Health Economics (Second Edition). London: Routledge, 2012. Details here
  • Jones AM, Rice N, Contoyannis PC. The dynamics of health. In: Jones AM, editor. Elgar Companion to Health Economics (second Edition). Cheltenham: Edward Elgar; 2012.
  • Jones AM, Rice N, Robone S. A comparison of parametric and non-parametric adjustments using vignettes for self-reported data. Health Economics and Data Group (HEDG), University of York 2012;12/10. Download from HERC
  • Jones AM, Rice N, Rosa-Dias P. Quality of schooling and inequality of opportunity in health. Empirical Economics 2012;42(2):369-394.
  • Joyce VR, Barnett PG, Chow A, Bayoumi AM, Griffin S, Sun H, Holodniy M, Brown ST, Kyriakides TC, Cameron DW, Youle M, Sculpher M, Anis AH, Owens DK. Effect of treatment interruption and intensification of antiretroviral therapy on health related quality of life in patients with advanced HIV: a randomized, controlled trial. Medical Decision Making 2012;32(1):70-82. Download from sagepub
  • Kontopantelis E, Doran T, Gravelle H, Siciliani L, Sutton M, Goudie R. Pay-for-performance and influenza immunization: the impact of raising the bar in the UK Quality and Outcomes Framework. Health Services Research 2012;47(3, part 1):1117-36.
  • Laudicella M, Siciliani L, Cookson R. Waiting times and socioeconomic status: evidence from England. Social Science and Medicine 2012;74(9):1331-41.
  • Luce B, Drummond MF. Principles for the conduct of comparative effectiveness research. Journal of Comparative Effectiveness Research 2012;1(5):431-40.
  • Manca A, Asseburg C, Bravo-Vergel Y, Seymour MT, Meade A, Stephens R, Parmar M, Sculpher MJ. The cost-effectiveness of different chemotherapy strategies for patients with poor prognosis advanced colorectal cancer (MRC FOCUS). Value in Health 2012;15(1):22-31.
  • Martin R, Muûls M, de Pruex L, Wagner U. Anatomy of a paradox: management practices, organizational structure and energy efficiency. Journal of Environmental Economics and Management 2012;63(2):208-223.
  • Martin S, Rice N, Smith PC. Comparing costs and outcomes across programmes of healthcare. Health Economics 2012;21(3):316-337.
  • Mason A, Or Z, Renaud T, Street A, Thuilliez J, Ward P. How well do DRGs for appendectomy explain variations in resource use? An analysis of patient-level data from 10 European countries. Health Economics 2012;21(S2):30-40. Download from wiley
  • Maund E, Craig D, Suekarran S, Neilson AR, Wright K, Brealey S, Dennis L, Goodchild L, Hanchard N, Rangan A, Richardson G, Robertson J, McDaid C. Management of frozen shoulder: a systematic review and cost-effectiveness analysis. HTA Report 09/13/02 2012.
  • McKenna C, Maund E, Sarowar M, Fox D, Stevenson M, Pepper C, Woolacott N, Palmer S. Dronedarone for the treatment of atrial fibrillation. A NICE Single Technology Appraisal. Pharmacoeconomics 2012;30:35-46.
  • McKenna C, Wade R, Faria R, Yang H, Stirk L, Gummerson N, Sculpher M, Woolacott N. EOS 2D/3D X-ray imaging system: a systematic review and economic evaluation. Health Technology Assessment 2012;16(14):1-188. Download from HTA
  • McKenna CWalker S, Lorgelly P, Fenwick E, Burch J, Suekarran S, Bakhai A, Witte K, Harden M, Wright K, Woolacott N, Palmer S. Cost-effectiveness of aldosterone antagonists for the treatment of post-myocardial infarction heart failure. Value in Health 2012;15(3). More details  from Value in Health
  • Miraldo M, Siciliani L, Street A. Price adjustment in the hospital sector, Reply. Journal of Health Economics 2012;31(1):323-25.
  • Mujica-Mota RE, Tarricone R, Ciani O, Bridges JFP, Drummond MF. Determinants of demand for total hip and knee arthroplasty: a systematic literature review. BMC Health Services Research 2012;12(1).
  • O'Reilly J, Busse R, Häkkinen U, Or Z, Street A, Wiley M. Paying for hospital care: the experience with implementing activity-based funding in five European countries. Health Economics Policy and Law 2012;7(1):73-101.
  • Pichon-Riviere A, Augustovski F, Marti SG, Sullivan SD, Drummond MF. Transferability of health technology assessment reports in Latin America: an exploratory survey of researchers and decision makers. International Journal of Technology Assessment in Health Care 2012;28(2):180-86.
  • Pitman RL, White LJ, Sculpher MJ. Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales. Vaccine 2012;30:1208-24.
  • Revill P, Sculpher MJ. Cost effectiveness of interventions to tackle non-communicable diseases. British Medical Journal 2012;344:d7883. Download from bmj
  • Rodgers M, Asaria M, Walker S, McMillan D, Lucock M, Harden M, Palmer S, Eastwood A. The clinical effectiveness and cost-effectiveness of low-intensity psychological interventions for the secondary prevention of relapse after depression: a systematic review. Health Technology Assessment 2012;16(28):1-129. Download from HTA
  • Rice NRobone S, Smith P. Vignettes and health systems responsiveness in cross-country comparative analyses. The Journal of the Royal Statistical Society A 2012;175(2):1-21.
  • Saramago PManca A, Sutton AJ. Deriving input parameters for cost-effectiveness modelling: taxonomy of data types and approaches to their statistical synthesis. Value in Health 2012;15(5):639-649.
  • Saramago P, Sutton A, Cooper NJ, Manca A. Mixed treatment comparisons using aggregate-and individual-participant level data statistics in medicine Statistics in Medicine 2012;doi:10.1002.sim.5442.
  • Schut FT, Van den Berg B. Long-term care insurance in the Netherlands. In: Costa-Font J, Courbage C, editors. Financing Long-Term Care in Europe: Palgrave; 2012.
  • Sculpher MJ, Claxton K. Real economics needs to reflect real decisions a response to Johnson. Pharmacoeconomics 2012;30(2):133-36. Download from Springer
  • Smith PC, Street A. Concepts and challenges in measuring the performance of health care organizations. In: Jones A, editor. Elgar Companion to Health Economics: Second Edition: Edward Elgar, Cheltenham; 2012. p.341-49.Further details
  • Smith PC, Street A. On the uses of routine patient-reported health outcome data. Health Economics 2012;22(2):119-131.
  • Soares MO. Is the QALY blind, deaf and dumb to equity? NICE's considerations over equity. British Medical Bulletin 2012;101(1):17-31. Download from oxfordjournals
  • Soares MO, Canto e Castro L. Continuous time simulation and discretized models for cost-effectiveness analysis. Pharmacoeconomics 2012;30(12):1101-17. Download from springer
  • Soares MO, Dumville J, Ashby R, Iglesias C, Bojke L, Adderley U, McGinnis E, Stubbs N, Torgerson D, Claxton K, Cullum N. Methods to assess cost effectiveness and value of further research when data are sparse: negative pressure wound therapy for severe pressure ulcers. Medical Decision Making 2012;doi:10.1177/0272989X12451058. Download from sagepub
  • Soares MO, Welton NJ, Harrison DA, Peura P, Hari MS, Harvey SE, Madan JJ, Ades AE, Palmer SJ, Rowan KM. An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis. Health Technology Assessment 2012;16(7).
  • Sorenson C, Drummond MF. Socio-economic value of orthopedic devices: evidence and methodological challenges. Orthopedic Research and Reviews 2012;4:87-96.
  • Sorenson C, Drummond MF, Chalkidou K. Comparative effectiveness research: the NICE experience. Journal of Clinical Oncology 2012;30(34).
  • Spackman DE, Kadiyala S, Neumann PJ, Veenstra DL, Sullivan SD. Measuring alzheimer disease progression with transition probabilities: estimates from NACC-UDS. Current Alzheimer Research 2012;9(9):1050-58.
  • Street A, Kobel C, Renaud T, Thuilliez J. How well do Diagnosis Related Groups explain variations in costs or length of stay among patients and across hospitals? Methods for analysing routine patient data. Health Economics 2012;S21:6-18. Download from wiley
  • Thwaites G, Auckland C, Barlow G, Cunningham R, Davies G, Edgeworth J, Greig J, Hopkins S, Jeyaratnam D, Jenkins N, Llewelyn M, Meisner S, Nsutebu E, Planche T, Read RC, Scarborough M, Soares MO, Tilley R, Török ME, Williams J, Wilson P, Wyllie S, Walker AS. Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial. Trials 2012;13:241. Download from trials journal
  • Towse A, Drummond MF, Sorenson C. Measuring value:pharmacoeconomics theory and practice. In: Danzon P, Nicholson S, editors. The Oxford Handbook of The Economics of the Biopharmaceutical Industry. Oxford: Oxford University Press; 2012. p.394-437.
  • Van den Berg B. SF-6D population norms. Health Economics 2012;21(12):1508-1512.
  • Wade R, Yang H, McKenna C, Faria R, Gummerson N, Woolacott N. A systematic review of the clinical effectiveness of EOS 2D/3D X-ray imaging system. European Spine Journal 2012;DOI 10.1007/s00586-012-2469-7.
  • Wagstaff A, Culyer AJ. Four decades of Health Economics through a bibliometric lens. Journal of Health Economics 2012;31:406-39.
  • Walker S, Griffin S, Claxton K, Palmer S, Sculpher M. Guest editorial, Appropriate perspectives for health care decisions. In: Curtis L, editor. Unit costs of health and social care 2012. Kent: PSSRU; 2012. p. 8-11. Download from pssru
  • Walker S, Sculpher M, Claxton K, Palmer S. Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework for coverage decisions. Value in Health 2012;15(3)570-579. More details from Value in Health
  • Wang S, Chalkley M, Tilley C. Comparing the treatment provided by UK and non-UK trained health professionals: dentists in Scotland. Health Services Research & Policy 2012;17(4):227-232. Download from sage journals
  • Wasi N, Van den Berg B, Buchmueller T. Heterogeneous effects of child disability on maternal labor supply: evidence from the 2000 US census. Labour Economics 2012;19(1):139-154.
  • Yang H, Craig D, Epstein D, Bojke L, Light K, Bruce I, Sculpher M, Woolacott N. Golimumab for the treatment of psoriatic arthritis: A NICE Single Technology Appraisal. Pharmacoeconomics 2012;30:257-70.
  • Zucchelli E, Harris M, Zhao X. Ill-health and transitions to part-time work and self-employment among older workers. Health Economics and Data Group (HEDG), University of York 2012;working paper 12/04. Download from HERC
  • Zucchelli E, Jones AM, Rice N. The evaluation of health policies through dynamic microsimulation methods. International Journal of Microsimulation 2012;5(1):2-20.

2011

  • Asaria M, Norman G, Hinde S, O'Connor J, Palmer S, Light K, Soares M, Eastwood A. Fingolimod for the treatment of relapsing remitting multiple sclerosis. (PDF  , 2,151kb). CRD/ CHE Technology Assessment Group, University of York, 2011.
  • Backhouse M, Wonder M, Hornby E, Kilburg A, Drummond MF, Mayer FK. Early dialogue between the developers of new technologies and pricing and reimbursement agencies. Value in Health 2011;14:608-15.
  • Barnett PG, Chow A, Joyce VR, Bayoumi AM, Griffin S, Nosyk B, Holodniy M, Brown ST, Sculpher M, Anis AH, Owens DK. Determinants of the cost of health services used by veterans with HIV. Medical Care 2011;49(9):848-56.Download from pubmed
  • Bloudek LM, Spackman DE, Blankenburg M, Sullivan SD. Review and meta-analysis of biomarkers and diagnostic imaging in alzheimer's disease. J Alzheimers Dis 2011;26(4).
  • Bloudek LM, Spackman DE, Veenstra DL, Sullivan SD. CDR state transition probabilities in alzheimer's disease with and without cholinesterase inhibitor intervention in an observation cohort J Alzheimers Dis 2011;24(3).
  • Bojke L, Epstein D, Craig D, Rodgers M, Woolacott N, Yang H, Sculpher M. Modelling the cost-effectiveness of biologic treatments for psoriatic arthritis. Rheumatology 2011;50:iv39-iv47.
  • Brown S, Dietrich M, Ortiz-Nuñez A, Taylor K.  Self-employment and attitudes towards risk: timing and unobserved heterogeneity. Journal of Economic Psychology 2011;32:425-433.
  • Brown S, Ortiz-Nuñez A, Taylor K. What will I be when I grow up? an analysis of childhood expectations and career outcomes. Economics of Education Review 2011;30:493-506.
  • Burgess J, Street A. Measuring organisational performance. In: Smith PC, Glied SA, editors. The Oxford handbook of health economics. Oxford: Oxford University Press;2011.
  • Campbell HE, Epstein D, Bloomfield D, Griffin SManca A, Yarnold J, Bliss J, Johnson L, Earl H, Poole C, Hiller L, Dunn J, Hopwood P, Barrett-Lee P, Ellis P, Cameron D, Harris AL, Gray AM, Sculpher MJ. The cost-effectiveness of adjuvant chemotherapy for early breast cancer: a comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses. European Journal of Cancer 2011;Nov 47(17):2517-30.Download from Sciencedirect
  • Carr-Hill R. A large-scale donor attempt to improve educational status of the poor and household income distribution; the experience of PEDC in Vietnam. International Journal of Educational Development 2011;31(3):251-61.
  • Castelli A, Laudicella M, Street AWard P. Getting out what we put in: productivity of the English NHS. Health Economics, Policy and Law 2011;6:313-335. Download from Cambridge Journals ©Cambridge Journals.
  • Chalkley M, Stewart G. Trade liberalisation, market structure and the incentive to merge. The World Economy 2011;34(8):1327-47.
  • Chase R, Culyer AJ, Dobrow M, Coyte P, Sawka C, O'Reilly S, Laing K, Trudeau M, Smith S, Hoch J, Morgan S, Peacok S, Abbott R, Sullivan T. Access to cancer drugs in Canada: looking beyond coverage decisions. Healthcare Policy 2011;6:27-35.
  • Chuang LH, Soares MO, Watson JM, Bland JM, Cullum N, Iglesias C, Kang'ombe AR, Torgerson D, Nelson EA, on behalf of the VenUS III team. Economic evaluation of a randomized controlled trial of ultrasound therapy for hard-to-heal venous leg ulcers. British Journal of Surgery 2011;98(8):1099-1106. Download from Wiley
  • Claxton K, Paulden M, Gravelle H, Brouwer W, Culyer AJ. Discounting and decision making in the economic evaluation of health care technologies. Health Economics 2011;20:2-15. Download from Wiley interscience
  • Cookson R. The tough test for the NHS isn’t cost but care. Parliamentary Brief 2011;13(6).
  • Cookson R, Laudicella M. Effects of Health Reform on Health Care Inequalities - Final ReportNIHR SDO Programme - London 2011.
  • Culyer AJ. Maximising the odds. New Statesman (supplement: Competition in a New Society: National Health) 2011;15 December 6-8.
  • Culyer AJUK report: NHS 'reforms: Health Care Cost Monitor 1-2, The Hastings Center; 2011.Download from the Hastings Center
  • Culyer AJ, Bombard Y. An equity framework for health technology assessments. Medical Decision Making 2012;32(3):428-441.
  • de Preux L. Anticipatory ex ante moral hazard and the effect of medicare on prevention. Health Economics 2011;20(9):1056-72.
  • Dixon J, Smith PC, Gravelle H, Martin S, Bardsley M, Rice N, Georghiou T, Dusheiko M, Billings J, De Lorenzo M, Sanderson C. A person based formula for allocating commissioning funds to general practices in England: development of a statistical model. British Medical Journal 2011;DOI: 10.1136/bmj.d6608.
  • Drummond MF, Augustovski F, Melendez G, Lemgruber A. Implementing pharmacoeconomic guidelines in Latin America: lessons learned. Value in Health 2011;14:S3-S7.
  • Drummond MF, Jönsson B, Rutten F, Stargardt T. Reimbursement of pharmaceuticals: reference pricing versus health technology assessment. The European Journal of Health Economics 2011;12:263-71.
  • Dusheiko M, Doran T, Gravelle H, Fullwood C, Roland M. Does higher quality of diabetes management in family practice reduce unplanned hospital admissions? Health Services Research 2011;46:27-46.
  • Dusheiko M, Gravelle H, Martin S, Rice N, Smith PC. Does disease management in primary care reduce hospital costs? Evidence from English primary care. Journal of Health Economics 2011;30(5):919-32.
  • Elston J, Santaniello-Newton A, Meigh J, Harmer D, Allgar V, Allison T, Richardson G, Meigh R, Palmer SR, Barlow G. Increasing incidence of invasive pneumococcal disease and pneumonia despite improved vaccination uptake- surveillance in Hull and East Yorkshire, United Kingdom, 2002-2009. Epidemiology and Infection 2011;DOI:10.1017/S0950268811001907.
  • Epstein D, Sutton A. Modelling correlated clinical outcomes in health technology appraisal. Value in Health 2011;14(6):793-99.Download from Value in Health
  • Felix J, Andreozzi V, Soares M, Borrego P, Gervasio H, Moreira A, Costa L, Marcelo F, Peralta F, Furtado I, Pina F, Albuquerque C, Santos A, Passos-Coelho JL. For the Portuguese group for the study of bone metastases. Hospital resource utilization and treatment cost of skeletal-related events in patients with metastatic breast or prostate cancer: An estimation for the Portuguese National Health System. Value in Health 2011;14(4).
  • Fleetcroft R, Cookson R, Steel N, Howe A. Correlation between prescribing quality and pharmaceutical costs in English primary care: national cross-sectional analysis. British Journal of General Practice 2011;61:554-55.
  • Garau M, Shah K, Mason A, Wang Q, Towse A, Drummond M. Using QALYs in cancer: a review of the methodological limitations. Pharmacoeconomics 2011;29(8):673-85.
  • Goudie R, Goddard M. Review of evidence on what drives economies of scope and scale in the provision of NHS services, focusing on A & E and associated hospital services. Report for the OHE Commission on Competition in the NHS. London: Office of Health Economics;2011. Download from OHE
  • Gravelle H, Hole AR, Santos R. Measuring and testing for gender discrimination in physician pay: English family doctors. Journal of Health Economics 2011;30(4):660-74.
  • Griffin S, Claxton K. Analysing uncertainty in cost-effectiveness for decision making. In: Glied S, Smith PC, editors. Oxford Handbook of Health Economics. Oxford: Oxford University Press; 2011.
  • Griffin S, Claxton K, Palmer S, Sculpher M. Dangerous omissions: the consequences of ignoring decision uncertainty. Health Economics 2011;20:212-24.
  • Harrison M, Bansback N, Marra C, Drummond MF, Tugwell B. Valuing health for clinical and economic decisions: directions relevant for rheumatologists. The Journal of Rheumatology 2011;38(8):1770-75.
  • Hassink WHJ, Van den Berg B. Time-bound opportunity costs of informal care: Consequences for access to professional care, caregiver support, and labour supply estimates. Social Science and Medicine. 2011;73(10):1508-16.
  • Hastrup LH, Van den Berg B, Gyrd-Hansen D. Do informal caregivers in mental illness feel more burdened? A comparative study of mental versus somatic illnesses. Scandinavian Journal of Public Health 2011;39:598-6-7.
  • Hawkins N, Richardson G, Sutton A, Cooper N, Griffiths C, Rogers A, Bower P. Surrogates, meta-analysis and cost-effectiveness modelling: a combined analytic approach. Health Economics 2011;DOI:10.1002/hec.1741.
  • Hvenegaard A, Nielsen Arendt J, Street A, Gyrd-Hansen D. Exploring the relationship between costs and quality: Does the joint evaluation of costs and quality alter the ranking of Danish hospital departments? European Journal of Health Economics 2011;12:541-51.
  • Ishikawa N, Pridmore P, Carr-Hill R, Chaimuangdee K. The attitudes of primary school children in Northern Thailand towards their peers who are affected by HIV and AIDS. Aids Care 2011;23:237-44.
  • Jackson CH, Bokje L, Thompson SG, Claxton K, Sharples LD. A framework for addressing structural uncertainty in decision models. Medical Decision Making 2011;31(4):662-674.Download from sagepub
  • Jacobs R, Barrenho E. The impact of crisis resolution and home treatment teams on psychiatric admission rates in England. British Journal of Psychiatry 2011;199(1):71-76.
  • Jones AM, Lomas J, Rice N. Applying beta-type size distributions to healthcare cost regressions. Health Econometrics and Data Group (HEDG),University of York 2011;11/31Download from HERC  
  • Jones AM, Laporte A, Rice NZucchelli E. A model of the impact of smoking bans on smoking with evidence from bans in England and Scotland. Health Economics and Data Group (HEDG), University of York 2011;working paper 11/05.Download from HERC
  • Jones AM, Rice NRosa Dias P. Long-term effects of schooling quality on health and lifestyle: Evidence from comprehensive schooling reforms in England. Journal of Human Capital 2011;5(3):342-76.
  • Jones AM, Rice N, Robone SRosa-Dias P. Inequality and polarisation in health systems' responsiveness: a cross-country analysis. Journal of Health Economics 2011;30(4):616-25.
  • Kolosa K, Manca A, Schubert S. A review of Health Technology Assessment (HTA) recommendations for drug therapies issued between 2007 and 2009 and their impact on policy making processes in Poland. Health Policy 2011;102(2-3):145-151.
  • Longworth L, Sculpher MBokje L, Tosh J. Bridging the gap between methods research and the needs of policy makers: A review of the research priorities of the National Institute for Health and Clinical Excellence. International Journal of Technology Assessment in Health Care 2011;27(2):180-7.Download from pubmed
  • Mandalà M, Imberti G, Piazzalunga D, Belfiglio M, Di Biagio K, Robone S, Labianca R, Marchesi L, Merelli B, Poletti P, Milesi A, Milesi L, Tondini C. Socio-economic status and education grade influence Breslow thickness, disease free and overall survival in clinical stage I-II AJCC skin melanoma: outcome analysis from a single institution experience. Mayo Clinic Proceedings 2011;16(2).
  • Marks L, Cave S, Wallace A, Mason A, Hunter DJ, Mason JM, Peckham S. Incentivising preventive services in primary care: perspectives on the use of Local Enhanced Services. Journal of Public Health 2011; 33 (4): 556-564.
  • Martin M, Lensberg B, Drummond MF, McGuire A. Relative efficacy - towards a new frontier? ISPOR Connections 2011;17(5):8-10.
  • Mason A, Goddard M, Myers L, Verzulli R. Navigating uncharted waters? How international experience can inform the funding of mental health care in England. Journal of Mental Health 2011;20(3);234-48. Download from informa.
  • Mason A, Ward P, Street A. England: the Healthcare Resource Group system. In: Busse R, Geissler A, Quentin W, Wiley M, editors. Diagnosis related groups in Europe: moving towards transparency, efficiency and quality in hospitals. Berkshire, England: Open University Press;2011;p197-220.
  • Mauskopf JA, Walter J, Copley-Merriman K, Birt J, Bowman LLB, Drummond MF. Differences among formulary submission guidelines:implications for health technology assessment. International Journal of Technology Assessment in Health Care 2011;27(3):261-70.
  • Maynard A, Street A, Hunter R. Using ‘payment by results’ to fund the treatment of dependent drug users-proceed with care! Addiction 2011;106(10):1715-1882.
  • McKenna C, Claxton K. Addressing adoption and research design decisions simultaneously: the role of value of sample information analysis. Medical Decision Making 2011;31:853-865.Download from Pubmed
  • Miraldo M, Siciliani LStreet A. Price adjustment in the hospital sector. Journal of Health Economics;30(1):112-125.
  • Morris S, Goudie R, Sutton M, Gravelle H, Elliott R, Hole A, Ma A, Sibbald B, Skatun D. Determinants of general practitioners’ wages in England. Health Economics 2011;20:147-60.
  • Norman G, Rice S, Spackman E, Stirk L, Danso-Appiah A, Suh D, Palmer S, Eastwood A. Trastuzumab for the treatment of HER2 positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction. Health Technology Assessment 2011;15(Suppl 1):33-42.
  • Paulden M, Claxton K. Budget allocation and the revealed social rate of time preference for health. Health Economics 2011;21(5):612-618. Download from Wiley
  • Powdthavee N, van den Berg B. Putting different price tags on the same health condition: Re-evaluating the well-being valuation approach. Journal of Health Economics 2011;30(5):1032-43.
  • Rice N, Robone S, Smith PC. Analysis of the validity of the vignette approach to correct for heterogeneity in reporting health system responsiveness. The European Journal of Health Economics 2011;12(2):141-62.
  • Robone S, Jones AM, Rice N. Contractual conditions, working conditions, health and well-being in the British Household Panel Survey. The European Journal of Health Economics 2011;12(5):429-44.
  • Robone S, Rice N, Smith P. Health systems` responsiveness and its characteristics: a cross-country comparative analysis. Health Services Research 2011;46(6):2079-100.
  • Rodgers M, Epstein D, Bojke L, Yang H, Craig D, Fonseca T, Myers L, Bruce I, Chalmers R, Bujkiewicz S, Lai M, Cooper N, Abrams K, Spiegelhalter D, Sutton A, Sculpher M, Woolacott N. Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. Health Technology Assessment 2011;15(10):1-329. Download from HTA
  • Rodgers M, Soares MEpstein D, Yang H, Fox D, Eastwood A. Bevacizumab in combination with a taxane for the first-line treatment of HER2-negative metastatic breast cancer. Health Technology Assessment 2011;15:Suppl.1.Download from HTA
  • Rogers A, Vassilev I, Sanders C, Kirk S, Chew-Graham C, Kennedy A, Protheroe J, Bower P, Blickem C, Reeves D, Kapadia D, Brooks H, Fullwood C, Richardson G. Social networks, work and network-based resources for the management of long-term conditions: a framework and study protocol for developing self-care support. Implementation Science 2011;6:56(May).
  • Sampat B, Drummond MF. Another special relationship? interactions between health technology policies and health care systems in the United States and the United Kingdom. Journal of Health Politics, Policy and Law 2011;36:119-39.
  • Soares MOBojke L, Dumville J, Iglesias C, Callum N, Claxton K. Methods to elicit experts' beliefs over uncertain quantities: application to a cost effectiveness transition model of negative pressure wound therapy for severe pressure ulceration. Statistics in Medicine 2011;30(19):2363-2380. Download from Wiley
  • Sorenson C, Tarricone R, Siebert M, Drummond MF. Applying health economics for policy decision making: do devices differ from drugs? Europace Spotlight Supplement 2011;13:ii54-ii58.
  • Star SM, Van den Berg B. Individual responsibility and health-risk behaviour: A contingent valuation study from the ex ante societal perspective. Health Policy 2011;101:300-311.
  • Street A, O'Reilly J, Ward P, Mason A. DRG-based hospital payment and efficiency: theory, evidence, and challenges. In: Busse R, Geissler A, Quentin W, Wiley M, editors. Diagnosis Related Groups in Europe: moving towards transparency, efficiency and quality in hospitals. Berkshire, England:Open University Press;2011:p93-114.
  • Sullivan PW, Slejko JF, Sculpher MJ. Catalogue of EQ-5D Scores for the United Kingdom. Medical Decision Making 2011;31(6):800-804.
  • Tarricone R, Drummond MF. Challenges in the clinical and economic evaluation of medical devices:The case of transcatheter aortic valve implantation. Journal of Medical Marketing 2011;11(3):221-29.
  • Towse A, Drummond MF, Sorenson C. Measuring value:pharmacoeconomics theory and practice. London: Office of Health Economics; 2011.
  • Tso P, Culyer AJ, Brouwers M, Dobrow MJ. Developing a decision aid to guide public sector health policy decisions: A study protocol. Implementation Science 2011;6(46).
  • Wagstaff A, Culyer AJ. Four decades of Health Economics through a bibliometric lens. World Bank Policy Research Working Paper Series 2011;5829.
  • Walker S, Burch J, McKenna C, Wright K, Griffin S, Woolacott N. Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: Health Technology Assessment 2011;15:Suppl.1:13-21.
  • Walker S, Sculpher M, Drummond MF. The methods of cost-effectiveness analysis to inform decisions about the use of health care interventions and programmes. In: Smith PC, Glied S, editors. Oxford Handbook of Health Economics. Oxford: Oxford University Press; 2011. p. 733-58.
  • Watson JM, Kang'ombe AR, Soares MO, Chuang LH, Worthy G, Bland JM, Iglesias C, Cullum N, Torgerson D, Nelson EA on behalf of the VenUS III Team. Use of weekly,low dose, high frequency ultrasound for hard to heal venous leg ulcers: the VenUS III randomised controlled trial. BMJ 2011;342. Download from BMJ
  • Watson JM, Kang'ombe AR, Soares MO, Chuang LH, Worthy G, Bland JM, Iglesias C, Cullum N, Torgerson D, Nelson EA on behalf of the VenUS III team. A randomised controlled trial of therapeutic ultrasound in the management of venous leg ulcers. Health Technol Assess 2011;15(13):1-176. Download from HTA
  • Watt M, Mealing S, Eaton J, Piazza N, Moat N, Brasseur P, Palmer S, Busca R, Sculpher M. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart 2011;98:370-76.Download from BMJ
  • Weatherly H, Kirk S, Kyle RG, Callery P. Comparison of costs of acute care by children's community nursing teams Archives of Disease in Childhood 2011;96(Suppl 1):A92.